Quality of life of food allergic patients by Velde, Jantina Lucia van der
  
 University of Groningen
Quality of life of food allergic patients
Velde, Jantina Lucia van der
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Velde, J. L. V. D. (2012). Quality of life of food allergic patients. [S.n.].
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
TiP 1an ,::i Vel ,::i 
�ualih of life of food aller�ic pa ie ts 
Kwaliteit van leven van patienten met voedselallergie 
--
Quality of life of food allergic patients 
The studies described in this thesis were funded by the EU through the Europrevall project 
(FOOD-CT-2005-514000), the Nutricia Research Foundation and the Stichting Astma 
Bestrijding. 
Printing of this thesis was financially supported by the University of Groningen (RuG), the 
Graduate School for Drug Exploration (GUIDE), the University Medical Center Groningen 
(UMCG), Al pro Soya BV, Mead Johnson, ALK Abell6 BV, Phadia BV, Nutricia BV and Stichting 
Astma Bestrijding. 
Quality of Life of food allergic patients 
ISBN: 978-90-367-5871-0 
© J.L. van der Velde, 2012 
All rights reserved. No parts of this publication may be reproduced or transmitted in any 
form or by any means, without permission from the author. 
Cover-design by: Janyte Holwerda, Groningen, the Netherlands 
Lay-out by: Nikki Vermeulen, Ridderprint BV, Ridderkerk, the Netherlands 
Printed by: Ridderprint BV, Ridderkerk, the Netherlands 
Stellingen 
behorend bij het proefschrift 
Quality of life of food allergic patients 
door Tina van derVelde 
1. Door voedselallergie neemt de gezondheidsgerelateerde kwaliteit van !even van 
patienten met voedselallergie af (dit proefschrift). 
2. De voedselallergie en kwaliteit van !even vragenlijsten zijn betrouwbare, valide en 
responsieve instrumenten om kwaliteit van !even bij patienten met voedselallergie te 
meten (dit proefschrift). 
3. Ouders van voedselallergische kinderen (8-12 jaar) onderschatten de impact 
van voedselallergie op de gezondheidsgerelateerde kwaliteit van !even van hun 
voedselallergische kind (dit proefschrift). 
4. De leeftijd van de tiener is een belangrijke voorspeller van verschillen in rapportages 
tussen voedselallergische tieners en hun ouders wat betreft de impact van voedselallergie 
op de kwaliteit van !even van de tiener (dit proefschrift). 
5. De gezondheidsgerelateerde kwaliteit van !even van de meeste patienten met 
voedselallergie verbetert na een dubbelblinde placebogecontroleerde voedselprovocatie 
en de daarop volgende veranderingen in de behandeling (dit proefschrift). 
6. Objectieve maatstaven voor voedselallergie zijn niet zo sterk geassocieerd met 
gezondheidsgerelateerde kwaliteit van !even als subjectieve maatstaven voor 
voedselallergie zoals de risico-inschatting en verwachtingen van de patient met 
betrekking tot de uitkomst van een allergische reactie (dit proefschrift). 
7. Melk is goed voor elk, behalve voor Jan want die krijgt er netelroos van. 
8. Dat is een waarheid als een koe. 
9. De huisarts is de spit van de gezondheidszorg. 
10. Een mens lijdt het meest door het lijden dat men vreest. 
11. Succes is krijgen wat je verlangt. Geluk is houden van wat je hebt. 
12. Eten is genieten. 
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FOOD ALLERGY 
Food allergy is a growing health issue in Western societies and appears to be increasing 
in prevalence from the late 1990s 1• About 6 to 8 percent of children suffer from food al­
lergy in the first year of life. The prevalence then falls progressively and remains stable 
at approximately 3 to 4 percent in adulthood2• There are several theories regarding this 
apparent increase in prevalence. These theories focus on increased hygiene, decreased 
consumption of omega-3 fatty acids, antioxidants or vitamin D, on dual-allergen exposure 
and on food processing. However, the exact cause of this apparent increase in prevalence 
is still unknown3• Any food has the potential to cause allergy, although there are certain 
foods which cause most of them such as milk, egg, peanuts, tree nuts, fish and shellfish. 
Milk allergy and egg allergy are usually outgrown during childhood, whereas peanut al­
lergy and nut allergy are most likely to persist into adulthood4. 
Food allergy is an abnormal immunologically mediated reaction toward food pro­
teins and may be non lgE-mediated (cellular processes involving T cells and eosinophils) 
or lgE-mediated (humoral processes involving mast cells and basophils), whereas food 
intolerances involve all reactions to food that are non-immunologically mediated5• Most 
symptoms of food allergy are caused by mediators released from mast cells and basophils 
and may involve the skin, oro-pharyngeal tract, gastro-intestinal tract, respiratory tract 
and cardiovascular system. The variety of symptoms and allergic reactions is great and the 
disease has an unpredictable nature. People with only mild allergic reactions may have a 
severe and life-threatening reaction on re-exposure6• Food is even the most common trig­
ger of anaphylaxis, which can be fatal7·8• 
At this moment the only proven therapy is to carefully avoid the causal food(s) and 
to provide medication for emergency treatment. Consequently, an accurate diagnosis is 
very important in order to identify which foods should be avoided, followed by proper 
patient education. The most common tools for diagnosing food allergy are physical 
examination, trial elimination diets, skin-prick tests, allergen-specific lgE testing and oral 
food challenges2•9• A Double-Blind Placebo-Controlled Food Challenge (DBPCFC) is the 
gold standard for diagnosing food allergy10• Currently, there is much research on the 
development of improved diagnostic tests 11, which are needed to determine the presence 
and severity of food allergy and to determine whether an allergy is likely to be outgrown 
or not. Additionally, the development of promising novel treatment strategies, such as 
immunotherapy12•13, have caused much excitement. Although immunotherapy has been 
proven to be successful in venom and respiratory allergies14, further research is needed 
before immunotherapy can be used for treating food allergy15• 
Due to the potentially life-threatening and unpredictable nature of food allergy, 
accidental exposure may occur and high levels of anxiety of an allergic reaction may 
exist6• Since there is no cure for food allergy, patients are continuously faced with dietary 
and social restrictions during the day. For example, patients always have to read labels of 
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food products, which may be time consuming and frustrating, especially when labels are 
insufficient. Additionally, there is always a chance of accidental exposure, when ingredients 
of food products are changed or when other people are not aware of the danger of food 
allergy. Thus, the need for taking precautions to prevent allergen exposure and the fear of 
an allergic reaction may have a considerable impact on quality of life 16• 
HEALTH-RELATED QUALITY OF LIFE (HRQL) 
Quality of life is a broad concept and the term is used to evaluate the general well-being 
of individuals. Quality of life can be described as the subjective value a person places 
upon satisfaction with his or her own life17 and includes several different factors such as 
financial, security, freedom, spiritual contentment, quality of environment, education, 
health and the way these factors interrelate 18• As the term quality of life means different 
things to different people in different cultures, many definitions have been attempted to 
define this broad and multi-dimensional concept. Quality of life has been defined by the 
WHO as "the individual's perception of their position in life in the context of the culture 
and value systems in which they live and in relation to their goals, expectations, standards 
and concerns"19 (figure 1 ). 
















The component of overall quality of life that pertains to an individual's health is called 
health-related quality of life (HRQL) and includes the psychological, physical and social 
aspects of one's quality of life that are related to somebody's health. HRQL has been 
defined by the WHO as a state of complete physical, mental and social well-being and 
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not merely the absence of disease 19• Thus, HRQL measures the impact of an illness (and 
its therapy) on a patient as perceived by the patient and consists of aspects considered 
important by patients rather than aspects considered important by doctors (figure 1 ). 
NEED FOR MEASURING HRQL IN FOOD ALLERGY 
There are several reasons for studying HRQL. Firstly, HRQL measurements give clinicians 
insight into the impact of a disease on a patient, from a patients perspective and the 
specific problems a patient has to face. Consequently, clinicians could help food allergic 
patients managing their specific problems. Additionally, some aspects of food allergy that 
are considered important by clinicians (for example, objective clinical outcome measures) 
may not always be the aspects considered important by patients. Moreover, a similar 
level of objective clinical impairment may have a different impact on HRQL in different 
patients, because they vary in their illness perceptions20• HRQL measurements are the 
only systematic scientific way to study these differences in HRQL between patients with a 
similar level of objective clinical impairment and can be used to help each patient coping 
with their food allergy. 
Secondly, HRQL instruments can be used as outcome measure for studying the impact 
of diagnostic or management interventions from the patient's perspective. Especially 
in chronic diseases such as food allergy, HRQL may be of special interest, because there 
is no cure for food allergy and mortality is low. Consequently, such parameters cannot 
be used as outcome measures. Additionally, no appropriate objective clinical outcome 
measure is available in food allergy which reflects the ongoing severity of food allergy 
(such as FEV1 in asthma). One might suggest that the severity of a food allergic reaction 
can be used as an objective clinical outcome measure for some study purposes. However, 
a food allergic reaction only occurs intermittently (when a patient is exposed to a culprit 
food), whereas patients perceive an ongoing burden of food allergy despite the absence 
of objective symptoms between different food allergic reactions. This ongoing burden 
can be measured by HRQL instruments. Consequently, HRQL instruments may be an 
important tool in clinical decision making. 
HOW TO MEASURE HRQL 
Qualitative and quantitative methods 
HRQL can be measured using qualitative methods and quantitative methods. 
Qualitative research is described as the non-numerical examination and interpretation 
of observations, usually using a relatively open structure such as narrative description, 
to discover underlying meanings and patterns and to identify new areas of interest and 
forming hypotheses. In the context of HRQL, quantitative research may be described as 
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the numerical representation of observations to describe and explain HRQL. In order 
to measure HRQL in a quantitative way, validated instruments are needed, because 
they provide precise outcomes. These instruments may be useful outcome measures in 
research or clinical practice21 •22• 
Quantitative methods: Generic and disease-specific instruments 
In order to study HRQL in a quantitative way, a large number of specially designed and 
tested instruments have been developed for measuring HRQL, which can be divided into 
two major types of HRQL instruments: generic HRQL instruments and disease-specific 
HRQL instruments. The type of instrument that is selected for a clinical trial depends on 
the purpose of the study. 
Generic HRQL instruments are intended for general use, irrespective of the disease of 
the patient. These instruments are useful in evaluating and making comparisons between 
different diseases. Disadvantages of these instruments are that they are not targeted to 
issues of particular concern of patients with a specific disease18•20• Consequently, they 
simultaneously measure the impact of co morbid diseases and they are less likely to 
detect smaller differences in HRQL resulting from a particular disease. 
In order to measure HRQL related to a particular disease, disease-specific HRQL 
instruments are significantly more sensitive than generic ones and are therefore more 
likely to detect differences in HRQL resulting from a particular disease. These instruments 
are thus used to investigate and measure disease-specific HRQL problems and are better 
suited as outcome measure evaluating the impact of interventions for specific diseases23. 
Mostly, only one type of instrument is selected for a clinical trial depending on the 
purpose of the study. In food allergy, the indications for choosing one instrument over 
the other, or whether they should be used together, are not known. Therefore, Chapter 2 
discusses the use of generic and disease-specific HRQL in food allergy. 
Quantitative methods: Self- and proxy-reported instruments 
HRQL can be measured by generic or disease-specific HRQL instruments completed by 
patients themselves (self-reports) or by instruments completed by external raters such as 
parents or health-care professionals (proxy-reports). It has been shown that self-reports 
are often poorly or moderately correlated with proxy-reports and that the patient's view 
often differs from the view of external raters. In some conditions external raters tend to 
consistently overestimate HRQL, whereas in other conditions they tend to consistently 
underestimate HRQL. Additionally, external raters may tend to base their HRQL ratings 
primarily on physical signs and more obvious symptoms instead of the impact of 
psychological aspects18• Therefore, self-report is the primary method of assessing the 
subjective aspects of health. Self-reports can be used from the age of 8 years, as these 
children are able to reliably complete self-reported instruments on the subjective aspects 
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of health24•25 and have the necessary language skills and cognitive abilities for accurate self­
reporting. Although self-report is the primary method of assessing HRQL, proxy-reports 
are the only method to measure HRQL in patients who are unable to assess their own 
HRQL such as very young children, very ill patients or cognitively impaired patients26• 
Additionally, proxy-reports may provide additional information to self-report and 
may complete the view on a patient's HRQL. On the other hand, it is important to assess 
the quality of proxy-reporting especially when the parent report is used to provide a 
substitute for the child's response in children who are unable to self report on their health 
(too young, too ill or cognitively impaired). It is thus important to study both self- and 
proxy-reports. Therefore, this is described in chapter Sand 6. 
FOOD ALLERGY AND HRQL: WHAT IS KNOWN? 
The first well-designed study on the impact of food allergy on HRQL was published in 2000 
by Primeau et al.27• Since then, HRQL has gradually become an emerging focus of interest 
in food allergy. The early studies on this topic showed that food allergy has a considerable 
impact on quality of life of both patients and families in a variety of ways6•16•27•33• It was 
shown that the child's food allergy affected meal preparation, school attendance, familial 
activities and social activities outside the home (sleepover, birthday parties)16• If such 
activities are restricted, this may interfere with developing social skills and may for some 
children result in social isolation. It was also shown that general health, parental distress 
and worry of parents of food allergic children were worse than the general population29• 
Comparing food allergy to other diseases, the early studies showed that parents of 
peanut allergic children reported significantly more disruption in daily activities, familial 
problems and social problems than parents of children suffering from rheumatologic 
disease27• Additionally, peanut allergic children reported poorer HRQL and more fear 
than children with insulin dependent diabetes mellitus6• On the other hand, food allergic 
patients showed less impairment in HRQL than patients suffering from chronic liver 
disease or irritable bowel syndrome32• However, these studies used HRQL scales that were 
not validated or measured only a single domain of HRQL. A more recent study showed 
that food allergic patients had poorer generic HRQL than patients with diabetes mellitus, 
but better generic HRQL than patients with asthma, irritable bowel syndrome and 
rheumatoid arthritis34• 
A few studies were performed on factors possibly influencing HRQL in food allergic 
patients. Factors that were associated with poorer HRQL of the child and/or the parent were 
associated atopic disease35•36, a higher number of food allergies16•29•31, female gender30•37, 
and having siblings with food allergy36• Additionally, younger child age was associated 
with greater parental anxiety and stress, despite more direct control over the child's diet at 
younger ages31 • The presence of parent-reported anaphylaxis was associated with greater 
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anxiety levels and family impact31 • However, the opposite has also been shown16• The 
authors suggested that it may be rather the risk of food reactions and measures to avoid 
them that are associated with lower HRQL rather than the clinical reactivity induced by 
food intake36• However, the exact nature of predictors of HRQL in food allergy sti ll needs 
further investigation. 
Although food allergy is usually over-diagnosed by the public, it may be under­
diagnosed by physicians38• Nevertheless, it has been shown that food hypersensitivity 
impairs HRQL regardless of whether the condition had been doctor-diagnosed or not30• 
The authors30 suggested that this might be explained by the fact that a diagnostic test 
that verifies allergy says nothing about the individual's experience of the severity of the 
allergic condition. On the other hand, a diagnostic test ruling out food allergy may prevent 
unnecessary elimination diets and consequently, may reduce unnecessary deterioration 
in well-being and deficient nourishment. Therefore, an accurate diagnosis of food allergy 
is very important and the impact of diagnosis as perceived by the patient needs further 
investigation (Chapter 7). 
Although the first studies on food allergy and HRQL revealed some relevant and 
interesting HRQL issues, these studies also have a couple of limitations. Firstly, most 
studies focused on parents of food al lergic children instead of food allergic children 
or adolescents themselves 16•27•28•30•35 and data on HRQL of food allergic adults were 
scarce27• Secondly, most studies used non validated disease-specific HRQL instruments 
for measuring HRQL6•16•27•30•32 or generic HRQL instruments30•35, because no appropriate 
disease-specific HRQL instruments existed for measuring HRQL in food allergic patients as 
perceived by patient's themselves. 
WHICH FOOD ALLERGY SPECIFIC HRQL INSTRUMENTS WERE 
AVAILABLE? 
A few food allergy specific HRQL questionnaires were available before the start of the 
studies described in this thesis. 
Cohen et al. developed the first disease-specific HRQL instrument in 2004, the Food 
Allergy Quality of Life Parental Burden questionnaire (FAQL-PB)28• This is an internally 
valid, reliable and cross-sectionally valid questionnaire for measuring the parental burden 
of living with a child with food allergy aged 5-1 8 years. However, this instrument is not 
longitudinally validated and focuses on the parent's HRQL, not on the patient's HRQL. 
Additionally, three other preliminary food allergy specific HRQL instruments were 
published6•16•31 • One study assessed the parental adjustment to and coping with children's 
food allergy using the Food Allergy Parent Questionnaire (FAPQ)3 1 • This is a brief condition­
specific measure that screens for parental anxiety, perceived impact of food al lergy, level 
of family support and coping skills. Another study determined the impact of food allergy 
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on the daily activities of food allergic children and their families using the Food Allergy 
Impact Scale (FAIS) 16• This instrument has been developed for children aged 8 months to 
17 years and was designed to determine the impact of food allergy on the daily activities 
of children and their families. Finally, an instrument was developed to compare quality 
of life of food allergic children with children with diabetes mellitus6• However, none of 
these three instruments has been validated6•16•31, which is a very important limitation of 
these studies. Validation is indispensable to determine whether the instrument is really 
measuring what it is supposed to measure. Moreover, the first two instruments focus16•31 
on the parent's wellbeing rather than the child's wellbeing. 
There thus was a need for validated and food allergy specific HRQL instrument's 
focusing on the patient's HRQL39• 
DEVELOPMENT OF THE FOOD ALLERGY QUALITY OF LIFE 
QUESTIONNAIRES (FAQLQS) 
Recently, a number of food allergy specific health-related quality of life questionnaires 
(FAQLQs) were developed4044 in order to measure HRQL of food allergic patients focusing 
on the patient's HRQL. These instruments were developed as part of the Europrevall 
project, a multi-centre research study on food allergy. Different FAQLQs were developed 
for different age-groups, because it has previously been shown that children, adolescents 
and adults are developmentally different45. Therefore, the experience of food allergy and 
its subsequent interventions may differ for each age-group as well. 
The development of the FAQLQs was performed using established methods involving 
several phases46•47• Firstly, all potential items for the new questionnaires were assembled 
using patient interviews, literature search and expert opinion (item generation phase). 
Secondly, the long list with all potentially relevant items was presented to another group 
of food allergic patients in order to select the items which are considered most important 
by patients (item reduction phase). These patients were asked to indicate whether an 
item was applicable to them ("yes" or "no"), and if so, to rate on a five-point scale how 
troublesome that particular item was. Items identified most frequently and rated the 
most important were selected for the final FAQLQs. This method is called the clinical 
impact method48•49• 
In this way three self-administered food allergy specific quality of life questionnaires 
were developed in the Netherlands for measuring food-allergy related quality of life 
in children aged 8-12 years (-Child Form, FAQLQ-CF)40, adolescents aged 13-17 years 
(-Teenager Form, FAQLQ-TF)41 and adults aged ;,: 1 8  years (-Adult Form, FAQLQ-AF)42• 
Additionally, two parent-administered instruments were developed in Ireland and the UK 
for measuring the impact of food allergy on the child's HRQL for parents of food allergic 
children aged 0-12 years (-Parent Form, FAQLQ-PF)43 and adolescents aged 13-1 7 years 
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(-Parent Form, Adolescent version, FAQLQ-PFA)44 respectively. The latter instruments are 
thus proxy-reports on the child's HRQL. 
Each FAQLQ consists of different items and different domains, because some HRQL 
items were regarded as important by specific age-groups, but regarded as unimportant 
and therefore not selected for other age-groups. Some striking similarities and differences 
were shown for children, adolescents and adults40-42• Examples of similar items were: 
"Able to eat fewer products'; "Must always be alert to what you are eating" and "Change 
of ingredients of a food product''. These items were considered important by chi ldren, 
adolescents and adults and therefore included in the FAQLQ-CF, -TF and -AF as well. 
Examples of age-specific items were: the item "Curious about forbidden products" which 
was included only for children, the item "Carrying an epinephrine auto-injector" which 
was only included for adolescents and the item "Incomplete food labels" which was only 
included for adults. 
The FAQLQs are thus disease-specific, age-specific and rater-specific instruments for 
measuring HRQL in food al lergic patients. 
RELIABILI TY AND VALIDITY OF THE FAQLQS 
I n  developing new instruments i t  i s  crucial that these instruments are reliable50 in order 
to ensure that the new instruments are dependable and repeatable. Reliability is the 
degree to which an instrument is free of random error. Classical approaches for examining 
reliability include internal consistency and reproducibil ity. I nternal consistency refers to 
what extent all items in the questionnaire measure the same concept. Internal consistency 
of the FAQLQs was previously measured with Cronbach a40-42• Reproducibil ity measures 
stabil ity over time when no change in condition has taken place. This is usual ly assessed 
using a test-retest study design: Patients, in which no change in condition has taken place, 
complete the questionnaire twice51 • Before the start of this thesis, the test-retest reliabil ity 
of the FAQLQs was unknown. Therefore, the assessment of the reproducibil ity of the 
recently developed FAQLQs is described in chapter 3. 
Additional ly, it is important to determine to what degree it is l ikely that an instrument 
is measuring what it is intended to measure; i.e. to assess the validity of new instruments50• 
Validation is important because the quality of l ife items generated in patients and 
reflecting their areas of concern may not relate to the disease in question. Usual ly, a new 
instrument is compared to the true value, a gold-standard, to make it plausible that the new 
instrument is valid (criterion validity). However, in H RQL research no such a gold standard 
exists to which a new HRQL questionnaire could be compared, because HRQL instruments 
measure presumed constructs that are experimental and subjective18• Therefore, other 
methods should be used to establish validity and other instruments should be used to 
which the new questionnaire can be correlated. For example, convergent and discriminant 
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validity were established by correlating the FAQLQs with generic HRQL questionnaires40-42• 
Convergent validity refers to what extent the new questionnaire correlates with other 
measures that are designed to assess similar constructs. Discriminant validity refers to 
what extent the FAQLQs do not correlate with other measures that are designed to assess 
dissimilar constructs. However, in order to validate the disease-specificity of an instrument, 
generic HRQL instruments are inappropriate to correlate the new instrument with. 
To assess validity in terms of disease-specificity, an independent measure related to 
the burden of symptoms characterising the disease is often used, such as the FEV l in 
asthma, and this independent measure should correlate with the new instrument. This 
is called construct validity. As mentioned previously, no independent outcome measure 
based on symptoms exists reflecting the ongoing severity of food allergy and may even 
be inappropriate because patients are usually symptom free. As it has previously been 
shown that the change in the expected outcome of future allergic reactions as perceived 
by patients, is the source of HRQL changes in anaphylactic disorders52, we developed an 
independent measure capable of measuring these "expectations of outcome" and risk 
perceptions as perceived by the patient. This independent measure is called the Food 
Allergy Independent Measure (FAIM). The questions of the FAIM capture the perceived 
expectation of patients of the chance of accidental exposure and the perception of 
what will happen following accidental exposure. HRQL instruments that were validated 
using the method of expectation of outcome questions have proved to be useful and 
consistent in measuring HRQL in anaphylactic disorders28•46• The development of the FAIM 
is described in chapter 4. 
In order to use the FAQLQs in different cultures, accurate translation and cross cultural 
validation should take place to check the performance of individual items in that language 
and culture using established guidelines53• A summary of the translation and validation of 
the FAQLQ-PFs for use in the Netherlands is described in chapter 5 and 6. 
LONGITUDINAL VALIDITY AND RESPONSIVENESS OF THE FAQLQS 
One of the major goals of disease-specific HRQL-instruments is to determine the impact 
of interventions on HRQL from a patient's perspective. Therefore, HRQL instruments that 
will be used as outcome measures must correlate over time with other relevant measures 
(longitudinal validity) and must be able to measure small but relevant HRQL changes over 
time (responsiveness)54•55• The longitudinal validity and responsiveness of the FAQLQs 
were not yet established at the start of this study. Assessing longitudinal validity and 
responsiveness can be performed in patients in whom HRQL is expected to change 
because of diagnostic or therapeutic interventions. For example, improved diagnosis, 
counseling and expert dietary guidance are interventions that are expected to change 
HRQL of food allergic patients. Chapter 7 describes the longitudinal validation and 
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responsiveness of the FAQLQ-CF, -TF and -AF using a Double-Blind Placebo-Controlled 
Food Challenge (DBPCFC) and its subsequent changes in management as an intervention. 
IMPACT OF DOUBLE-BLIND PLACEBO-CONTROLLED FOOD 
CHALLENGES (DBPCFC) 
Since the only available treatment for food allergy is strict avoidance of the culprit foods, 
an accurate diagnosis is very important to identify which foods should be avoided. 
Additionally, an accurate diagnosis ruling out food allergy may prevent unnecessary 
elimination diets and consequently, may reduce unwanted and unnecessary deterioration 
in HRQL, anxiety and deficient nourishment. A Double-Blind Placebo-Controlled Food 
Challenge (DBPCFC) is thus an important tool in the management of food allergy. A 
DBPCFC is considered to be a time-consuming process and suspected to be potentially 
burdensome and stressful to patients, because potential severe reactions may occur 
during food challenge. Although some studies have recently been published describing 
the impact of a DBPCFC on the child from the parent's perspective55 .oo, the impact of 
undergoing a DBPCFC from the patients' perspective remains unclear. It is thus important 
to study the impact of a DBPCFC on HRQL from the patient's perspective. 
The recently published studies55·60 on the parent's perspective of the impact of their 
child's food challenge, showed that the child's HRQL improved significantly'13, that 
parental concerns56•57 and anxiety60 were reduced and that most of the parents were 
satisfied57 following a food challenge irrespective of the outcome. The authors suggested 
that these improvements in HRQUwellbeing were caused by the fact that a definitive 
diagnosis provides a sense of certainty55•56, because uncertainty and lack of information 
were considered to be more worrisome than fear of the challenge procedure. However, 
the impact of a DBPCFC on HRQL from the patient's perspective still remains unclear. 
Therefore, this is described in chapter 7. 
AIMS OF THIS THESIS 
This thesis continues the studies on the development and cross-sectional validation of the 
FAQLQ-CF, -TF and -AF published by Flokstra-de Blok et al.40-42, the FAQLQ-PF published 
by Dunn Galvin et al43 and the FAQLQ-PFA44• The aim of this thesis was to assess some 
important psychometric properties (reliability, longitudinal validity and responsiveness) 
of the FAQLQs for children, adolescents and adults and to translate and validate the 
FAQLQ-PF and FAQLQ-PFA for use in the Netherlands. Additionally, the instruments were 
used to get insight into different aspects of the HRQL of food allergic patients such as 
differing views between parents and their children on the child's HRQL and to evaluate 
the impact of a DBPCFC from the patient's perspective. 
General Introduction I 23 
OUTLINE OF THIS THESIS 
In Chapter 2 the terms generic and disease-specific HRQL are introduced in the context 
of food allergy. A comparison is made between generic and disease-specific HRQL of 
food allergic children, adolescents and adults using generic and disease-specific HRQL 
instruments. Additionally, suggestions are given for choosing one instrument over the 
other. 
Chapter 3 is the first article of this thesis concerning the psychometric properties of 
the FAQLQs. This chapter describes the reliability of the FAQLQ-CF, -TF and -AF using a test­
retest reliability study design. 
Chapter 4 is related to the validation of the FAQLQs and describes the development 
of the instrument we used for validation of the FAQLQs. This instrument is called the 
Food Allergy Independent Measure (FAIM), which is based on the perceived risks and 
expectations of patients concerning the outcome of an allergic reaction. Such risk 
perceptions and expectations are known to be important predictors of HRQL and should 
therefore correlate with HRQL. Such a correlation makes the validity of the FAQLQs, which 
is an ongoing process, more likely. 
Chapter S gives insight into differing views between parents and their food allergic 
children on the child's HRQL. Additionally, a summary of the translation and validation 
process of the FAQLQ-PF for use in the Netherlands is described. 
In line with the previous chapter, chapter 6 describes disagreement in views between 
parents and adolescents regarding the adolescent's HRQL. Food allergic adolescents 
require special attention and need to be analyzed separately, because adolescents are 
developmentally different, behave differently, use different coping strategies and are of 
greatest risk for anaphylaxis. Do differences in views between parents and adolescents on 
the adolescent's HRQL give additional insight into the problems adolescents have to cope 
with? 
In chapter 7 the longitudinal validity and the responsiveness of the FAQLQs are 
demonstrated. Additionally, the impact of a DBPCFC on HRQL as perceived by the patient 
is described. 
Finally, in chapter 8 the results of the previous chapters are discussed resulting in an 
overview of this thesis. Additionally, implications for future research will be given. 
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ABSTRACT 
Objective: Health-Related Quality of Life (HRQL) has never been measured with both 
generic and disease-specific questionnaires in the same group of food allergic patients. 
The aim of this study was to compare HRQL of food allergic patients as measured with 
generic and disease-specific questionnaires. 
Methods: Generic questionnaires (CHQ-CF87 and RAND-36) and disease-specific HRQL 
questionnaires (FAQLQ-CF, -TF and -AF) were completed by 79 children, 74 adolescents 
and 72 adults with food allergy. Floor and ceiling effects, percentage of agreement and 
multivariate stepwise regression analysis were used to compare the generic and disease­
specific measurements. 
Results: The FAQLQs showed minimal floor or ceiling effects. The CHQ-CF87 and RAND-36 
showed minimal floor effects, but remarkable ceiling effects (>73%) were found for the 
scales role functioning-emotional (RE), role functioning-behaviour (RB), role functioning­
physical (RP) in children and adolescents and the scale RE (>79%) in adults. Additionally, 
we found low percentages of agreement between the generic and disease-specific 
questionnaires to identify the same food allergic patients with the best or worst HRQL. 
Only patients with the best disease-specific HRQL also tended to have the best generic 
HRQL. Finally, the explained variance in HRQL by patient characteristics was higher in 
the disease-specific questionnaires (30.7% to 62.8%) than in the generic scales (6.7% to 
31.7%). 
Conclusions: Disease-specific HRQL questionnaires may be more suitable to measure 
clinically important impairments in HRQL or HRQL differences over time in food allergic 
patients. However, generic HRQL questionnaire are indispensable for the comparison 
between different diseases and are thus complementary. 
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INTRODUCTION 
Although food allergic patients may experience symptoms only intermittently, they must 
maintain a high degree of vigilance in order to prevent exposure to foods to which they 
are allergic. This may be a great burden to themselves and their families1 •2• Despite taking 
precautions, there is always a chance of accidental exposure and for some patients such 
exposure may be fatal3• Consequently, food allergy has a significant impact on health­
related quality of life (HRQL}4• 
HRQL can be measured with two types of questionnaires: generic and disease-specific 
questionnaires. Generic questionnaires can be used to evaluate and compare different 
diseases. The disadvantages of generic questionnaires are that they may not focus 
adequately on problems specific to a particular disease and that they simultaneously 
measure the impact of comorbid diseases. Disease-specific instruments, as their name 
implies, are targeted to a specific disease. These disease-specific questionnaires are 
more likely to detect clinically important impairments specific for a particular disease 
or HRQL differences over time. However, disease-specific questionnaires do not allow 
direct comparison between different diseases5• In food allergy, HRQL is the only available 
measure that reflects the ongoing perceived severity of this disorder, since no objective 
disease parameters are available that reflect the ongoing severity6. 
In food allergy research, a number of studies have investigated the impact of food 
allergy on HRQL7-15• Only one of these studies used both generic and disease-specific 
questionnaires in food allergic children 13• However, the disease-specific questionnaire 
used in that study was not assessed for validity and reliability. Since valid and reliable 
self-administered disease-specific HRQL questionnaires for food allergic patients have 
become available only recently16-19, the administration of both generic and disease­
specific instruments to the same population of food allergic patients is now possible. 
Therefore, the aim of this study was to investigate the impact of food allergy on HRQL 
as measured with generic and disease-specific questionnaires in children (8 to 12 years), 
adolescents (13 to 17 years) and adults � 18 years). 
METHODS 
Participants 
The children (8-12 years), adolescents (13-17 years) and adults � 18 years) that participated 
in the present study were part of the studies on the cross-sectional validation of the 
Food Allergy Quality of Life Questionnaire-Child Form, -Teenager Form and -Adult Form 
(FAQLQ-CF, -TF and -AF) 17-19. These participants had a physician-diagnosed food allergy for 
at least one food, and were recruited from our outpatient (paediatric) allergy clinic or were 
recruited through food allergy support organisations (the Dutch Foundation for Food 
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Allergy and the Dutch Anaphylaxis Network) and by advertisement in local newspapers. 
Forty-seven children (59%), 43 adolescents (58%) and 42 adults (58%) were recruited from 
our allergy outpatient clinic. The food allergy was confirmed by a double-blind placebo­
controlled food challenge (DBPCFC) in 25 children (31 %), 1 9  adolescents (26%) and 1 4  
adults (1 9%). The other patients had a physician-diagnosed food allergy based o n  history 
and skin prick and/or blood test. The majority of them were awaiting a DBPCFC. All patients 
recruited by advertisement (32 children [41 %], 3 1  adolescents [42%] and 30 adults [42%] ) 
reported physician-diagnosed food allergies. The most common types of food allergies 
and different types and severities of symptoms were represented in the study sample. The 
study was reviewed by the local medical ethical committee (METc 2005/05 1 )  who deemed 
that approval was not needed. 
Procedure 
The HRQL questionnaires (the age appropriate generic and disease-specific questionnaire), 
the Food Allergy Independent Measure (FAIM)20 and descriptive questions on age, sex, 
type and number of food allergies, type of symptoms and diagnosis were sent by mail 
to be completed at home. Participants were not paid for their participation. The children 
(8 to 1 2  years) and their parents were instructed that the children should fill out the 
questionnaires by themselves. Parents were allowed to explain a question when needed, 
but they were not allowed to tell the child which answer to give. For completing the 
descriptive questions parents were allowed to help their child when needed. The FAIM 
measures the patients' perceived expectation of outcome. It was used as a validation 
measure in the studies on the development and validation of the FAQLQs 17•19_ 
Questionnaires 
Generic HRQL questionnaires 
I n  children and adolescents, the Child Health Questionnaire-Child Form (CHQ-CF87) was 
administered21 •22• This questionnaire is self-administered by the child and contains 87 
items divided into twelve scales (Table 1 ). After recoding the raw scores, scale scores are 
computed and transformed into a 1 00-point scale. Higher scores indicate better HRQL. 
In adults we administered the RAND-36, which is the Dutch translation of the MOS 
36-item Short-Form Health Survey23•24. The RAND-36 consists of 36 items divided into nine 
scales (Table 1 ). After recoding the raw scores, scale scores are computed and transformed 
into a 1 00-point scale. Higher scores indicate better HRQL. 
1 
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Table 1 .  Scales of the generic and disease-specific HRQL questionnaires, number of items and the 
mean (SD) score in food allergic patients 
HRQL questionnaires Abbreviation No. of Mean (SD) 
Domain items 
CHQ-CF871 (Children and adolescents) Children Adolescents 
Physical functioning PF 9 96.0 (8.2) 94.4 ( 1 0.5) 
Role functioning-emotional RE 3 94.9 (14.3) 91 .4 ( 1 8.4) 
Role functioning-behaviour RB 3 95.1 (1 2.7) 94.3 ( 1 5.4) 
Role functioning-physical RP 3 94.9 (14.2) 92.9 (20.9) 
Bodily pain BP 2 76.8 (24.7) 70.0 (23.3) 
General behaviour BE 1 7  84.0 (1 2.5) 80.6 (1 0.4) 
Mental health MH 16  78.5 (1 3.1 ) 74.6 (1 3.7) 
Self-esteem SE 14 79.4 (1 3.8) 70.8 (14.4) 
General health GH 1 2  72.0 (1 9.2) 64.4 (1 8.8) 
Family activities FA 6 86.9 (1 4.7) 84.8 ( 1 6. 1 )  
Family cohesion FC 80.9 (1 8.6) 73.4 (21 .3) 
Change in health' CH 
RAND-36 (SF-36)1 (Adults) Adults 
Physical functioning PF 1 0  86.1 (1 8.9) 
Social functioning SF 2 75.5 (23.8) 
Role functioning-physical RP 4 70.8 (40.2) 
Role functioning-emotional RE 3 83.8 (34.0) 
Mental health MH 5 75.2 (16.1 ) 
Vitality VT 4 60.1 (1 9.0) 
Bodily pain BP 2 79.4 (22.4) 
General health GH 5 56.8 (23.1) 
Change in health' CH 
FAQLQ-CF3 (Children) 24 3.96 (1 .41 )  
Allergen avoidance AA 7 3.62 (1 .56) 
Risk of accidental exposure RAE 5 4.1 8 (1 .73) 
Emotional impact El 6 4.00 (1 .70) 
Dietary restrictions DR 6 4.21 (1 .56) 
FAQLQ-TF3 (Adolescents) 23 4.1 5 ( 1 . 18) 
Allergen avoidance and dietary AADR 1 0  3.96 (1 .38) 
restrictions 
Risk of accidental exposure RAE 6 4.1 9 (1 .30) 
Emotional impact El 7 4.40 (1 .47) 
FAQLQ-AF3 (Adults) 29 4.48 (1 .3 1 )  
Allergen avoidance and dietary AADR 1 1  4.90 (1 .37) 
restrictions 
Risk of accidental exposure RAE 8 4.34 (1 .44) 
Emotional impact El 7 4.47 ( 1 .61)  
Food allergy related health FAH 3 3.78 (1 .73) 
The CHQ-CF87 and RAND-36 (SF-36) scores are based on a 1 00-point scale, where 1 00 is the best possible 
score (best HRQL). 
2 Not used in this study. 
The FAQLQ-CF, -TF and -AF scores are based on a 7-point scale, where 1 is the best possible score (best HRQL). 
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Disease-specific HRQL questionnaires 
The d isease-specific HRQL questionnaires used in this study were the FAQLQ-CF for 
children aged 8-12  years, the FAQLQ-TF for adolescents aged 1 3-1 7 years and the FAQLQ­
AF for adults aged 1 8  years and older11-19• All three questionnaires were validated in the 
Netherlands and showed excellent reliabil ity25• These questionnaires consist of 24, 23 and 
29 items, respectively, divided into 4, 3 and 4 domains (Table 1 ). The raw FAQLQ scores O to 
6 were recoded as 1 to 7. The total score is the mean of a l l  items of each questionnaire and 
ranges from 1 (minimal impairment of HRQL) to 7 (maximal impairment of HRQL). Thus 
higher scores indicate poorer HRQL. 
Statistical analysis 
Statistical analyses were performed with SPSS for Windows 1 4.0 (SPSS Inc., Chicago, IL, 
USA). Domain scores for the CHQ-CF8721 and RAND-3623 were calculated and total scores 
and domain scores were calculated for the FAQLQs17 19. Additional ly, floor and ceiling 
effects (percentage of patients with the minimal or maximal score, respectively) of the 
generic and disease-specific questionnaires were investigated. The floor and ceiling of the 
generic CHQ-CF87 and RAND-36 were a score of O and 1 00, while these were a score of 1 
and 7 for the disease-specific FAQLQs. To investigate whether generic and disease-specific 
HRQL questionnaires identify the same patients, we identified the 1 0% of patients with 
the best HRQL and the 1 0% of patients with the worst HRQL as measured with the generic 
and disease-specific questionnaires and compared these. Final ly, to investigate the extent 
to which patient characteristics explain generic and disease-specific HRQL, we performed 
multivariate stepwise regression analysis. The disease-specific FAQLQs and two scales 
of the generic CHQ-CF87 and RAND-36 were used as dependent variables. The patient 
characteristics were used as independent variables. Adjusted R2 was used to describe 
the degree of variance in HRQL explained by the model in percentage. We choose the 
two generic scales with the highest and the lowest correlation with the disease-specific 
FAQLQs11-1 9, because these scales indicate the generic scales with the most and least 
agreement with the disease-specific FAQLQs, respectively. 
RESULTS 
Participants 
The questionnaire packages including the FAQLQs and the age appropriate generic HRQL 
questionnaires were sent to 31 2 participants divided over the three age groups. Response 
rates were high: children 84/1 1 4  (73%), adolescents 75/98 (77%) and adults 80/1 00 (80%). 
A few returned questionnaires were excluded from the analysis because a) no current food 
allergies were reported (three children and one adult) or b) no physician-diagnosed food 
allergy was reported (seven adults) or c) the descriptive characteristics were missing (one 
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child and one adolescent) or d) the generic questionnaire was not completed (one child). 
Therefore, 225 participants were included in the final analysis. The mean (SD) scores of 
the CHQ-CF87, RAND-36 and FAQLQs are shown in Table 1. Table 2 shows the descriptive 
characteristics of the participants. 
Table 2. Descriptive characteristics of the food allergic participants. 
Children Adolescents Adults 
Patients, n 79 74 72 
Sex, m/f 45/34 34/40 1 8/54 
Age, mean (SD), years 1 0.2 (1 .3) 14.7 (1 .3) 37.2 (1 4.3) 
Age range (years) 8-1 2  1 3- 1 7  1 8-72 
Type of food allergies, n (%) 
Peanut 59 (74) 57 (77) 42 (58) 
Tree nut 57 (72) 56 (76) 42 (58) 
Egg 29 (37) 26 (35) 16 (22) 
Milk 22 (28) 29 (39) 19 (26) 
Fish 2 (3) 1 3  ( 18) 1 1  (1 5) 
Shell fish 7 (9) 12 ( 16) 1 2  (1 7) 
Wheat 1 0 ( 13) 5 (7) 12 ( 17) 
Sesame 1 4 ( 18) 8 (1 1 )  1 3  ( 18) 
Soy 1 2  ( 15) 1 7  (23) 13 (1 8) 
Celery 1 ( 1 )  3 (4) 1 1  ( 15) 
Fruits 29 (37) 38 (51 )  35 (49) 
Vegetables 1 4 ( 18) 22 (30) 27 (38) 
Other' 1 5  ( 19) 20 (27) 30 (42) 
Number of food allergies, n (%) 
1 food 1 5  ( 19) 9 (1 2) 1 2  (1 7) 
2 foods 1 6 (20) 12 ( 16) 1 4 ( 19) 
3 foods 1 6 (20) 15 (20) 8 (1 1 )  
> 3  foods 32 (41 )  38 (51 )  38 (53) 
Type of symptoms, n (%) 
Cardiovascular symptoms2 28 (35) 31 (58) 44 (61 )  
Respiratory symptoms' 56 (71 )  6 1  (82) 60 (83) 
Gastrointestinal symptoms• 49 (62) 47 (64) 48 (67) 
Skin symptoms' 69 (87) 60 (81 ) 55 (76) 
Other6 66 (84) 66 (89) 62 (86) 
' E.g. lupine, kernels and seeds, herbs and spices, meat. 
2 dizziness, feeling your heart beat fast, loss of vision, inability to stand, light headedness, collapse, loss of 
consciousness / passing out 
3 tightening throat, difficulty swallowing, hoarseness / hoarse voice, difficulty breathing in, shortness of breath, 
wheezing, cough 
4 nausea, stomach cramps, vomiting, diarrhea 
5 itchy skin, red rash, urticaria, worsening eczema, swelling of the skin 
6 oral allergy, swollen tongue or l ips, symptoms of the nose or eyes 
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Floor and ceiling effects 
In children, the CHQ-CF87 showed almost no floor effects because the minimal score 
(worst HRQL) was seldom reported (Table 3). However, remarkable ceiling effects were 
seen for the scales role functioning-emotional (RE), role functioning-behaviour (RB) and 
role functioning-physical (RP) where more than 80% of the children reported the maximal 
score (best HRQL). A similar pattern was seen in adolescents. In adults, the RAND-36showed 
some floor effects (worst HRQL), and pronounced ceiling effects (best HRQL), especially for 
the scale RE (79%). The disease-specific FAQLQs and domains showed minimal if any floor 
or ceiling effects, indicating that almost no food allergic patients reported the minimal 
FAQLQ score (best HRQL) or maximal FAQLQ score (worst HRQL), respectively. This indicates 
that these questionnaires are potentially longitudinally responsive to the specific concerns 
of food allergic patients and it underscores the internal validity of these questionnaires. 
Table 3. Percentage offloor and ceiling effects of the CHQ-CF87, RAND-36 and FAQLQ-CF, -TF and -AF 
Children Adolescents 
Floor % Ceiling % Floor % 
CHQ-CF87 CHQ-CF87 
PF 0 64.8 PF 0 
RE 1 .3 8 1 .0 RE 1 .4 
RB 0 82.3 RB 0 
RP 0 86.1 RP 2.7 
BP 0 41 .8 BP 1 .4 
BE 0 5.1 BE 0 
MH 0 2.6 MH 0 
SE 0 6.3 SE 0 
GH 0 3.8 GH 0 
FA 0 3 1 .6 FA 0 
FC 0 25.3 FC 0 
FAQLQ-CF 1 .3 0 FAQLQ-TF 0 
AA 1 .3 0 AADR 0 
RAE 2.5 3.8 RAE 1 .4 
El 5.1 1 .3 El 0 
DR 2.5 2.5 
Floor effect = percentage of patients with minimal score. 


















Floor % Celling % 
RAND-36 
PF 0 26.0 
SF 1 .4 23.0 
RP 1 9.4 58.3 
RE 1 1 .1 79.2 
MH 0 2.8 
VT 0 1 .4 
BP 0 37.5 
GH 0 2.8 
FAQLQ-AF 1 .4 0 
AADR 2.8 0 
RAE 1 .4 1 .4 
El 1 .4 1 .4 
FAH 6.9 4.2 
Floor and ceiling of CHQ-CF87 and RAND-36 are score 0 (worst HRQL) and 1 00 (best HRQL), respectively. Floor 
and ceiling of the FAQLQ-CF, -TF and -AF are score 1 (best HRQL) and 7 (worst HRQL), respectively. 
PF=Physical functioning, RE=Role functioning-emotional, RB=Role functioning-behaviour, RP=Role functioning­
physical, BP=Bodily pain, BE=General behaviour, MH=Mental health, SE=Self-esteem, GH=General health, 
FA=Famlly activities, FC=Family cohesion, SF=Social functioning, VT =Vitality, AA=Allergen avoidance, RAE=Risk 
of accidental exposure, El=Emotional impact, DR=Dietary restrictions, AADR=Allergen avoidance and dietary 
restrictions, FAH=Food allergy related health 
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Percentage of agreement 
Disease-specific questionnaires as starting point 
Table 4 shows the percentage of agreement of the 10% of patients with the worst or best 
HRQL identified by the disease-specific FAQLQs. For example, of the 10% of children with 
the worst disease-specific HRQL measured with the FAQLQ-CF, 25% of them also had the 
worst generic HRQL as measured with the CHQ-CF87 scale physical functioning (PF). The 
agreement between the 10% of patients with the best disease-specific HRQL and best 
generic HRQL was generally higher than the agreement between the 10% of patients with 
the worst disease-specific HRQL and worst generic HRQL. 
Table 4. Percentage of agreement of the 1 0% of patients with the worst1 or best2 HRQL identified 
by the disease-specific questionnaires. 
CHQ-CF87 
PF RE RB RP BP BE MH SE GH FA FC 
FAQLQ-CF 
Worst', % 25 38 1 3  1 3  1 3  1 3  25 so 25 1 3  0 
Best', % 63 75 75 88 63 1 3  1 3  1 3  0 38 1 3  
FAQLQ-TF 
Worst', %  14  14  1 4  14  1 4  29 29 57 1 4  29 1 4  
Best', % 71 1 00 1 00 100 43 29 29 43 1 4  71 43 
RAND-36 
PF SF RP RE MH VT BP GH 
FAQLQ-AF 
Worst', % 14  43 43 43 29 29 14  0 
Best', % 14  14  7 1  71  29 0 14  0 
1 Worst = the 10% of patients with the h ighest scores on the FAQLQs, thus the worst HRQL 
Best = the 1 0% of patients with the lowest scores on the FAQLQs, thus the best HRQL 
PF=Physical functioning, RE=Role functioning-emotional, RB=Role functioning-behaviour, RP=Role functioning-
physical, BP=Bodily pain, BE=General behaviour, MH=Mental health, SE=Self-esteem, GH=General health, 
FA=Family activities, FC=Family cohesion, SF=Social functioning, VT =Vitality. 
Generic questionnaires as starting point 
When taking the generic questionnaires as starting point, we found that of the 10% of 
children with the worst HRQL measured with the CHQ-CF87 scales, 0% (FC) to 44% (RP) 
of them also had the worst disease-specific HRQL as measured with the FAQLQ-CF. Of 
the 10% of adolescents with the worst HRQL measured with the CHQ-CF87 scales, 11 % 
(RE) to 57% (SE) of them also had the worst disease-specific HRQL as measured with the 
FAQLQ-TF. Of the 10% of adults with the worst HRQL measured with the RAND-36 scales, 
14% (PF) to 44% (VT) of them also had the worst disease-specific HRQL as measured with 
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the FAQLQ-AF. However, it was not possible to accurately identify the 1 0% of patients with 
the best HRQL for the majority of CHQ-CF87 or RAND-36 scales, because many patients 
scored the maximal score of 1 00, which indicates the best generic HRQL (see also Table 3 
on ceiling effects). 
Table 5. Results of the multivariate regression analysis of the disease-specific and generic HRQL 
questionnaires. 
Children 
Explained variance, %1 
Intercept 
Mean FAIM 
Severity of symptoms 
Number of food a l lergies 
Adolescents 
Explained variance, %' 
Intercept 
Mean FAIM 
Severity of symptoms 
Number of food allergies 
Adults 
Explained variance, %' 
Intercept 
Mean FAIM 
Severity of symptoms 
Number of food allergies 
1 based on adjusted R2 
















0.83 (p<0.001 ) 






-3.3 (p=0.01 9) 
n.s. 












-8.5 (p<0.001 )  
4.6 (p=0.002) 
n.s. 


















FA=Family activities, PF=Physical functioning, RE=Role functioning-emotional, MH=Mental health, 8P=8odily 
pain. 
Generic and disease-specific HRQL explained by patient characteristics 
The explained variance in HRQL was higher in the disease-specific questionnaires, ranging 
from 30.7% for the FAQLQ-TF to 62.8% for the FAQLQ-AF, than in the generic scales (Table 
5). Even in the generic scales that correlated the best with the FAQLQs, family activities (FA) 
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in children and adolescents and mental health (MH) in adults respectively, the explained 
variance in HRQL was lower than in the disease-specific questionnaires, ranging from 
14.5% for FA in children to 26.2% for MH in adults. 
In the disease-specific FAQLQs the mean FAIM had the most pronounced association 
with HRQL (higher score indicates greater impact on HRQL). This was also seen in the 
generic FA and MH scale, but here the association was negative since a higher score on 
the generic questionnaires indicates a better HRQL. Interestingly, having more severe 
symptoms was associated with a better MH score in adults. Type of food allergy, defined as 
a dichotomous variable peanut allergy versus other food allergies, showed no significant 
association with HRQL (not shown). 
DISCUSSION 
In this study we found very high ceiling effects for some scales of the generic 
questionnaires. No significant floor or ceiling effects were found for the disease-specific 
FAQLQs. Additionally, we found generally low percentages of agreement between the 
generic and disease-specific questionnaires in the identification of the same food allergic 
patients with the best or worst HRQL. Only patients with the best disease-specific HRQL 
also tended to score the best generic HRQL. Finally, the explained variance in HRQL by 
patient characteristics was higher for the disease-specific questionnaires than for the 
generic scales. 
One of the disadvantages of generic questionnaires is that they are by design 
comprehensive, so they may not focus adequately on problems specific to a particular 
disease. In the current study, we found very high ceiling effects for some scales of the 
generic questionnaires, which indicate that a substantial part of the food allergic patients 
reported no problems in these areas. Thus, some areas measured by generic questionnaires 
are irrelevant to food allergy. Generic questionnaires may therefore be not useful for 
measuring disease-specific clinically important impairments in HRQL or HRQL differences 
over time in food allergic patients. In contrast, no significant floor or ceiling effects were 
observed for the disease-specific FAQLQs. This indicates that these questionnaires are 
potentially longitudinally responsive to the specific concerns of food allergic patients and 
it underscores the internal validity of these questionnaires. 
Furthermore, we found that patients with the best disease-specific HRQL also tended 
to score the best generic HRQL (high percentage of agreement). However, patients 
with the worst disease-specific HRQL do not always have the worst generic HRQL (low 
percentage of agreement). A possible explanation is that coping strategy differences 
may modify scores in severely affected patients, while this is not the case in relatively 
unaffected patients. The same result was found when comparing the RAND-36 with 
disease-specific questionnaires in patients with diabetes mellitus type 126• Again, this 
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low percentage of agreement suggests that the disease-specific questionnaires are 
more capable of capturing the specific aspects that impair HRQL in a food allergy than 
the broader generic questionnaires. This implies that if one wishes to identify or select 
food allergic patients with the worst HRQL, the type of questionnaire will influence which 
patients are identified26• 
When looking at the results of the regression analyses, we found that the FAIM had a 
more pronounced association with HRQL than the clinical patient characteristics such as 
severity of symptoms and number of food allergies. Even the type of food allergy showed 
no association with HRQL. This underlines our premise published earlier that objective 
parameters in food allergy are not as closely linked to HRQL of food allergic patients 
as the FAIM scores6, and that these objective measures are thus less appropriate as an 
independent measure for the development of HRQL instruments in food allergy2°. 
Although generic HRQL questionnaires may be not as sensitive as disease-specific 
questionnaires, the advantages of generic questionnaires is that they can be used to 
compare patients with the general population and that they can be used to compare 
different diseases27• In a previous study we showed that, in general, food allergic patients 
reported poorer HRQL than the general population. Additionally, it was shown that 
generic HRQL was more impaired in food allergic patients than in patients with diabetes 
mellitus type I, but less impaired than in patients with asthma, irritable bowel syndrome 
and rheumatoid arthritis28• Therefore, the effect of an intervention in food allergy may be 
best evaluated by using both generic and disease-specific HRQL questionnaires, as the 
FAQLQs may be more sensitive to detect disease-specific clinically important impairments 
in HRQL or HRQL differences over time, whereas generic HRQL questionnaires allow for 
comparison between different diseases which may be relevant in comparative economic 
analysis29• 
In conclusion, the very high ceiling effects that were found for some generic scales may 
indicate that generic HRQL questionnaires are not sufficiently responsive in food allergy to 
measure disease-specific but potentially clinically important impairments in HRQL or HRQL 
differences over time. This finding was further supported by the low agreement between 
the generic and disease-specific questionnaires to identify food allergic patients with the 
best or worst HRQL, as well as the higher explained variance in HRQL by characteristics 
of food allergic patients in the disease-specific questionnaires than in the generic scales. 
Therefore for measuring disease-specific clinically important impairments in HRQL or 
HRQL differences over time in food allergic patients, it may be preferable to use disease­
specific HRQL questionnaires. However, generic HRQL questionnaire are indispensable for 
the comparison between different diseases and are thus complementary. 
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ABSTRACT 
Objective: The self-administered Food Allergy Quality of Life Questionnaire-Child Form 
(FAQLQ-CF), -Teenager Form (FAQLQ-TF) and -Adult Form (FAQLQ-AF) were recently 
developed within EuroPrevall, a multi-centred study of food allergy in Europe. The primary 
aim of this study was to evaluate the test-retest reliability of the FAQLQ-CF, -TF and -AF. 
Methods: One-hundred-and-one Dutch patients (31 children, 34 adolescents and 36 
adults) completed the FAQLQ twice with a 1 0-14 day interval. The intraclass correlation 
coefficient (ICC), Lin's concordance correlation coefficient (CCC) and Bland-Altman plots 
were used to assess test-retest reliability. 
Results: Test-retest reliability was excellent with ICCs and CCCs above 0.907, 0.975 and 
0.951 for the FAQLQ-CF, -TF and -AF, respectively. Bland Altman plots showed that the 
mean differences of the test and re-test were al l  close to zero for the FAQLQs. 
Conclusions: The FAQLQs are reliable over a short time interval. The FAQLQs are not only 
promising tools for group comparison studies, but also for monitoring individual patients. 
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INTRODUC TION 
Food allergy affects almost 4 % of the general population in westernized countries1 and 
it is the primary cause of anaphylaxis presenting to emergency departments2• The only 
proven therapy is careful avoidance of the causal food(s} and provision of medication 
for emergency treatment3• Consequently, patients often fear an allergic reaction and are 
continuously faced with dietary and social restrictions in their daily lives, which can have 
a negative impact on quality of life4•1 1 • 
To measure Health-Related Quality of Life (HRQL}, disease-specific questionnaires 
are significantly more sensitive than generic ones and they are important for estimating 
the general burden of food allergy as well as measuring the response to interventions or 
future treatments. However, generic HRQL instruments allow comparison of the burden 
of disease between patient populations with different diseases 12• Recently, as part of the 
EuroPrevall project, the first self-administered HRQL questionnaires specific for food allergy 
have been developed and validated; the Food Allergy Quality of Life Questionnaire-Child 
Form, -Teenager Form and -Adult Form (FAQLQ-CF, -TF, -AF}. The FAQLQs showed good 
validity, internal consistency and discriminative abilities13'16, but test-retest reliability was 
not extensively investigated. 
Reliability measures are important to ensure that what the questionnaire is measuring 
is dependable and repeatable12 and allow sample sizes to be determined for clinical 
trials 17• The aim of this study was therefore to assess the test-retest reliability of the self­
administered FAQLQ-CF, -TF and -AF. 
METHODS 
Patients 
We contacted Dutch children (8-12 years}, adolescents (13-17 years} and adults � 18 years} 
with food allergy, who were recruited from our clinic or by advertisement. We included 
patients with the most prevalent food allergies. 
Questionnaires 
The FAQLQ-CF contains 24 items and 4 domains, the FAQLQ-TF contains 23 items and 3 
domains and the FAQLQ-AF contains 29 items and 4 domains13•15• Following the guidelines 
of other established RHQL studies, each item is scored on a scale ranging from 1 (minimal 
impairment in HRQL} to 7 (maximal impairment in HRQL}18-19• The total FAQLQ score is the 
sum of all the items divided by the number of items. 
Procedures 
We sent the FAQLQs by mail to be completed at home. Regarding the FAQLQ-CF, 
parents were instructed that they were allowed to explain a question when needed, 
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but they were not allowed to tell the child which answer to give. All patients who 
completed the first questionnaires (test) received the second questionnaires (re-test) 
1 0- 14 days after completion of the first. Patients who did not respond in time were 
excluded from the study20,21 as well as patients who reported a clinically important 
change in disease between the measurements or within two months before the study. 
We defined a clinically important change in disease which may influence HRQL as 
a food allergic reaction of grade 3 or 4 according to the Mueller classification22• The 
study was approved by the local medical ethics review commission (METc 2005/051 ). 
Statistical Analysis 
Data were analysed using SPSS software for Windows (Version 1 4.0). To investigate test­
retest reliability of the FAQLQs we used the intraclass correlation coefficient (ICC), using 
a one-way ANOVA2°·21•23• Values should be above 0.70 for group comparison studies and 
above 0.90-0.95 for individual measurements over time24• 
As a second measure of test-retest reliability we calculated the Lin's concordance 
correlation coefficient (CCC). The different components of the CCC (Pearson correlation 
coefficient [measure of precision], location shift and scale shift [measures of accuracy]), 
were calculated. We plotted the first measurement against the second measurement and 
we used major axis analyses to calculate the best fitting line25• 
Visual assessment of test-retest agreement was obtained by use of Bland-Altman 
plots26• Differences between the first and the second measurement were plotted against 
the mean of the first and the second measurement. Limits of agreement (mean difference 
+/- 1 .96*SD of the difference) were calculated, which reflect the interval within which 
about 95% of the differences between the two measurements should lie27•28• A regression 
coefficient (r) was calculated to estimate a relationship between the difference and the 
mean26• 
Table 1 .  Patient Recruitment 
Patients Children Adolescents Adults Total 
Contacted patients, n 48 51 49 1 48 
Returned 1st questionnaire, n 41 47 43 1 31 
Returned 2nd questionnaire, n 38 38 38 1 1 4 
Excluded patients', n 7 4 2 1 3  
Analysed patients, n 31 34 36 101  
' Seven patients (3  children, 3 adolescents, 1 adult) were excluded, because they completed the second 
questionnaire more than 1 4  days after completion of the first. One child and 1 adult were excluded because of 
a grade 3 or 4 allergic reaction between the first and second measurement. One child was excluded because 
she was aged under 8 years. Two children and 1 adolescent were excluded because they experienced their 
most severe reaction ever within 2 months before the first measurement. 





We contacted 148 patients, of which 131 patients completed and returned the first 
questionnaire and 114 responded to the second questionnaire. This resulted in an 
overall response rate of 77%. A few patients were excluded, resulting in 101 patients that 
were eligible for analysing test-retest reliability (Table 1 ). The descriptive characteristics 
of the participants are shown in table 2. Mean duration between the first and second 
measurement was 11 days for all three age groups. 
Table 2. Demographics and Clinical Characteristics 
Mean age, years (SD) 
Gender, n (%) 
Male 
Female 


















> 3 foods 
Severity of Symptoms 






Most severe reaction, 
How many years ago? (SD} 






Children (n= 3 1 )  
1 0.6 (1 .5) 
1 7  (55) 
1 4  (45) 
25 (81 ) 
1 7  (55) 
1 5  (48) 
1 4  (45) 




6 ( 19) 
0 (0) 
1 4  (45) 
6 ( 19) 
25 (81 )  
6 ( 19) 
4 ( 13)  
4 ( 13) 
1 7  (55) 
6 ( 19) 
2 (6) 
1 7  (55) 





4 ( 1 3) 
0 (0) 
0 (0) 
Adolescents (n= 34) Adults (n= 36) 
1 5.0 (1 .5) 37.3 (1 4.5) 
1 8  (53) 7 ( 1 9) 
1 6  (47) 29 (81 ) 
30 (88) 25 (69) 
28 (82) 25 (69) 
1 5  (44) 1 5  (42) 
1 6  (47) 7 ( 1 9) 
4 ( 1 2) 7 ( 1 9) 
1 3  (38) 8 (22) 
9 (26) 6 ( 1 7) 
5 ( 15) 9 (25) 
8 (24) 1 2  (33) 
4 ( 12) 8 (22) 
1 3  (38) 26 (72) 
6 ( 18) 1 0  (28) 
24 (71 ) 1 3  (36) 
3 (9) 1 (3) 
4 ( 12) 3 (8) 
8 (24) 1 0  (28) 
1 9  (56) 22 (61 )  
2 (6) 3 (8) 
3 (9) 3 (8) 
1 8  (53) 1 3  (36) 
9 (26) 1 7  (47) 
2 (6) 0 (0) 
7.1 (5.4) 5.2 (7.5) 
25 (74) 25 (69) 
1 (3) 0 (0) 
6 ( 18) 3 (8) 
0 (0) 4 (1 1 )  
2 (6) 1 (3) 
' Other food allergy types not specified in the Mueller Classification, for example the Oral Allergy Syndrome. 
2 Allergist, Dermatologist or Paediatrician 
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Analysis of FAQLQs 
ICCs were ;?. 0.900 for the FAQLQs and CCCs were comparably high. Location shift and scale 
sh ift, should all be considered minimal according to Lin's examples29• Pearson correlation 
should be considered moderate in the FAQLQ-CF and good in the FAQLQ-TF and -AF 
(Table 3). Comparable results were found for the individual domains of the FAQLQs (data 
not shown). 
Table 3. Reliability and Agreement measures of the FAQLQs 
FAQLQ-CF 
M1 (SD l )  4. 1 3  ( 1 . 15) 
M2 (SD2) 4.08 (1 .34) 
Mean of both scores, 4.1 1 (1 .22) 
M1 +M2 (SD) 
Mean difference, 0.045 (0.537) 
M1-M2 (SD) 
Limits of agreement - 1 .008 to 1 .097 
( 1 .96 SD) 
ICC one-way 0.9 1 0  (0.823-0.955) 
(95 % CI) 
Error variance 0.1 47 
CCC (95% CI) 0.907 (0.847-0.967) 
Scale shift 1 . 1 62 
Location shift 0.036 
Pearson 0.91 8  
Kendall's tau-b 0.759 
Ml = Total FAQLQ score measurement 1 
M2 = Total FAQLQ score measurement 2 
SD = Standard deviation 
Cl = Confidence interval 
FAQLQ-TF 
4.37 (1 .20) 
4.42 (1 .29) 
4.40 (1 .24) 
-0.05 1 (0.274) 
-0.588 to 0.486 
0.976 (0.952-0.988) 
0,038 





limits of agreement: Mean difference +/- 1 .96 SD of the mean difference 
ICC = Intraclass correlation coefficient 
CCC = Concordance correlation coefficient 
Scale shift (SD2/SD1 ) 
Location shift: (Ml -M2) 
SDlx SD2 
FAQLQ-AF 
4.49 ( 1 .44) 
4.34 ( 1 .59) 
4.41 (1 .50) 
0.1 47 (0.451 )  
-0.737 to 1 .031 
0.952 (0.909-0.975) 
0.1 02 
0.951 (0.921 -0.981 )  




Figure 1 illustrates the correlation between the first and second measurement. Major axis 
analysis revealed no significant d ifferences of the slope and intercept of the best fitting 
line from the concordance l ine for the FAQLQ-CF and -TF. For the FAQLQ-AF there were 
significant but modest differences of the slope ( 1 . 1 0, p = 0.046) and the intercept (-0.61 2, 
p = 0.01 9) of the best fitting line from the concordance line. The slope and intercept of the 
best fitting line of the FAQLQ-CF, -TF and -AF did not differ significantly from each other. 
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Figure 1 .  FAQLQ score of the first measurement against FAQLQ score of the second measurement 
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Figure 2. Bland-Altman plots for the FAQLQs in (A) children, (B) adolescents and (C) adults. The 
mean of both measurements are plotted against the difference of both measurements (calculated 
as first measurement minus second measurement) 
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The Bland-Altman plots are shown in figure 2. About 95% of the differences lie within 
the 1.96 SD limits of agreement. There was no significant correlation between the mean 
of both scores and the differences of both scores for the FAQLQ-CF and -TF. There was a 
significant but modest correlation between the mean of both scores and the differences 
of both scores for the FAQLQ-AF (r = -0.334; p = 0.046). No significant systematic bias was 
observed, which means that mean differences of both scores were all close to zero. The 
limits of agreement are most narrow for FAQLQ-TF and wider for FAQLQ-CF and -AF. 
DISCUSSION 
This article describes the evaluation of the test-retest reliability of the recently developed 
self-administered FAQLQ-CF, -TF and -AF. Overall, reliability was considered to be excellent 
for the FAQLQs as measured with the ICC and CCC. Additionally, Bland-Altman plots 
showed that mean differences were all close to zero, supporting the high reliability of the 
FAQLQs. 
In this study we used ICCs calculated by a one-way ANOVA, CCCs and Bland-Altman 
plots to assess test-retest reliability. However, different methods can be used to assess 
test-retest reliability and there is much discussion in literature on the best way to do 
this20• A disadvantage of the ICC is that if patient groups are very homogeneous, the ICC 
tends to be low, because the ICC compares variance among patients to total variance. If 
patient groups are very heterogeneous, the ICC tends to be high. Thus, the ICC would only 
generalize to similar populations. Additionally, the one-way ICC does not take into account 
the order in which observations were taken29• Therefore, the CCC is a useful additional 
measure. The CCC takes into account not only mean differences between the first and 
second measurement, such as ICCs calculated by a one-way ANOVA, but also takes into 
account variance differences between the first and second measurement by reducing the 
magnitude of the resulting test-retest reliability estimate. In addition, the CCC is a better 
tool to distinguish between bias and imprecision20•29• There can be large differences in ICC 
and CCC scores, especially in studies with heterogeneous groups. The similar scores we 
found in our study reflect that both coefficients worked very well in this population and 
that results can be generalized to other groups. Bland-Altman plots are very illustrative in 
assessing test-retest agreement. They were useful to identify some extreme and outlying 
differences, to analyse the magnitude of the measurement error, which was small, and to 
visualize a possible relationship between the difference and the mean of both scores26• 
This study may also have some limitations. Firstly, the sample sizes were relatively 
small. However, we found that the reliability of the questionnaires was very high, which 
indicates that the sample sizes were adequate and that a greater number of patients would 
probably not have influenced the outcomes. Another limitation may be that the majority 
of adults in this study was female. However, we did not find significant differences in the 
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test-retest reliably outcomes between men and women {data not shown). Therefore, we 
think that the imbalance between men and women did not influence the generalisability 
of the results of the FAQLQ-AF. Finally, the significant correlation between the first and 
second measurement of the FAQLQ-AF {figure 1 C) and between the mean of both scores 
and the d ifferences of both scores of the FAQLQ-AF {figure 2C) was an unexpected finding. 
We think this correlation might be due to an outlier. This assumption was supported by 
a re-analysis excluding this outlier, which showed that the correlation was no longer 
significant. 
In summary, the FAQLQs showed excellent reliability and are thus promising measures 
in evaluative studies in patients with food allergy, but also in monitoring individual 
patients. The high test-retest reliability supports the value of the FAQLQs for clinical trials 
with relatively small sample sizes. We recommend the use of the FAQLQs in clinical trials 
of current management strategies of food allergy and they may also be useful when new 
treatments become available. Currently, the longitudinal validity of the FAQLQs and the 
validity of several other European language versions of the FAQLQs are being investigated. 
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ABSTRACT 
Objective: The Food Allergy Quality of Life Questionnaire-Child Form, -Teenager Form 
and -Adult Form (FAQLQ-CF, -TF and -AF) have recently been developed. In order to 
measure construct validity in the FAQLQs, a suitable independent measure was needed 
with which FAQLQ scores could be correlated. However, in food allergy, no appropriate 
independent measure existed, which could be used for this purpose. The aim of this study 
was to describe the development of a Food Allergy Independent Measure Child-Form, 
-Teenager Form and -Adult Form (FAIM-CF, -TF and -AF) and to assess their validity and 
reliability. 
Methods: The FAIMs were developed using previously established methodology to 
capture the patients' expectation of outcome (EO). Face validity was determined by expert 
opinion. FAIM questions showing no correlation to any potential items in the FAQLQs 
were considered irrelevant and eliminated. In order to measure test-retest reliability, 
one-hundred-and-one patients were included and completed the FAIM twice with a 10-
14 day interval. The intraclass correlation coefficient (ICC), Lin's concordance correlation 
coefficient (CCC) and Bland-Altman plots were used to assess test-retest reliability. 
Results: Six FAIM questions were developed and considered relevant for the FAIM-CF and 
-AF and five questions were relevant for the FAIM-TF. The FAIMs showed good reliability 
with ICCs and CCCs above 0.70 and with mean differences all close to zero. 
Conclusions: Food allergy independent measures were developed for children, 
adolescents and adults and were shown to be valid, relevant and reliable. This supports 
the suitability of the FAIMs for evaluating construct validity. 
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INTRODUCTION 
In Health Related Quality of Life (HRQL) research, construct validity is the only approach 
possible to establish validity1 . Construct validity refers to whether the questionnaire is 
measuring what it is supposed to measure and can be assessed by correlating a new 
questionnaire with an independent measure, which reflects disease severity. 
In order to measure construct validity in the recently developed Food Allergy Quality 
of Life Questionnaire-Child Form, -Teenager Form and -Adult Form (FAQLQ-CF, -TF and 
-AF)2-1, we needed to demonstrate that the FAQLQs were measuring only that part of HRQL 
affected by food allergy and not general quality of life aspects. However, in food allergy 
no appropriate independent measure existed, which could be used for this purpose. 
Therefore, a Food Allergy Independent Measure-Child Form, -Teenager Form and -Adult 
Form (FAIM-CF, -TF and -AF) were developed. This study describes the development, 
validity and reliability of the FAIMs. 
METHODS 
Development 
Development of a Dutch independent measure was carried out using Expectation of 
Outcome (EO) questions, previously described by Oude Elberink5·6• The EO questions 
capture the perceived expectation of patients of the chance of accidental exposure 
and the perception of what will happen following accidental exposure. This is likely to 
be the source of quality of life differences in anaphylactic disorders and is therefore an 
appropriate independent measure6• Each question was scored on a seven-point scale. A 
consultant for sick children, psychologist and a linguist reviewed the FAIMs for clarity and 
ease of use. 
Validity and relevance 
Face validity was determined by expert opinion. Three experts participated in and agreed 
on the validity of the possible FAIM questions. FAIM questions were considered valid if 
they addressed aspects of food allergy outcomes that patients were likely to perceive 
as determining the severity of their condition. Questions showing no correlation to any 
potential FAQLQ item were not considered relevant and therefore eliminated. 
Reliability 
Patients and procedures 
Dutch children (8-12 years), adolescents (13-17 years) and adults � 18 years) with food 
allergy were recruited from our clinic or by advertisement from January 2007 to May 2007. 
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Figure 1 .  The FAIM-CF (A) and the FAIM-TF and -AF (B) 
A. The Food Allergy Independent Measure - Child Form (8-12 years) 
The following four questions are about the chance that you think you have of something happening to you because of 
your food allergy. Choose one of the answers. This is followed by two more questions about your food allergy. Answer every 
question by putting an ·x· in the box next to the proper answer. 
0 1 2 3 4 5 6 
never very small always 
(0% chance) chance 
small chance fair chance big chance very big chance 
(1 00% chance) 
How big do you think the chance Is that you ••• 0 2 3 4 5 6 
E01. will accidentally eat something to which you are allergic? D D D D D D D 
E02. will have a severe reaction if you accidentally eat something to which you are D D D D D D D 
allergic? 
E03. w\11 die If you accidentally eat something to which you are allergic? D D D D D D D 
E04. Can not do the right things for your allergic reaction should you accidentally eat D D D D D D D 
something to which you are allergic 
IM1 How many foods are you unable to eat IM2 
because of your food allergy? 
Everyone does things with other people, such as; playing with friends, 
going to a birthday party, visiting, staying over with someone for a 
meal or eating out. How much does your food allergy affect things 
you do with others? 
D almost none 
D very few 
O a few 
O some 
D many 
D very many 
D almost all 
D so little I don't actual ly notice it 
D very little 
D a little 
D moderately 
D a good deal 
D a great deal 
D a very great deal 
B. The Food Allergy Independent Measure-Teenager Form (13-17 years) and -Adult Form. 
The following four questions are about the chance that you think you have of something happening to you because of your food 
allergy. Choose one of the answers provided. This is followed by two questions about your food allergy. Answer every question 
by putting an 'x' in the box next to the appropriate answer. 
0 1 2 3 4 5 6 
never very small very great always 
(0% chance) chance 
small chance fair chance great chance 
chance (100% chance) 
How great do you think the chance Is that you ... 0 2 3 4 5 
EOl. will accidentally eat something to which you are allergic? 0 0 0 0 0 0 
E02. will have a severe reaction if you accidentally eat something to which you are allergic? 0 D 0 0 0 0 
E03.' will die if you accidentally eat something to which you are al lergic? 0 0 0 0 0 0 
E04. can l!Q! effectively deal with an al lergic reaction should you accidentally eat something D 0 0 0 0 0 
to which you are allergic 
IM1 How many products must you avoid IM2 How great is the impact of your food allergy on your social life? 
because of your food allergy? 
D almost none 
D very few 
O a few 
D some 
D many 
O very many 
O almost all 
D negligibly small 




D very great 






' EO question 3 was not considered to be an appropriate Independent measure questionnaire for food allergy in adolescents. 
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Patients with the most prevalent food allergies were included. The FAIMs were sent by 
mail to be completed at home. Participation was completely voluntary. Regarding the 
FAIM-CF, parents were instructed that they were allowed to explain a question when 
needed, but they were not allowed to tell the child which answer to give. All patients who 
completed the first questionnaires (test) received the second questionnaires (re-test) 1 0-
1 4  days after completion of the first. Patients who did not respond within 1 4  days were 
excluded from the study as well as patients who reported a clinically important change in 
health state (defined as a food allergic reaction of grade 3 or 4 according to the Mueller 
classification7) between the measurements or within two months before the study. This 
study ran in parallel with the test-retest reliability study of the FAQLQs8• The study was 
approved by the local medical ethics review commission (METc 2005/05 1 ). 
Statistical Analysis 
Data were analyzed using SPSS software for Windows (Version 1 4.0). The intraclass 
correlation coefficient (ICC), using a one-way ANOVA9, and Lin's concordance correlation 
coefficient (CCC) 10  were calculated to investigate test-retest reliability. ICCs and CCCs 
should be above 0.7 for group comparison studies1 1 . P values < 0.05 were considered 
to be significant. The different components of the CCC (Pearson correlation coefficient, 
location shift and scale shift) were calculated. A value of O represents no location shift. A 
value of 1 represents no scale shift. The first measurement was plotted against the second 
measurement and we used major axis analyses to calculate the best fitting line1 2• Visual 
assessment was obtained by use of Bland-Altman plots. Mean differences were calculated 
and should be close to zero. Limits of agreement were calculated as mean difference 
+/- 1 .96*SD of the mean difference. Ninety-five percent of the differences (calculated as 
measurement 1 - measurement 2) should lie between these limits. A regression coefficient 
was calculated to estimate a relationship between the difference and the mean. 
RESULTS 
Development 
The original FAIM-CF, -TF and-AF contain six questions (figure 1 ). The wording of the 
questions was changed for children to improve understanding. EO questions 2 and 3 were 
adapted from questions which were successfully developed for validation of the Vespid 
allergy Quality of Life Questionnaire (VOLO) 5 and the Food Allergy Quality of Life-Parental 
Burden questionnaire (FAQL-PB) 13• Two other EO questions (1 and 4) were developed, 
which were likely to be an additional source of HRQL differences in food allergic patients. 
Additionally, two independent measure questions (IM 1 and 2) were developed, which 
reflect aspects of the perceived severity of food allergy not captured by the other four 
questions. 
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Validity and relevance 
EO question 3 did not correlate with any of the items of the FAQLQ-TP and was there­
fore eliminated. Additionally, EO question 4 did not correlate with any of the items of 
the FAQLQs. This was considered to be due to the original positive formulation of this 
question versus the negative formulation of the other EO questions. The positive formula­
tion ( . . .  can effectively deal. . .  ) and a negative formulation ( . . .  cannot effectively deal. . .  ) 
were compared in an additional analysis of 28 children, 34 adolescents and 32 adults and 
showed significantly better correlations of the negative formulation with the total FAQLQ­
CF, -TF and -AF scores than the positive formulation (data not shown). Therefore, we finally 
included EO question 4 in its negative formulation. The other questions were shown to be 




We contacted 1 48 patients, of which 131 patients completed and returned the first 
questionnaires and 1 14 responded to the second questionnaires. Thirteen patients were 
excluded because they did not respond in time or had a grade Ill or IV allergic reaction 
between the first and second measurement or within two months before the first 
measurement. This resulted in 101 patients (31 children, 34 adolescents and 36 adults) 
that were eligible for analysing test-retest reliability. Table 1 shows types and numbers of 
food allergies. 
Table 1 .  Type and number of food allergies 
Children (n= 31 )  Adolescents (n= 34) Adults (n= 36) 
Type food allergy, n (%) 
Peanut 25 (81 ) 30 (88) 25 (69) 
Nut 1 7  (55) 28 (82) 25 (69) 
Milk 15 (48) 1 5  (44) 1 5  (42) 
Egg 14  (45) 1 6  (47) 7 ( 19) 
Wheat 5 ( 1 6) 4 ( 1 2) 7 ( 19) 
Soy 9 (29) 1 3  (38) 8 (22) 
Sesame 7 (23) 9 (26) 6 ( 17) 
Fish 2 (6) 5 (1 5) 9 (25) 
Shell fish 6 (1 9) 8 (24) 1 2  (33) 
Celery 0 (0) 4 (1 2) 8 (22) 
Fruit 14  (45) 1 3  (38) 26 (72) 
Vegetables 6 ( 1 9) 6 ( 18) 1 0  (28) 
Others 25 (81 )  2 4  (71 )  1 3  (36) 
Number of food allergies, n(%) 
1 food 6 ( 1 9) 3 (9) 1 (3) 
2 foods 4 ( 1 3) 4 (12)  3 (8) 
3 foods 4 (1 3) 8 (24) 1 0  (28) 
> 3 foods 1 7  (55) 19 (56) 22 (61 )  
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Analysis 
Table 2 shows the results of the test-retest analysis. ICCs were 0.87, 0.86 and 0.76 for FAIM­
CF, -TF and -AF, respectively. CCCs were nearly identical. Location shift and scale shift could 
all be considered minimal according to Lin's examples10• Pearson correlation could be 
considered moderate for FAIM-CF and -TF and acceptable for FAIM-AF according to Lin's 
examples 1°. Figure 2 illustrates the correlation between the first and second measurement. 
Major Axis analysis revealed no significant difference of the slope and the intercept of the 
best fitting line from the concordance line for the FAIMs. The slope and intercept of the 
best fitting lines of all FAIMs did not differ significantly from each other. Bland-Altman 
plots are shown in Figure 3. Mean differences of both scores were all close to zero. About 
95 % of the differences lie within the 1.96 SD limits of agreement. Limits of agreement 
of the FAIM-AF were wide. There is no significant correlation between the mean of both 
scores and the difference of both scores. 
Table 2. Test-retest reliability results of the Food Allergy Independent Measure-Child Form, -Teen­
ager Form and -Adult Form (FAIM-CF, -TF and -AF). 
FAIM-CF FAIM-TF FAIM-AF 
Ml (SD1 )  3.72 (0.93) 4. 1 S  (0.93) 3.97 (1 .0S) 
M2 (SD2) 3.80 ( 1 . 10) 4.1 0  (1 .09) 4.04 (1 .20) 
Mean of both scores (SD) 3.76 (0.99) 4.1 3  (0.97) 4.00 (1 .05) 
(Ml +M2/2) 
Mean difference (SD) -0.08 (0.52) 0.05 (0.55) -0.07 (0.79) 
(M1 -M2) 
Limits of agreement -1 .09 to 0.93 -1 .02 to 1 . 1 2  -1 .61 to  1 .47 
(MD +/- 1 .96 SD) 
ICC (95 % CI) 0.87 (0.76-0.94) 0.86 (0.74-0.93) 0.76 (0.58-0.87) 
p < 0.001 p < 0.001 p < 0.001 
Error variance 0.1 3  0.1 5 0.31 
CCC (95% CI) 0.87 (0.79-0.95) 0.85 (0.76-0.94) 0.75 (0.61 -0.90) 
p < 0.001 p < 0.001 p < 0.001 
Scale shift 1 . 1 8  1 . 1 7  1 .14 
Location shift -0.08 0.05 -0.06 
Pearson 0.88 0.87 0.76 
M 1 :  Total FAIM score measurement 1 
M2: Total FAIM score measurement 2 
MD: Mean Difference 
ICC: Intraclass Correlation Coefficient 
CCC: Concordance Correlation Coefficient 
SD: Standard Deviation 
Scale shift (SD2/SD1 ) 
Location shift: (M I-M2) 
SD1x 5D2 
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Figure 2. FAIM score of the first measurement against FAIM score of the second measurement in (A) 
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DISCUSSION 
This article describes the development, face validity and test-retest reliabil ity of the FAIMs. 
Questions were chosen for good face val id ity and selected on the basis of relevance. The 
FAIMs showed good reliabil ity with ICCs and CCCs above 0.70 and with mean differences 
all close to zero. There was little evidence for scale shift and location shift supporting the 
accuracy of the FAIMs. 
General ly, independent measures used to validate HRQL questionnaires are some sort 
of objective measurement of the severity of a disease. An objective measurement is often 
related to the burden of symptoms characterising the disease. However, in food a l lergy 
no such clinical measure based on symptoms exists. Moreover, such a clinical measure 
would even be inappropriate because food al lergic patients only experience symptoms 
on accidental exposure, while their HRQL is continuously affected by their condition. An 
independent measure based on food al lergic outcomes attempts to capture the aspects 
of disease severity which drive HRQL in an ongoing way. HRQL instruments built upon the 
method of EO questions have proved to be useful and consistent in measuring HRQL5•13• 
It was an unexpected finding that in adolescents EO question 3 was not correlated 
with any of the items of the FAQLQ-TF. As this question has successfully been used 
before in other age groups, we expected the question to be valid and relevant. However, 
this finding might indicate that adolescents are not afraid of dying of anaphylaxis and 
underestimate exposure in contrast to adu lts and chi ldren. Previously, it has been reported 
that adolescents perceived their anaphylaxis as 'no big deal,,4 despite the fact that they 
are at highest risk of dying from food allergy 15• 
Another remarkable finding was shown in the results of the validity of EO question 
4. These results i l lustrate that the wording of a question is very important. Changes in 
wording may result in misreading of the question or misdirection of the answer in 
sometimes unexpected ways. 
According to the reliability results, the FAIM-AF showed the lowest ICC and CCC and 
the widest l imits of agreement. This may have been caused by two outliers in the FAIM­
AF. This assumption was supported by a re-analysis excluding the two outliers, which 
showed an ICC of 0.84 (p<0.001 ), a nearly identical CCC and limits of agreement of-1 .31 to 
1 .1 9. Another explanation might be that children and adolescents are more used to fil l ing 
out questionnaires as they are frequently examined at school, causing higher reliabil ity 
statistics. 
A limitation of the method of EO questions might be that EO questions are subjective 
and therefore prone to inaccuracy. However, expectations are l ikely to be the driving force 
in HRQL (i.e. patients who expect to die after exposure, would be expected to have a poor 
HRQL, independent of the truth of this expectation}16• Moreover, there is no appropriate 
objective measure in food allergy. Therefore, the FAIMs are the best independent measures 
for food al lergy thus far. 
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In summary, we described the development of a food allergy specific independent 
measure for children, adolescents and adults. Overall, the FAIMs showed good face 
validity, relevance and reliability. Therefore, these results support the suitability of the 
FAIMs for evaluating construct validity of HRQL questionnaires for food allergy. 
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ABSTRACT 
Objective: Food allergy affects 5-6% of children and impairs Health-Related Quality-of­
Life (HRQL). Children and parents may differ in their views concerning the child's HRQL. 
In food al lergy, child- and parent-proxy-reported HRQL have never been compared using 
valid disease-specific instruments. The aim of this study was to compare child- and parent­
proxy-reports on HRQL in food allergic children (8-1 2  years) . 
Methods: The Food Allergy Quality of Life Questionnaire-Child Form (FAQLQ-CF), and 
-Parent Form (FAQLQ-PF) and the Food Allergy Independent Measure-Child Form and 
-Parent Form (FAIM-CF and -PF) were completed by Dutch food allergic child-parent pairs. 
Child- and parent-proxy-reports were correlated and tested for significant differences. 
Construct validity (correlation FAQLQs and FAIMs) and internal consistency (Cronbach's a) 
were assessed and compared. 
Results: Seventy-four child-parent pairs were included. FAQLQ-CF score was significantly 
higher than FAQLQ-PF score (3.74 versus 2.68, p<0.001 ,  where 1 signifies no impairment 
and 7 signifies extreme impairment). FAIM-CF and -PF scores were nearly identical (3.29 
versus 3.33, p=0.594). There was moderate agreement between FAQLQ-CF and -PF scores 
(ICC=0.57 [p<0.001 ]) and good agreement between FAIM-CF and -PF scores (ICC=0.80 
[p<0.001 ]) .  Construct validity was confirmed for the FAQLQ-CF (rho=0.60, p<0.001 )  and 
-PF (rho=0.58, p<0.001 ). Internal consistency was excellent for the FAQLQ-CF (a=0.95) and 
-PF (a=0.95). 
Conclusions: Parents reported significantly less impact of food allergy on the child's HRQL 
than children themselves, whereas reported perceptions of disease severity were nearly 
identical .  This may reflect real differences in perspectives between children and parents 
and may indicate that parents tend to underestimate their child's HRQL impairment. It is 
important for clinicians to include both the child's and their parent's perceptions in order 
to make a complete assessment of the impact of food al lergy on the child's HRQL and to 
identify areas of disagreement which need special attention in clinical practice. 
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INTRODUCTION 
Food allergy affects up to 5-6 o/o of children in western countries1•2 and may cause severe 
anaphylactic reactions. Living with the fear of allergic reactions and living with the need 
to avoid the culprit foods in numerous situations may interfere with daily life of food 
allergic children and their families3A. Therefore, Health-Related Quality of Life (HRQL) 
measurements are important to investigate the impact of daily problems of food allergic 
children and their families5•7• As no clinical objective measure is available which reflect the 
ongoing disease severity of food allergy, measuring HRQL is also important to determine 
the effects of diagnostic or therapeutic interventions on HRQL. 
HRQL of children can be measured with questionnaires which are self-reported 
or proxy-reported. Assessment of HRQL in children has traditionally relied on parent­
reporting, as it was thought that children lack the necessary language skills and cognitive 
abilities for accurate self-reporting8•9• However, it has been reported that children �8 
years are able to assess their HRQL appropriately10•1 1 • Consequently, a number of HRQL 
questionnaires have been developed for and validated in children1 2•1 3• As parents seem 
to be less able to make judgments regarding the experience of symptoms, relationships 
with peers or worries about the future of their child 14•1 5, self-report is the primary method 
of assessing the subjective aspects of health. On the other hand, it is obvious that parent­
reports are indispensable in children who are unable to assess their own HRQL 1 6• Moreover, 
parental attitudes may influence their child's own attitudes and the utilization of health­
care services for their child. Additionally, parents may provide information not provided 
by children themselves. It is thus important to study child- and parent-proxy-reports on 
the child's HRQL and to assess the quality of parent-proxy-reporting. However, in food 
allergic children, a comparison of child- and parent-reported HRQL has never been made 
using validated disease-specific instruments. 
Two disease-specific HRQL instruments, the Food Allergy Quality of Life Questionnaire­
Child Form {FAQLQ-CF) and -Parent Form (FAQLQ-PF) have recently been developed and 
validated as part of the EuroPrevall project7•1 3•17.18. The FAQLQ-CF was originally developed 
in the Netherlands for children aged 8-12 years and provides a valid and reliable self­
report on the child's HRQL. The FAQLQ-PF was originally developed in Ireland for parents 
of children aged 0-12 years and provides a valid and reliable parent-proxy-report on the 
child's HRQL. Therefore, the aim of this study was to compare outcome (i.e. total FAQLQ 
scores and domain scores) and psychometric properties of the FAQLQ-CF and -PF and to 
investigate areas of (dis)agreement between child- and parent-reports. 
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METHODS 
Patients and procedures 
Dutch food al lergic children (8-1 2 years) and their parents were recruited from our 
paediatric allergy clinic between May 2007 and March 2009. Al l  children with at least one 
physician diagnosed food allergy were included. All common food al lergies and different 
types and severities of symptoms were represented. 
The Dutch versions of the FAQLQs and the Food Allergy Independent Measure 
questionnaires (FAIMs) were sent by mail to be completed at home13•19• Participation was 
completely voluntary. Chi ld-parent pairs were requested not to discuss questions and 
responses with each other. Chi ld-parent pairs were excluded when less than 85% of the 
questions were completed. 
This study was approved by the local medical ethics review commission (METc 
2005/05 1 )  who deemed that permission from the commission was not required. 
Questionnaires 
The FAQLQ-CF provides a self-report on the child's HRQL and contains 24 items and 4 
domains (Risk of Accidental Exposure, Emotional Impact, Al lergen Avoidance and Dietary 
Restrictions)13• Items were scored on a seven-point scale ranging from not troubled to 
extremely troubled. In order to improve understanding, the scale was i l lustrated by 
drawings of faces ('smileys'), ranging from a smiling face to a sad face. The total FAQLQ 
score is the sum of al l the items divided by the number of items and ranges from 1 (minimal 
impairment in HRQL) to 7 (maximal impairment in HRQL). 
The FAQLQ-PF provides a parent-report on the child's HRQL and contains 1 4  items, 
26 items and 30 items for children aged 0-3 years, 4-6 years and 7-1 2  years, respectively7. 
Items are divided into 3 domains (Emotional Impact, Food Anxiety and Social & Dietary 
Limitations) and scored in the same way as the FAQLQ-CF. The FAQLQ-PF was translated 
from English into Dutch by a native Dutch speaker and back translated by a native English 
speaker, using established guidelines20• The original Engl ish version was compared with 
the back-translated English version by an expert panel. No important l inguistic or semantic 
differences emerged. 
The Food Allergy Independent Measure-Child Form and Parent-form (FAIM-CF and -PF) 
were originally developed as an independent measure for food al lergy in order to evaluate 
the construct val idity of the FAQLQs19• The FAIMs contain  four expectation of outcome 
questions, concerning the child's perceived expectation of the chance of accidental 
exposure and of what will happen following accidental exposure and two questions 
reflecting perceived disease severity. Such expectations are likely to be the source of 
quality of l ife differences in anaphylactic disorders and are therefore an appropriate 
independent measure for anaphylactic disorders2 1 • Furthermore, HRQL instruments built 
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upon the method of expectation of outcome questions have proved to be useful and 
consistent in measuring HRQL6•7•13•22·24• Questions were scored on a seven-point scale. The 
translation procedure, as described for the FAQLQ-PF, was followed for the FAIM-PF as 
well. 
Additionally, child-and parent characteristics were asked on age, sex, type and number 
of food allergies etc. Parental health and well-being was measured using a question which 
was previously used during the development of the FAQLQ-PF7: "How would you describe 
your general health and well-being?" (seven-point scale ranging from excellent to very 
poor). 
Statistical analysis 
Comparison of child-self and parent-proxy-reports 
Data were analyzed using SPSS software for Windows (Version 16.0). Total FAQLQ-CF and 
-PF scores (and domain scores) were tested for significant differences using Wilcoxon 
signed-rank tests. Total FAQLQ-CF and -PF scores were correlated using Spearman's 
correlation coefficient and the Intraclass correlation coefficient (ICC, two-way mixed 
effects model). Correlations were classified as follows: <0.4=poor to fair, 0.4-0.6=moderate, 
0.6-0.8=good and >0.8=excellent. Bland-Altman plots illustrated the differences of each 
child-parent pair (FAQLQ-CF score minus FAQLQ-PF score), which were plotted against the 
mean FAQLQ score of each child-parent pair. Limits of agreement were calculated as mean 
difference +/- 1.96*standard deviation of the mean difference. 
The procedure, as described above, was followed for the comparison of the FAIMs as 
well. 
Influence of child characteristics on child-parent agreement 
Univariate linear regression analyses were performed to investigate which child 
characteristics influenced child-parent agreement. The mean difference between child­
and parent-reported HRQL was used as the dependent variable and child characteristics 
(age, sex, anaphylaxis, last experience of anaphylaxis, number of food products which 
must be avoided) were used as independent variables. The same procedure was followed 
for the FAIMs. 
Psychometric properties of the questionnaires 
Construct validity of the FAQLQs was investigated using Spearman's correlation coefficient 
between the total FAQLQ-CF score and the total FAIM-CF score and between the total 
FAQLQ-PF score and the total FAIM-PF score, respectively. A moderate correlation (0.4-
0.6) was to be expected25• Internal consistency was investigated using Cronbach's alpha 
(a �0.70 was considered to be good)26• Discriminative abilities were investigated by 
comparing total questionnaire scores for boys versus girls, for patients who have one 
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versus more than one food al lergy, for patients who must avoid :510 versus >10 food 
products and for patients who experienced anaphylaxis versus patients who did not. 
Experience of anaphylaxis was determined using the definition of the 'Symposium on the 
Definition and Management of Anaphylaxis'27• Floor and ceiling effects were calculated 
as percentage of patients with questionnaire scores of 1 (minimal impact on HRQL} and 7 
(maximal impact on HRQL}, respectively. 
RESULTS 
Patients 
The questionnaire package was sent to 109 Dutch child-parent pairs and returned by 84 
child-parent pairs (response rate 77%}. Ten chi ld-parent pairs were excluded because less 
than 85% of one of the questionnaires was completed. Thus, 74 child-parent pairs were 
eligible for analysis. Descriptive characteristics of the child-parent pairs are shown in Table 
1. 
Table 1. Child- and parent-characteristics 
Participants, n (%) 74 ( 1 00) 
Mean age, years (SD) 1 0.4 (1 .6) 
Child sex, male/female (%} 46/28 (62/38) 
Type of food allergies, n (%) 
Peanut 54 (73) 
Nut 54 (73) 
Milk 9 ( 1 2) 
Egg 1 2  ( 16) 
Wheat 4 (5) 
Soy 1 1  ( 15) 
Sesame 3 (4) 
Fish (1 ) 
Shell fish 4 (5) 
Fruit 1 0  (14) 
Vegetables 4 (5) 
Number offood allergies, n (%) 
1 food 23 (31 )  
2 foods 28 (38) 
3 foods 9 ( 12) 
> 3 foods 1 4  ( 19) 
Number of food products which 
must be avoided, n (%) 
0-2 30 (41 }  
3-6 1 6  (22) 
7-1 0 6 (8) 
> 10  19  (26) 
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Table 1 .  Child- and parent-characteristics (Continued) 






Anaphylaxis, yes/no (%) 
Last experience of anaphylaxis, years (SD) 
Epinephrine autoinjector, yes/no (%) 
Parent sex, male/female (%) 
Reported parental 






Oral Allergy Syndrome, swollen tongue or lips and symptoms of the nose or eyes. 
Comparison of the FAQLQ-CF and -PF 
21 (28) 
60 (81 )  
45 (61 ) 
49 (66) 
65 (88) 
62/1 2 (84/16) 
4.8 (3.6) 
56/1 8 (76/24) 
7/67 (9/91 }  
1 1  ( 15) 




The total FAQLQ-CF score was significantly higher (indicating more severe impact on 
HRQL) than the total FAQLQ-PF score (3.74 versus 2.68, p<0.001) (Table 2). All domain 
scores of the FAQLQ-CF were significantly higher than the domain scores of the FAQLQ­
PF. Spearman's correlation coefficient between the total FAQLQ-CF and -PF score was 
0.56 (p<0.001 ). The ICC of 0.57 (95% Cl; 0.40-0.71, p<0.001) was comparable. Figure 1 A 
illustrates this moderate correlation. The Bland-Altman plot illustrates the mean difference 
(1.06, SD=1.10) between the FAQLQ-CF and -PF score (Figure 2A). 
Table 2. Outcome of the questionnaires 
Mean total 
scores (SD) 
FAQLQ-CF 3.74 (1 .34) 
Allergen avoidance 3.35 ( 1 .4 1 )  
Risk accidental exposure 3.78 (1 .57) 
Emotional impact 4.1 3 (1 .57) 
Dietary restrictions 3.74 (1 .44) 
FAQLQ-PF 2.68 (1 .02) 
Emotional impact 2.61 (0.95) 
Food anxiety 2.96 ( 1 . 15) 
Social & dietary limitations 2.53 (1 .29) 
FAIM-CF 3.29 (1 .09) 
FAIM·PF 3.33 (0.94) 
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Comparison of the FAIM-CF and -PF 
There was no significant difference between the total FAIM-CF and -PF scores (3.29 versus 
3.33, p=0.594) (Table 2). Spearman's correlation coefficient between the total FAIM-CF and 
-PF score was 0.82 (p<0.001 ). The ICC of 0.80 was comparable (95% Cl; 0.69-0.87, p<0.001 ). 
Figure 1 B i l lustrates this good correlation. The Bland-Altman plot i l lustrates that the mean 
difference between the FAIM-CF and -PF was close to zero (-0.04, SD=0.65) (Figure 2B). 
Figure 1. FAQLQ-CF versus -PF scores (A) and FAIM-CF versus -PF scores (B) 
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Influence of child characteristics on child-parent agreement 
Univariate linear regression analyses are shown in table 3. The mean difference between 
child- and parent-reported HRQL was significantly associated with child age; i.e. the 
difference was smaller for the oldest children (11-12 years) than for the youngest children 
(8-10 years). The mean difference between child- and parent-reported FAIM scores was 
not significantly associated with any of the child characteristics. 
Figure 2. Bland Altman plot for FAQLQ-CF versus -PF (A) FAIM-CF versus -PF (B) 
iL' :,-
Cf 2" < 
... 0-


















O O oO 





n o O O O 
.., "' o o o o .., 
0 






or9 o o 
- - - -0- _sR1. 0 O<IJ<> 2.






lower limit of agreement 
Mean FAOLO score IFAOLO-CF and -PFI 
0 
0 
0 o0 0 0 0 
upper limit of agreement 
0 0 0 00
0 
- � .0.0
0 0 0 - 0 -
0 0 0 0  0 0 0 0  00 mean difference 00 
0 0 0  0 0 0 0� O �o0 0 
0 0  0 0 
0 lower limit of agreement 
0 
Mean FAIM scores (FAIM-CF + -PF score) 
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Table 3. Univariately associated factors influencing the difference between child-self and parent­
proxy reported HRQL and disease severity 
HRQL (FAQLQs) Disease severity (FAIMs) 
B R' (%) p B R' (%) p 
Sex (girls versus boys) 0. 1 27 7.5 0.630 0.013 2.2 0.933 
Age (8- 1 0  vs 1 1 - 12 years) -0.547 6.2 0.034 -0.270 4.2 0.080 
Number food products 0.1 24 0.3 0.677 0.101 0.4 0.463 
(0-1 0  VS > 1 0) 
Anaphylaxis (no vs yes) 0.21 6  0.7 0.464 0.084 0.3 0.636 
Last experience of anaphylaxis -0.043 2.0 0.249 -0.008 0.2 0.702 
(how long ago in years) 
Table 4. Psychometric properties of the questionnaires 
Discriminative abilities 
Floor& Sex Food Number of Experience of 
ceiling products• food allergies Anaphylaxis 
effects• 
Rho1 a '  % /% boys vs girls 0-10 vs >10 1 vs >1 No vs Yes 
FAQLQ-CF 0.60 0.95 0 /0 3.76 vs 3.70 3.45 vs 4.63 3.49 vs 3.87 3.1 3 vs 3.85 
(p=0.780) (p=0.007) (p=0.21 0) (p=0.078) 
Al lergen avoidance 0.52 0.88 2.70 /0 n.p.' n.p. n.p. n.p. 
Risk accidental 0.62 0.83 1 .35 /0 n.p. n.p. n.p. n.p. 
Exposure 
Emotional impact 0.60 0.87 1 .35 /1 .35 n.p. n.p. n.p. n.p. 
Dietary restrictions 0.49 0.82 1 .35 /1 .35 n.p. n.p. n.p. n.p. 
FAQLQ-PF 0.58 0.95 0 /0 2.65 vs 2.73 2.45 vs 3.21 2.33 vs 2.86 2.23 vs 2.77 
(p = 0.902) (p=0.023) (p=0.037) (p=0.102) 
Emotional impact 0.47 0.87 0 /0 n.p. n.p. n.p. n.p. 
Food anxiety 0.68 0.86 1 .35 /0 n.p. n.p. n.p. n.p. 
Social & dietary 0.48 0.92 5.41 /0 n.p. n.p. n.p. n.p. 
limitations 
FAIM-CF 0.81 0 /0 3.1 8 vs 3.53 2.89 vs 3.98 3.05 vs 3.42 2.74 vs 3.42 
(p=0.264) (p=0.001 )  (p=0.1 22) (p=0.022) 
FAIM-PF 0.79 0 /0 3.22 vs 3.53 2.98 vs 3.90 3.08 VS 3.44 2.96 vs 3.41 
(p=0.1 84) (p=0.006) (p=0.1 3 1 )  (p=0.017) 
Construct validity of the FAQLQs; i.e. Spearman correlations between the FAQLQ score and the FAIM score, 
p<0.001 for all values. 
2 Internal consistency, cronbach's a. 
3 Percentage of patients with the minimal (floor) or maximal (ceiling) FAQLQ-PF score 
4 Number of food products that must be avoided 
5 N.p. not performed 
Bold scores represent significant P values (p<0.05). 
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Psychometric properties of the questionnaires 
Construct validity was confirmed for the FAQLQs (Table 4). Internal consistency was 
considered to be excellent for the FAQLQs and good for the FAIMs. There were no 
remarkable floor- or ceiling effects for the FAQLQs and the FAIMs. 
None of the questionnaires discriminated between boys and girls. The FAQLQ-PF 
discriminated between patients who had one versus more than one food allergy; i.e. 
scores were significantly higher (indicating more severe impact on HRQL) in patients who 
had more than one food allergy. A trend in the same direction was shown for the FAQLQ­
CF, FAIM-CF and -PF. All questionnaires discriminated between patients who must avoid 
$,;l O versus > 1 O food products. The FAIM-CF and -PF discriminated between patients who 
had experienced anaphylaxis versus patients who did not. A trend in the same direction 
was shown for the FAQLQ-CF and -PF. 
DISCUSSION 
This is the first study comparing child-reports and parent-proxy-reports on the child's 
HRQL in food-allergic children (8-12 years) using equally valid disease-specific instruments. 
A moderate correlation was shown between the total FAQLQ-CF and -PF score, which 
means that children and parents had concordant judgments concerning the child's HRQL. 
However, children systematically reported a significantly greater impact of food allergy 
on their HRQL than their parents, while reported perception of disease severity and 
expectation of outcome of an allergic reaction were nearly identical in children and their 
parents. The difference between child- and parent-proxy-reported HRQL (1.06) is highly 
likely to be a clinically important difference as it exceeds the minimal important difference 
(MID) that patients find meaningful using HRQL questionnaires with a seven-point scale 
(0.5)28 and exceeds at least twice the established MID for the FAQLQ-PF (0.45)17• 
Generally, child- and parent-proxy reports on the child's HRQL are moderately 
correlated29• Disagreement between child- and parent-proxy reports may reflect real 
differences in perspectives of children and parents, but some other causes of disagreement 
should be considered9, including child characteristics, parent characteristics, questionnaire 
characteristics and response styles of children and parents. 
Firstly, child characteristics may influence disagreement between child- and parent­
reports on the child's HRQL. In our study, the age of the child may have influenced this 
disagreement. We found that the difference between child- and parent-proxy-reported 
HRQL was smaller for the oldest children (11-12 years) than for the youngest children (8-
10 years). This is in line with previous results, which showed that in asthmatic children 
under the age of 11, complementary information can be obtained by questioning both 
children and parents, but for children aged over 11, parents provide little information 
beyond that obtained from questioning the child30• A possible explanation may be that as 
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children mature they become more articulate in expressing their feelings or concerns and 
consequently, parents may have a better insight into their child's HRQL30• Additionally, it 
has previously been shown that children's conceptions on health and disease are shown 
to be related to age and this may suggest a developmental trend in their understanding 
of the concepts of health maintenance and illness; i.e. the older the child the more the 
child's thinking about disease approaches the adult way of thinking. Furthermore, the 
impact of illness experience seemed to vary with age as well3 1 33• However, the fact that 
there was little difference between the FAIM reporting in children and parents, suggests 
that there is no significant lack of understanding of the disease severity in these children. 
Moreover, it has previously been shown that children �8 years are able to assess their 
HRQL appropriately 1 0•1 1• Additionally, a consultant for sick children and a linguist 
previously reviewed the FAQLQ-CF and FAIM-CF in order to improve clarity and ease of 
use 13. The difference between child- and parent-proxy-reported HRQL may thus suggest a 
real difference in perspectives and may well be age-related. 
Secondly, parent-characteristics may influence disagreement between child- and 
parent-reports. In our study, almost all parents were mothers and they reported less 
impact on the child's HRQL than their children. It has previously been shown that mothers 
tend to report a greater impact on the child's HRQL than fathers34 36 and it is thus unlikely 
that maternal (as opposed to paternal) reporting was the cause of the greater impact of 
food allergy on the child's HRQL reported by children than by parents. Impaired parental 
health and well being may also influence agreement between child- and parent reports 
as this may be a psychosocial stressor for children and parents36 38• In our study, all parents 
classified their own health as moderate to excellent. Therefore, parent-characteristics did 
not seem to be an important cause of the difference between child- and parent-proxy­
reported HRQL. 
Thirdly, questionnaire characteristics such as validity, sensitivity and content may 
influence agreement between child- and parent-proxy-reports on the child's HRQL. The 
FAQLQ-CF and -PF were both developed using the same methods and were previously 
shown to be valid and reliable7•1 3• However, the FAQLQ-CF and -PF are developed in 
a different language and culture. It has previously been shown that translation of an 
instrument may compromise the validity and sensitivity (the ability to detect differences 
between groups in a cross-sectional study design) of a translated instrument due to 
semantic differences or flaws in the cross cultural adaptation process39A0• Additionally, 
this may be due to the fact that some HRQL items may be regarded as unimportant by 
patients or proxies from a particular cultural setting (and therefore not included in the 
original instrument), whereas the same items would have been regarded as important by 
patients or proxies from another cultural setting. Therefore, detailed guidelines have been 
proposed20 in order to achieve a high quality of the translated instruments. The translated 
Dutch FAQLQ-PF was a valid, reliable and discriminative instrument for measuring HRQL 
in food allergic children (8- 1 2  years) and the psychometric properties were comparable to 
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the original Irish FAQLQ-PF. Despite the use of established guidelines20, loss of sensitivity 
of a translated instrument is not completely avoidable and may cause an underestimation 
of the real impact of a disease on HRQL compared to the impact as measured by the 
translated instrument. However, indicators of sensitivity (slight floor effects, no ceiling 
effects and good discriminative abilities) do not suggest a relevant loss of sensitivity of 
the Dutch FAQLQ-PF. Moreover, the FAIM-PF has been translated and adapted in the same 
way as the FAQLQ-PF, but no significant difference was shown between child- and parent­
proxy-reported FAIM scores. Therefore, we think that loss of sensitivity of the translated 
FAQLQ-PF is not likely to contribute significantly to the differences between HRQL scores 
reported by children and their parents. We recommend comparing the FAQLQ-CF and -PF 
in the English language to fully exclude loss of sensitivity in the translated instruments. 
Fourthly, differences in response styles between children and parents may cause 
disagreement41; In general, young children tend to choose extreme scores (never and 
always instead of sometimes and often) than adults do. In our study, the risk of choosing 
extreme scores was minimized using visual aids ('smileys') for children. Moreover, an 
additional analysis showed that only 16.6% of all individual items of the FAQLQ-CF were 
given the lowest score and 13.0% the highest score. Therefore, it seems unlikely that 
differences in response styles influenced disagreement between child- and parent-proxy­
reported HRQL. Future studies based on the item response theory may be useful for more 
in depth investigation of child- and parent-responses to the items of the FAQLQ-CF and 
-PF and to determine how scores on one questionnaire calibrate against scores on the 
other. 
In addition to the factors which may have influenced agreement between child- and 
parent-reports, real differences in perspectives between children and their parents may 
at least be partially responsible for the differences in HRQL scores we found. Children and 
parents often agree on objective domains (symptoms or functioning), while there is less 
agreement for socio-emotional domains, because parents may have a lack of insight into 
their child's experiences and beliefs 1 5• As the FAQLQ-CF and -PF mainly consist of socio­
emotional domains, this may explain part of the difference between child- and parent­
reports and may reflect a real difference in perspectives. A difference in perspectives is 
also suggested by the direction of the difference between FAQLQ and FAIM scores. In 
parents, the FAQLQ-PF score (2.68) was lower than the FAIM-PF score (3.33), possibly 
suggesting that parents may underestimate the impact of food allergy on their child's 
HRQL. In children, the opposite is seen with higher FAQLQ-CF (3.74) than FAIM-CF scores 
(3.29), possibly suggesting that children overestimate their HRQL. This seemingly real 
difference in perception between children and their parents may also be contributing to 
the difference between child- and parent-proxy-reported HRQL. 
A difference in perspectives is also reflected by the differences in content of the 
FAQLQ-CF and -PF for children aged 8-12 years. The two FAQLQs were developed using 
the same preferred methods in order to measure the same concept 'the child's quality of 
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life'; Firstly, all potential items for the new questionnaires were assembled using literature 
search, expert opinion and interviews with food allergic chi ldren aged 8-1 2 years (FAQLQ­
CF) or parents of food allergic chi ldren aged 8-1 2  years (FAQLQ-PF). Secondly, the clinical 
impact method42•43 was used to select the most important items for children and their 
parents for the final versions of the FAQLQ-CF and -PF, respectively (i.e. For each item, 
respondents were asked to indicate whether an item was important to them ('yes or no'), 
followed by a 5-point response option indicating the degree of importance related to that 
item. Items identified most frequently and rated the most important were selected for the 
final FAQLQ-CF and -PF). As some HRQL items were regarded as important by parents, but 
regarded as unimportant by children, these items were included in the FAQLQ-PF, but not 
in the FAQLQ-CF and vice versa. These differences in content of the FAQLQs thus highlight 
the areas of disagreement in perspectives between children and parents on HRQL (such 
as worries about the future, self-confidence compared to other children of his/ her age, 
feeling left out). Therefore, the FAQLQs are not interchangeable, but complement each 
other in the assessment of the child's HRQL from two perspectives and highlight areas of 
disagreement which need special attention. 
Despite an increase in the number of studies evaluating child- and parent-proxy­
reports on the chi ld's HRQL9, only some studies used reliable and well-validated HRQL 
instruments. Generally, child- and parent-proxy reports on the child's HRQL are moderately 
correlated29• In food allergy, only one study evaluated child- and parent-proxy-reports on 
the child's HRQL34• King et al. showed that mothers estimated the impact of peanut allergy 
on their child (8-1 2  years) as more severe than the children themselves, their siblings and 
their fathers. Part of the difference between the previous and the current study results 
may be explained by the fact that different HRQL instruments were used in the two 
studies. King et al. used validated generic HRQL instruments and unvalidated disease­
specific HRQL instruments, whereas our study employed validated disease-specific HRQL 
instruments. Additionally, the previous study was performed in another cultural setting, 
which may cause different results compared to our study. Examples of such cultural 
differences may include differences in the allergy services of the United Kingdom and the 
Netherlands causing different levels of medical awareness in English and Dutch parents. 
Also, it has been shown that the psychosocial determinants of HRQL, such as coping 
strategies, attitudes, knowledge, social support, socio-economic status, education and 
beliefs may differ between cultures4447• Final ly, studies on cultural differences in children's 
emotional reactions to difficult situations have shown that children from different cultures 
differ in the way they communicate negative emotions48• Dutch and English children may 
thus express their emotions differently to their parents, which might have influenced the 
difference between the previous and the current study results. 
In summary, this study clearly demonstrated that children reported more impact of 
food allergy on their HRQL than their parents, while the psychometric properties of the 
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FAQLQ-CF and -PF were nearly identical. This difference between child- and parent-proxy­
reports on the child's HRQL appears to reflect real differences in perspectives between 
children and parents and was related to the age of the child. Since parental and child 
perspectives are thus likely to be different, it is important for clinicians to include both 
the child's and their parent's perceptions in order to make a complete assessment of the 
impact of food allergy and the effects of diagnostic or therapeutic interventions on the 
child's HRQL. Additionally, studying both perspectives allows identification of areas that 
need special attention. 
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ABSTRACT 
Objective: Food allergic adolescents are at highest risk for food allergy fatalities, which 
may be partly due to compromised self-management behaviour. Such behaviour may be 
negatively influenced by conflictual situations caused by adolescent-parent disagreement 
on the adolescent's Health-Related Quality of Life (HRQL). Comparisons of adolescent­
self- and parent-proxy-reported HRQL of food allergic adolescents have never extensively 
been studied. The aims of this study were to investigate disagreement in adolescent-self­
and parent-proxy-reports on the HRQL of food allergic adolescents and to investigate 
factors influencing adolescent-parent disagreement. 
Methods: Teenager Form (-TF) and -Parent Form (-PF) of the Food Allergy Quality of 
Life Questionnaire (FAQLQ), Food Allergy Independent Measure (FAIM) and Brief-Illness 
Perception Questionnaire (Brief-lPQ) were sent to Dutch food allergic adolescents (13-17 
years) and their parents. ICCs, t-tests and Bland-Altman plots were used to investigate 
adolescent-parent disagreement. Participant characteristics, illness expectations and 
perceptions influencing adolescent-parent disagreement were studied (regression 
analysis). 
Results: Seventy adolescent-parent pairs were included. There was a moderate correlation 
(ICC=0.61, p<0.001) and no significant difference (3.78 versus 3.56, p=0.103) between 
adolescent-self and parent-proxy-reported HRQL at group level. However, Bland-Altman 
plots showed relevant differences (exceeding the minimal important difference) for 63% 
of all adolescent-parent pairs. Adolescent's age (> 15 years), poorer adolescent-reported 
illness comprehension (Brief-lPQ-TF, coherence) and higher adolescent-reported perceived 
disease severity (FAIM-TF) were associated with adolescent-parent disagreement. 
Conclusions: Adolescent-parent disagreement on the adolescent's HRQL, was mainly 
associated with adolescents' rather than parents' perceptions and characteristics. Illness 
comprehension of the adolescent may be an important target for intervention aimed at 
reducing adolescent-parent disagreement. 
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INTRODUCTION 
Food al lergy affects about 2.3% of adolescents 1 and they are at highest risk for food al lergy 
fatalities2• This may be caused by the fact that adolescents often engage in risk-taking 
behaviors2-4 resulting in reduced vigilance about food consumption or reluctance to carry 
the epinephrine auto-injector (EAl)4-6. Such compromised self-management behaviour 
may be exacerbated by parent-patient conflicts on the adolescent's Health-Related 
Quality of Life (HRQL). For example, parents may not recognize the social impact of food 
avoidance and carrying an EAi on their adolescent's HRQL. However, these and other 
aspects uf the adolescent's HRQL7·12 may be considered as problematic by adolescents 
themselves and this may cause parent-patient conflicts. Relationships between reduced 
disease management and family conflict have previously been shown in adolescents with 
diabetes 13• Additional ly, interventions reducing family conflict were associated with better 
blood glucose monitoring 14•15 and HRQL16• Therefore, it is important to study adolescent­
parent disagreement on the adolescent's HRQL in food al lergy as well. Another reason for 
studying parent-reports in addition to adolescent-self-reports on the adolescent's HRQL 
is the fact that parental attitudes may influence adolescents' own attitudes 17• For example, 
parental anxiety on vigilance about food consumption may serve as a psychosocial 
stressor for the adolescent. Additional ly, parental attitudes, bel iefs and fears can have an 
impact on the util ization of health care services for their child 18  and parents may provide 
information not provided by adolescents themselves 19• 
A number of factors may predict adolescent-parent disagreement on the adolescent's 
HRQL20•22, including socio-demographic variables, i l lness perceptions, expectations 
and anxiety. For example, adolescents who report low risk perception scores on i l lness­
expectation-questions such as "how big do you think the chance is of dying because of 
your food allergy?" may report better HRQL than parents reporting high risk perception. 
Consequently, this may cause adolescent-parent disagreement on the adolescent's 
HRQL. However, research findings remain inconclusive regarding the effects of these 
variables20•22• Moreover, these variables have not been studied in food al lergic adolescents 
(1 3-1 7 years). 
Therefore, the aims of this study were to compare adolescent-self and parent-reports 
on the HRQL of food a llergic adolescents and secondly, to investigate variables that may 
influence adolescent-parent disagreement on the adolescent's HRQL to identify potential 
targets for interventions aimed at reducing such disagreement. 
METHODS 
Participants and procedures 
Dutch food allergic adolescents (1 3-1 7 years) and their parents were recruited from the 
paediatric allergy clinic or through Dutch food al lergy support organizations10 between 
94 I Chapter 6 
May and July 201 0. Adolescents with at least one physician diagnosed food al lergy were 
included. Possible d ifferences between descriptive characteristics (Table 1 )  of adolescent­
parent pairs recruited by clinic and advertisement were examined using Chi-square-test 
(nominal/ordinal data) and Mann-Whitney-test (numeric data). 
Questionnaire-packages and a letter of invitation were sent by mail to be completed 
at home. Adolescent-parent pairs were instructed that they were not al lowed to discuss 
questions with each other. Participation in the study was completely voluntary. This study 
was approved by the local medical ethics review commission who deemed that formal 
approval by the commission was not required (METc 2005/05 1 ). 
Questionnaires 
Food Allergy Quality of Life Questionnaire-Teenager Form (FAQLQ-TF) 
The original Dutch FAQLQ-TF is a adolescent-self-report instrument for measuring the 
impact of food allergy on the adolescent's HRQLrn. The FAQLQ-TF contains 23 items and 
3 domains (Allergen Avoidance & Dietary Restrictions, Risk of Accidental Exposure and 
Emotional Impact). Items are scored on a seven-point scale. Total FAQLQ score is the sum 
of all items divided by the number of items and ranges from 1 (minimal impairment of 
HRQL) to 7 (maximal impairment of HRQL). 
Food Allergy Quality of Life Questionnaire-Parent Form, Adolescent version (FAQLQ­
PFA) 
The original English FAQLQ-PFA is a parent-proxy-report instrument for measuring the 
impact of food allergy on the adolescent's HRQL 23•24, appendix 1 .  The FAQLQ-PFA was 
translated into Dutch using the guidelines of the World Health Organization. Two native 
Dutch speakers translated the FAQLQ-PFA from English into Dutch and two native English 
speakers translated the Dutch FAQLQ-PFA back into English. The original English version 
was compared with the back-translated English version by an expert panel. No important 
differences in content or meaning of questions emerged during translation and pre­
testing. The FAQLQ-PFA contains 27 items and 4 domains (Emotional Impact, Food 
Anxiety, Social restrictions and Dietary restrictions). Items are scored in the same way as 
the FAQLQ-TF. 
Food Allergy Independent Measure-Teenager Form & -Parent Form (FAIM-TF & -PF) 
The FAIM reflects the participant's perceived disease severity and their food al lergy-related 
risk perception. The Dutch FAIM was originally developed as a n  independent measure for 
food al lergy25 to evaluate the construct validity of the FAQLQs. The FAIM-TF (adolescent­
self-report) and -PF (parent-proxy-report) contain four expectations of outcome questions, 
which capture the patients' perceived expectation of the chance of accidental exposure 
and of what will happen following accidental exposure and two questions reflecting 
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disease severity. Each question was scored on a scale ranging from 1 (no chance) to 7 
(certainty). Total FAIM score is the sum of all items divided by the number of items. 
Brief-Illness Perception Questionnaire-Teenager Form & -Parent-proxy Form (Brief­
lPQ-TF & -PF) 
The Brief-lPQ contains five items reflecting cognitive illness representations, two items 
reflecting emotional illness representations and two items reflecting coherence (illness 
comprehension, i.e. the adolescent's perceived understanding of food allergy) and causal 
illness representation. Items are scored on a scale ranging from 1 (benign view of illness) to 
11 (threatening view of illness), except for the open-ended causal item. The New Zealand's 
Brief-lPQ26 was previously validated in the Netherlands27• 
Descriptive characteristics 
Additional questions on food allergy, socio-demographic parameters and trait anxiety 
were administered. The trait anxiety scale of the State and Trait Anxiety Inventory (STAI) 
was used as an anxiety measure28•29 and was completed as a self-report by adolescent 
and parents. The scale contains 20 items, which are scored on a scale ranging from 1 (no 
anxiety) to 3 (severe anxiety) for adolescents and from 1 to 4 for adults. 
Statistical analysis 
Adolescent-parent disagreement 
Comparison of outcome 
Data were analyzed using SPSS software for Windows (Version 16.0). Three methods were 
used to investigate adolescent-parent disagreement to provide sufficient information 
on such disagreement. Firstly, total FAQLQ-TF and FAQLQ-PFA scores were tested for 
significant differences (paired-sampled t-test). P<0.05 was considered to be significant. 
Secondly, total FAQLQ-TF and FAQLQ-PFA scores were correlated using intraclass 
correlation coefficients (ICC, two-way mixed-effects model). Thirdly, Bland-Altman plots 
were used to visualize the differences between FAQLQ-TF and -PF scores for individual 
adolescent-parent pairs. Therefore, the mean FAQLQ score of each adolescent-parent pair 
was plotted against the difference (FAQLQ-TF minus FAQLQ-PFA score) of each adolescent­
parent pair. As it is important to know whether a difference between FAQLQ-TF and -PFA 
scores is clinically meaningful for patients, the minimal important difference (MID) was 
used to calculate the percentage of individual adolescent-parent pairs reporting clinically 
relevant differences exceeding the MID. The MID reflects the smallest difference or change 
in HRQL score associated with a difference or change in health status that patients find 
meaningful. In HRQL questionnaires with a seven-point scale the MID is usually around 
0.530• The mean difference +/- the MID (0.5) was used as limits of agreement. The same 
procedure was followed for comparisons between FAIM-TF and -PF and between Brief­
lPQ-TF and -PF. 
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Comparison of measurement properties 
Construct validity of the FAQLQs was investigated calculating Pearson's correlation 
coefficient between FAQLQ-PFA and FAIM-PF scores and between FAQLQ-TF and FAIM­
TF scores, respectively. Moderate correlations (0.40-0.60) were expected31. Internal 
consistency was investigated using Cronbach's alpha (02:0.70 was considered to be good). 
Discriminative abilities were investigated comparing total questionnaire scores for boys 
versus girls, for adolescents who have two or less versus more than two food allergies 
(independent-samples T-tests) and for adolescents who experienced anaphylaxis32 versus 
adolescents who did not (Mann-Whitney U-test). Floor and ceiling effects were calculated 
as percentage of patients with lowest and highest total questionnaire scores, respectively. 
Factors influencing adolescent-parent disagreement on HRQL 
Univariate and adjusted linear regression analyses were performed to investigate 
factors influencing adolescent-parent disagreement. The mean difference between 
adolescent- and parent-reported HRQL (FAQLQ-TF minus FAQLQ-PFA score) was used 
as outcome variable and participant characteristics (table 1 ), illness expectations (FAIM) 
and perceptions (Brief-lPQ) were used as predictor variables. Predictor variables were 
entered into the adjusted linear regression model (enter procedure) when they were 
associated with the outcome variable in the univariate regression analysis (p<0.05). There 
was rnulticolinearity (Pearson>0.60) for the variables Brief-lPQ-TF and FAIM-TF. Therefore, 
variable Brief-lPQ-TF was deleted from the adjusted model and replaced by domain 
coherence, which was not associated with FAIM-TF. 
RESULTS 
Participants 
Questionnaire-packages were sent to 1 22 adolescent-parent pairs and returned by 
74 adolescent-parent pairs. One adolescent-parent pair was excluded, because the 
adolescent had outgrown his food allergy. Three adolescent-parent pairs were excluded 
because less than 85% of the questions were completed. Therefore, 70 adolescent-parent 
pairs were eligible for analysis. 
Table 1 shows the descriptive characteristics. Forty-eight adolescent-parent pairs were 
recruited from our clinic, of whom 31 had a food allergy confirmed by a double-blind 
placebo-controlled food challenge (DBPCFC), two by an open food challenge and fifteen 
by skin prick test, blood test or both. Twenty-two adolescent-parent pairs were recruited 
by advertisement and all reported physician-diagnosed food allergies. There were no sig­
nificant differences in descriptive characteristics (Table 1 )  between adolescents recruited 
from clinic and advertisement (p-values ranged from 0.052 [presence of sesame allergy] 
to 0.946 [presence of vegetable allergy]) or between adolescents diagnosed by means of 
a DBPCFC and otherwise diagnosed. 
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Table 1 .  Descriptive characteristics adolescent-parent pairs 
Number adolescent-parent pairs, n 
Sex adolescent, girls/boys 
Mean age adolescent, years (SD) 
















> 3 foods 




Skin and other' 
Anaphylaxis adolescent, yes/no 
Last experience of anaphylaxls, years (SD) 
Trait-anxiety adolescent, score (SD) 
Boys [norm data boys] 
Girls [norm data girls] 




Parental sex, male/female 
Parental age, years (SD) 
Parental marital status, n 
Married/ Living together 
Divorced/ Living alone 
Parental workforce participation, yes/no 









Family income, n 
(missing data) 
< Middle income1 
Middle income 
> Middle income 
Oral allergy symptoms, nose/eye symptoms etc 
2 Based on calculations Dutch Central Planning Agency 
70 
30 / 40 
1 5.3 (1 .2) 
52 
52 
1 B  
1 4  
5 




1 8  
6 
1 4  
23 
1 7  







28.5 (5.6) [28.7 (6.4)] 
3 1 .1 (7.4) [32.5 (6.6)] 
42 
3 1  
42 
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Figure 1 .  Adolescent-self-reports versus parent-proxy-reports for (A) health-related quality of life (B) 
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FAIM Food Allergy Independent 
Measure Questionnaire. FAQLQ = Food 
Allergy Quality of Life Questionnaire. IPQ 
= Illness Perception Questionnaire. 
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Figure 2. Bland Altman plots i l lustrating adolescent-parent agreement for (A) food allergy-related 
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FAIM = Food Allergy Independent 
Measure Questionnaire. FAQLQ = Food 
Allergy Quality of Life Questionnaire . 
IPQ = Illness Perception Questionnaire. 
MID = Minimal clinically Important 
Difference of HRQL instruments using a 
7-point scale. 
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Table 2. Comparison of outcome of adolescent- and parent-reports on health-related quality of life 
(FAQLQ) , illness expectations (FAIM) and perceptions (IPQ) 
Outcome Outcome Correlation 
adolescent-report parent-report adolescent- parent 
Score (SD) Score (SD) reports 
ICC 
FAQLQ, total score 3.78 (1 .39) 3.56 (1 .07) 0.61 
Allergen avoidance & 3.88 (1 .46) 
Dietary Restrictions 
Risk of accidental 3.67 (1 .59) 
Exposure 
Emotional impact 3.71 (1 .57) 
Dietary Restrictions 4.1 8  (1 .37) 
Food anxiety 3.82 (1 . 14) 
Social Restrictions 3.21 (1 .32) 
Emotional impact 3.09 ( 1 . 16) 
FAIM (illness expectations), total score 3.55 ( 1 . 10) 3.61 (0.90) 0.64 
Chance of accidental exposure 3.54 ( 1 .20) 3.36 ( 1 .06) 0.34 
Chance of severe reaction 4.57 (1 .80) 4.63 (1 .66) 0.33 
Chance of dying following exposure 2.86 (1 .60) 2.97 ( 1 .55) 0.57 
Chance of not dealing with a reaction 3.1 9 (1 .40) 3.23 ( 1 .3 1 )  0.36 
Number of products to avoid 4.16  (1 .52) 4.23 ( 1 . 12) 0.70 
Impact on social life 2.99 ( 1 .62) 3.23 (1 .45) 0.69 
Brief-lPQ (illness perceptions). 5.04 (1 .31 ) 5.32 (1.19) 0.63 
total score 
Consequences 5.77 (2.70) 5.96 (2.34) 0.60 
nmeline 9.84 (2.26) 1 0.20 (1 .95) 0.63 
Personal control 3.51 (2.27) 3 . 12  (1 .98) 0.40 
Treatment control 6.31 (2.60) 6.37 (2.93) 0.28 
Identity 4.81 (3. 13) 5.29 (2.98) 0.45 
Illness concern 4.36 (3.1 1 )  5.14 (2.70) 0.52 
Coherence (illness comprehension) 2.56 ( 1 .7 1 )  2.31 (1 .57) 0.25 
Emotional representations 3.17 (2.63) 4.1 4 (2.54) 0.51 
Open ended question: n (%) n (%) 0.31 
Main cause of food allergy (Top 5) 
No idea 26 (38) 1 5  (22) 
Genetic/ Innate 29 (42) 34 (49) 
Environmental factors 6 (9) 5 (7) 
Dysfunction of immune system 3 (4) 3 (4) 
Coincidence/ bad luck 2 (3) 5 (7) 
Other' 4 (6) 8 (1 1 )  
Hygiene i n  Western Europe, combination with other atopic disorders, food industry etc. 
Scores in boldface represent significant values (P < 0.05). 
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Comparison FAQLQ-TF and FAQLQ-PFA 
There was no significant difference between FAQLQ-TF and FAQLQ-PFA total scores (3.78 
versus 3.56, p=0. l 03, df = 69) and the correlation between them was good (Table 2, Figure 
l A). The Bland-Altman plot illustrates that 63% of the differences between adolescent­
and parent-reported HRQL of all individual adolescent-parent pairs exceeded the limits of 
agreement reflecting the mean difference +/- the minimal clinically important d ifference 
(Figure 2A), i.e. 63% of all adolescent-parent pairs reported clinically relevant differences 
in the adolescent's HRQL. 
Measurement properties oft he FAQLQ-TF and -PFAwere considered to be good (Table 3). 
Comparison FAIM-TF and -PF 
There was no significant difference between adolescent- and parent-reported tota l FAIM 
scores (3.55 versus 3.6 1 ,  p=0.574) or between individual item scores (Table 2) .  There was 
a good correlation between adolescent- and parent-reported total FAIM scores (Figure 
1 B), and for the items "number of products to avoid" and "impact on social life''. There were 
moderate to poor correlations between adolescent- and parent-reports for the other items 
(Table 2). The Bland-Altman plot illustrates that 53% of all adolescent-parent pairs showed 
differences between adolescent- and parent-reported FAIM scores which exceeded the 
MID (Figure 28). 
Measurement properties of the FAIM-TF and -PF were considered to be good (Table 3). 
Comparison brief-lPQ-TF and -PF 
There was a significant difference between adolescent-self and parent-proxy-reported IPQ 
total scores (5.04 versus 5.32, p=0.037), item 'illness concern" (4.36 versus 5.1 4, p=0.024) 
and item "emotional representations" (3.1 7 versus 4. 1 4, p=0.002) (Table 2). The differences 
for the items exceeded the smallest detectable change (SDC)27• In other words, parents 
reported more emotions and concerns about food allergy than adolescents themselves. 
There was a good correlation between adolescent- and parent-reported total brief-lPQ 
scores (Figure 1 C). Items "treatment control" and "coherence" showed poor correlations 
(Table 2). The Bland-Altman plot illustrates that relevant differences were shown for some 
adolescent-parent pairs (Figure 2C). 
Measurement properties of the brief-lPQ-TF and -PF were considered to be moderate 
to good (Table 3). 
Factors influencing adolescent-parent disagreement on HRQL 
The final adjusted model explained 40.7% of variance in the difference between 
adolescent- and parent-reported HRQL (p<0.001 ); i.e. increased age of the adolescent 
( 1 6-1 7 years), higher perceived disease severity (FAIM-TF) and poorer adolescent­
reported perceived illness comprehension (coherence) all contributed significantly to a 
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larger difference between adolescent- and parent-reported HRQL (Table 4). There was 
borderline significance for the association between last experience of anaphylaxis and the 
difference between adolescent- and parent-reported HRQL; i.e. a more recent diagnosis of 
food allergy causes a larger difference between adolescent- and parent-reported HRQL. 
The effect of parental workforce was confounded by the variables adolescent coherence 
and age. 
Interestingly, adolescent-reported illness perceptions and expectations showed 
stronger associations with the mean difference on HRQL than parent-reported illness 
perceptions and expectations. 
Table 3. Comparison of measurement properties of the Food Allergy Quality of Life Questionnaires, 
(FAQLQ), Food Allergy Independent Measure (FAIM) and Illness Perception Questionnaire (IPQ) 
Validity 
Internal Floor& Ceiling 
Discriminative abilities 
Consistency effects' 
Sex Number food Anaphylaxis 
allergies 
Pearson a % I % boys vs girls :s:2 VS >2 no vs yes 
FAQLQ-TF 0.77 0.96 0 I 0 3.58vs 4.04 3.52 vs 4.06 3.1 4 vs 4.03 
{p=0.1 67) (p=0.1 1 0) (p=0.023) 
AADR 0.61 0.93 1 .4 / 1 .4 n.p.' n.p. n.p. 
RAE 0.74 0.85 2.9 I 1 .4 n.p. n.p. n.p. 
El 0.66 0.89 1 .4 / 1 .4 n.p. n.p. n.p. 
FAQLQ-PFA 0.64 0.94 0 I 0 3.36 VS 3.83 3.42 VS 4.04 2.88 vs 3.79 
(p=0.039)' (p=0.004) 
DR 0.58 0.89 0 I 0 n.p. n.p. n.p. 
FA 0.53 0.77 0 I 0 n.p. n.p. n.p. 
SR 0.44 0.82 2.9 I 1 .4 n.p. n.p. n.p. 
El 0.61 0.84 1.4 / 0 n.p. n.p. n.p. 
FAIM-TF n.a.• 0.81 0 I 0 3.44 vs 3.69 3.24vs 3.90 3.01 vs 3.75 
{p=0.343) (p=0.01 1 )  (p=0.029) 
FAIM-PF n.a. 0.73 0 I 0 3.50 vs 3.74 3.42 vs 3.82 3. 1 5 vs 3.77 
(p=0.273) (p=0.064) (p=0.016) 
Brief-lPQ-TF n.a. 0.59 0 I 0 4.83 VS 5.35 4.79 vs 5.30 4.79 VS 5.1 7 
(p=0.1 00) (p=0.1 08) (p=0.343) 
Brief-lPQ-PF n.a. 0.66 0 I 0 5.06 vs 5.69 4.99 vs 5.65 4.93 vs 5.46 
(p=0.027) (p=0.013) (p=0.079) 
Percentage of patients with the minimal (floor) or maximal (ceiling) questionnaire score. 
2 n.p. not performed 
3 The FAQLQ-PF discriminated between adolescents with :s:3 food allergies versus >3 food allergies 
4 n.a. not applicable. 
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Table 4. Univariate & adjusted associated factors influencing adolescent-parent agreement on 
HRQL 
Univariate associations Adjusted associations 
B R' (%) p Cl B p Cl 
Adolescent characteristics 
Sex (girls versus boys) -0.002 0.0 0.995 -0.532 - 0.529 
Age ( 13- 15 versus 16-1 7 years) 0.710  9.2 0.01 1 0.1 71 - 1 .249 0.823 0.001 0.332 -
1 .314 
Number food allergies 0.1 53 0.5 0.562 -0.372 - 0.678 
(0-2 versus >2) 
Anaphylaxis (no versus yes) -0.D28 0.0 0.926 -0.628 - 0.572 
Last experience of anaphylaxis -0.073 9.3 0.01 1 -0. 129 - -0.D1 8 -0.049 0.052 -0.098 -
(how long ago in years) 0.000 
Anxiety (STAI-TF) 0.01 7 2.9 0.1 61 -0.007 - 0.040 
Adolescent-reported perceived 0.365 1 3.4 0.002 0.140 - 0.590 0.21 6  0.040 0.01 0 -
disease severity (FAIM-TF) 0.422 
Adolescent-reported illness 0.413  24.3 <0.001 0.235 - 0.592 
perceptions (IPQ-TFJ 
Coherence 0.230 1 2.9 0.002 0.084 - 0.375 0.229 0.002 0.091 -
(illness comprehension) 0.367 
Emotional perceptions 0.182 1 8.7 <0.001 0.090 - 0.275 
Cognitive perceptions 0.309 1 2.8 0.003 0.1 1 2 - 0.505 
Parent characteristics 
Sex (female versus male) -0.013 0.0 0.977 -0.888 - 0.862 
Age (years) -0.020 0.5 0.561 -0.088 - 0.048 
Marital status 0.1 36 0.2 0.742 -0.688 - 0.961 
(together versus alone) 
Workforce participation 0.628 6.2 0.038 0.Q35 - 1 .221 0.203 0.447 -0.327 -
(no versus yes) 0.732 
Education (:s vocational versus -0.1 16  0.3 0.676 -0.669 - 0.437 
> vocational) 
Anxiety (STAI-PF) 0.026 2.9 0.1 62 -0.01 1 - 0.063 
Family income 0.266 1 .0 0.461 -0.451 - 0.983 
(:s middle versus > middle) 
Parent-reported perceived 0.047 0.2 0.750 -0.246 - 0.340 
disease severity (FAIM-PF) 
Parent-reported illness 0.067 0.6 0.539 -0. 149 - 0.283 
perceptions (IPQ-PF) 
Coherence -0.032 0.3 0.680 -0. 1 88 - 0.123 
(illness comprehension) 
Emotional representations 0.D28 0.4 0.615  -0.081 - 0.1 37 
Cognitive representations 0.080 0.7 0.477 -0.144 - 0.304 
Scores in boldface represent significant values (P < 0.05). 
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DISCUSSION 
This is the first study comparing self- and parent-reports on the adolescent's HRQL in 
food allergic adolescents using valid and disease-specific HRQL-instruments. Although 
substantial correlations and no significant differences were shown between adolescent­
self and parent-proxy-reported HRQL on a 9IQYQ....level, there was a clinically important 
difference in HRQL scores (i.e. exceeding the minimal important difference) for 63% of 
all individual adolescent-parent pairs; i.e. 63% of all individual adolescent-parent pairs 
reported clinically relevant differences in the adolescent's HRQL. As the minimal important 
difference reflects the smallest difference in HRQL score associated with a difference 
in health status that patients find meaningful, this is a very important parameter in 
interpreting our study results. Clinicians should thus be aware of disagreement in 
perspectives on the adolescent's HRQL and the factors contributing to such disagreement. 
Several factors were associated with adolescent-parent disagreement on the 
adolescent's HRQL. It was quite revealing that the adolescent's characteristics (age, last 
experience of anaphylaxis), illness perceptions and expectations (table 4) had much 
stronger associations with the mean difference on the adolescent's HRQL than parent­
proxy perceptions and expectations. In other words, a high subjective disease severity 
(amount of products to avoid, chance of severe reaction following exposure, etc.) and 
worse subjective illness comprehension (perceived understanding food allergy) as 
perceived by the adolescent caused larger differences between adolescent- and parent­
reported HRQL, whereas the same perceptions as perceived by the parent were not 
associated with the difference between adolescent- and parent-reported HRQL. This 
suggests that adolescents mainly determine adolescent-parent disagreement on the 
adolescent's HRQL, because most determinants of the adolescent's HRQL are poorly 
perceived by their parents. 
Additionally, adolescent's age was associated with adolescent-parent disagreement 
on the adolescent's HRQL. We found better adolescent-parent agreement for younger (13-
15 years) than for older adolescents (16-17 years). Associations between age and child­
parent agreement on HRQL have been previously shown33-35• We previously studied food 
allergic children aged 8-12 years35 and reported better child-parent agreement for older 
(11-12 years) than for younger children (8-10 years). This may be caused by the fact that as 
children mature they become more articulate in expressing their feelings or concerns and 
consequently, parents may have a better insight into their child's HRQL. The age-effect in 
the current study may be caused by the fact that as adolescents mature, they spend less 
time under parental supervision and develop their independence. Consequently, older 
adolescents may be less influenced by their parents and parents may have less insight into 
their older adolescent's HRQL. These factors may negatively influence adolescent-parent 
agreement. It thus seems likely that child-parent agreement on the impact of food allergy 
on the child's HRQL is associated with age and that child-parent agreement is highest for 
food allergic children aged 11-15 years. 
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As it was previously shown that family conflict negatively impacts on self-management 
behavior of diabetic adolescents1 4•1 5, it is possible that adolescent-parent disagreement 
on the adolescent's HRQL may influence self-management behavior of food allergic 
adolescents as well. As poorer adolescent-reported illness comprehension was associated 
with adolescent-parent disagreement, this may be a target for intervention aimed at 
reducing disagreement. The impact of illness comprehension on adolescent-parent 
disagreement may also be reflected by the fact that a less recent diagnosis of food 
allergy (last experience of anaphylaxis) was associated with better adolescent-parent 
agreement. Adolescents with a less recent diagnosis of food allergy and their parents 
have probably visited clinicians more often and may have improved their comprehension 
of food allergy resulting in better adolescent-parent agreement on HRQL. Although the 
relationship between adolescent-parent disagreement on the adolescent's HRQL and 
self-management behavior is hypothetical in food allergy, illness comprehension of the 
adolescent may be an important target for intervention aimed at reducing disagreement. 
Future studies might focus on education programs for adolescents able to improve 
their understanding of food allergy. Such programs may also reduce adolescent-parent 
disagreement and improve self-management. 
Our results provide insight into several determinants of adolescent-parent 
disagreement on the adolescent's HRQL. As 59.3% of the variance in the difference 
between self and parent-proxy-reports on the adolescent's HRQL has not been explained 
yet, further research may identify additional variables influencing adolescent-parent 
disagreement. Parental gender may be such a variable. In our study, the FAQLQ-PFA was 
mainly completed by mothers. As fathers may have a different view on their adolescent's 
HRQL than mothers, this may influence adolescent-parent disagreement. 
There is no consensus in literature on whether parents systematically report poorer 
or better HRQL than their child20-22,35 - 37_ These differences in results may depend on 
several factors such as the disease studied, the instruments used, the age of the child and 
culture. However, there is consensus on the fact that there generally is moderate child­
parent agreement on the child's HRQL. Therefore, it is important to recognize the fact that 
there is disagreement and to discuss areas, determinants and possible consequences of 
disagreement with child-parent pairs. 
In summary, the FAQLQ-TF and -PFA should be used together to highlight areas of 
adolescent-parent disagreement which require special attention. There is moderate 
adolescent-parent agreement on the adolescent's HRQL. Disagreement is determined 
mainly by the adolescent's characteristics and perceptions of food allergy rather than the 
parent's perceptions and characteristics. Illness comprehension of the adolescent may be 
an important target for intervention aimed at reducing adolescent-parent disagreement 
on the adolescent's HRQL. 
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APPENDIX 1 
Food Allergy Quality of Life Questionnaire-Parent Form-Adolescents aged 1 3-1 7 
years {FAQLQ-PFA) 
Instructions for participants:The following are all scenarios that parents have told us affect 
their adolescent's quality of l ife because of food allergy. Please indicate how much of an 
impact each scenario has on your adolescent's quality of life by placing a tick or a cross in 
one of the boxes number 0-6. If you believe the scenario has no impact please choose O 
(not at al l). 
0 2 4 5 6 
Not at all Barely Slightly Moderately Quite a bit Very much Extremely 
Question 0 , 2 3 4 s 6 
1. My teenager always eats the same foods because of food allergy. D D D D D D D 
2. My teenager has a restricted diet because of food allergy. D D D D D D D 
3. My teenager cannot experiment with different foods on holiday because of food allergy. D D D D D D D 
4. My teenager misses out because of food allergy. D D D D D D D 
5. My teenager is more cautious generally because of food allergy. D D D D D D D 
6. My teenager sticks to foods he/she knows. D D D D D D D 
7. My teenager has to be more sensible than his/her peers because of food allergy. D D D D D D D 
8. My teenager takes more of an interest in food because of food allergy. D D D D D D D 
9. My teenager reads the label on everything he/she eats. D D D D D D D 
10. My teenager is frustrated about food labeling. D D D D D D D 
1 1 .  My teenager is more wary of situations because of food allergy. D D D D D D D 
12. My teenager feels different because he/she cannot eat what his/her friends can eat. D D D D D D D 
13. My teenager feels anxious in restaurant. D D D D D D D 
14. My teenager finds it difficult to ask about food ingredients in restaurant. D D D D D D D 
1 5. My teenager avoids telling people about his/her food allergy until he/she knows them well. D D D D D D D 
16. My teenager gets irritated by his/her food allergy. D D D D D D D 
17. My teenager worries as he/she always has to carry a bag because of his/her medication. D D D D D D D 
18. School trips away are not easy for my teenager. D D D D D D D 
19. My teenager worries that he/she can only eat in a limited range of restaurants. D D D D D D D 
20. My teenager has been really scared by having a reaction. D D D D D D D 
21.  My teenager feels nervous around the food they are allergic to because of food allergy. D D D D D D D 
22. My teenager gets frightened about food allergy. D D D D D D D 
23. I feel my teenager has had to grow up more quickly because of food Allergy. D D D D D D D 
24. My teenager has to be more responsible than other teenagers. D D D D D D D 
25. My teenager has been teased because of food allergy. D D D D D D D 
26. My teenager gets frustrated because of food allergy. D D D D D D D 
27. My teenager feels different to other teenagers because of food allergy. D D D D D D D 
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ABSTRACT 
Objective: Currently, the longitudinal validity (validity over time) and responsiveness 
(abil ity to measure change over time) of the Food Allergy Quality of Life Questionnaire­
Adult Form, -Teenager Form and -Child Form (FAQLQ-AF, -TF, -CF) are unknown. Additional ly, 
the self-reported impact of a double-blind placebo-controlled food challenge (DBPCFC) 
on health-related quality of life (HRQL) in adults (� 1 8  years), adolescents ( 1 3-1 7 years) 
and children (8- 12  years) is currently unknown. The aims of this study were to assess the 
longitudinal validity and responsiveness of the FAQLQ-AF, -TF and -CF and to assess the 
impact of a DBPCFC on H RQL. 
Methods: Two-hundred-and-twenty-one participants suspected of food allergy were 
included from Dutch allergy centers. Participants undergoing a DBPCFC (experimental 
group) completed the FAQLQ and Food Allergy Independent Measure (FAIM) 1 month 
before (baseline) and 6 months after (follow-up) a DBPCFC. Participants not u ndergoing a 
DBPCFC (control group) completed the questionnaire-package twice with a seven-month 
interval. 
Results: HRQL improved following a DBPCFC with greater improvements in HRQL 
following a negative outcome (food al lergy ruled out) than a positive outcome (food 
allergy confirmed), demonstrating responsiveness of the FAQLQs. Significant correlations 
were shown between the change (follow-up minus baseline) in FAQLQ and FAIM scores 
supporting the longitudinal validity of these questionnaires: FAQLQ-AF (Pearson=0.71 ,  
p<0.001 ), FAQLQ-TF (Pearson=0.35, p=0.01 8) and FAQLQ-CF (Pearson=0.51 ,  p<0.001 ). 
Conclusions: Our findings demonstrate the longitudinal val idity and responsiveness of 
the FAQLQs. Greater improvements in HRQL were shown after a negative outcome than a 
positive outcome. 
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INTRODUC TION 
Food is essential for life and important in social activities. Consequently, living with food 
allergy may seriously disrupt daily life of food allergic patients 1. They are often afraid of 
allergic reactions on accidental exposure and are continuously faced with dietary and 
social restrictions2• Health-Related Quality of Life (HRQL) instruments can be used as 
outcome measures to evaluate this impact of food allergy and its subsequent interventions 
on HRQL3• HRQL is of particular interest as an outcome measure for food allergy, because 
symptoms of this disease are infrequent and mortality is low. 
Recently, the self-administered Food Allergy Quality of Life Questionnaire-Adult Form, 
-Teenager Form and -Child Form (FAQLQ-AF, -TF, -CF) were developed for measuring HRQL 
in food allergic patients2A,5_ The FAQLQ-AF, -TF and -CF were shown to be valid, reliable 
and discriminative instruments2A-6• However, HRQL-instruments that will be used as 
outcome measures in clinical trials must correlate over time with other relevant measures 
(longitudinally validity) and must be able to measure small but relevant HRQL changes 
over time (responsiveness)3.7. Currently, the longitudinal validity and responsiveness of 
the FAQLQ-AF, -TF and -CF are unknown. 
A double-blind placebo-controlled food challenge (DBPCFC), which is the gold 
standard for diagnosing food allergy, is likely to cause HRQL changes over time, especially 
if the test is negative (food allergy ruled out). Until now, only one study has been published 
on the impact of food challenges on HRQL. This study showed that parent-proxy-reported 
HRQL of food allergic children (0-12 years) improves following a food challenge3• So far, 
no studies have been published on the impact of a DBPCFC on HRQL in adolescents (13-
1 7  years) and adults (� 1 8  years). As these age-groups are developmentally different, the 
experience of food allergy and its subsequent interventions may differ for each age­
group. Additionally, no studies have been published on the impact of a DBPCFC on HRQL 
in children (8-12 years) from the child's perspective, whereas it is well known that there 
generally is child-parent disagreement on the child's HRQL8•9• Finally, no studies have 
been published comparing HRQL in participants who undergo a DBPCFC with control 
participants. 
Therefore, the aims of this study were to investigate the longitudinal validity and 
responsiveness of the FAQLQs and to investigate the self-reported impact of a DBPCFC on 
HRQL of food allergic adults, adolescents and children. 
METHODS 
Participants and procedures 
Adults (� 18 years), adolescents (13-17 years) and children (8-12 years), who were awaiting 
a clinically indicated DBPCFC were included from Dutch allergy centers in Groningen and 
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Voorburg between May 2007 and January 2011. The only criterion used for referral for 
DBPCFC was a clinical suspicion of food allergy. lgE measurements, skin prick tests or prior 
history of anaphylaxis were not routinely used in our decision to refer for DBPCFC. The two 
centers collaborate on uniform methodology of DBPCFC procedure10•1 1 • A DBPCFC consists 
of a placebo and active challenge, which were randomly administered on separate days 
with at least a two-week interval in between. Participants and any individuals with patient 
contact were blinded to the sequence of the two challenges. 
All patients visiting the clinic with suspected food allergy were placed on the waiting 
list for a DBPCFC on a first come first served basis. Participants were included in the 
experimental group or control group based on the expected duration of time spent on 
the waiting list for DBPCFC. Participants who were expected to have a DBPCFC within 
six months were included in the experimental group and completed the questionnaire­
package at home one month before (baseline) and six months after (follow-up) a DBPCFC 
(placebo and active challenge) was performed. Participants who were not expected to 
have a DBPCFC within six months were included in the control group and completed the 
questionnaire-package twice with a seven-month interval without undergoing a DBPCFC 
(no placebo or active challenge). Additionally, participants recruited through Dutch food 
allergy support organizations were included in the control group when they reported a 
physician diagnosed food allergy. 
Participants were excluded from the study if diagnostic/therapeutic interventions or 
accidental ingestions resulting in clinical allergic reactions (Mueller classification grade 1 1 1/ 
IV) had taken place between baseline and follow-up measurement or when less than 85% 
of the questions were completed. Possible differences between descriptive characteristics 
of participants recruited in the participating centers and between participants from the 
control and experimental group were examined using Chi-square-test (nominal data) and 
Mann-Whitney-test (ordinal, continuous data). 
This study was approved by the local medical ethics review commission who deemed 
that permission from the commission was not required. 
Questionnaires 
Food Allergy Quality of Life Questionnaires (FAQLQs) 
The Dutch FAQLQ-Adult Form (FAQLQ-AF)2, -Teenager Form (FAQLQ-TF)5 and -Child Form 
(FAQLQ-CF)4 are self-reported, disease-specific instruments for measuring the impact of 
food allergy on the adult's (� 18 years)2, adolescent's (13-17 years)5 and child's (8-12 years) 
HRQL 4, respectively. The FAQLQ-AF contains 29 items and 4 domains (Risk of Accidental 
Exposure, Emotional Impact, Allergen Avoidance & Dietary Restrictions, and Food Allergy 
related Health). The FAQLQ-TF contains 23 items and 3 domains (Allergen Avoidance & 
Dietary Restrictions, Risk of Accidental Exposure, and Emotional impact). The FAQLQ-CF 
contains 24 items and 4 domains (Risk of Accidental Exposure, Emotional Impact, Allergen 
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Avoidance, and Dietary Restrictions). Each item is scored on a seven-point scale. Total 
FAQLQ score of each questionnaire is the mean of all items and ranges from 1 (minimal 
impairment in HRQL) to 7 (maximal impairment in HRQL). 
Food Allergy Independent Measure (FAIM) 
The FAIM12, a self-report instrument, reflects the participant's perceived food allergy severity 
and food allergy-related risk. The FAIM consists of four expectation of outcome questions, 
which capture the participants' perceived expectation of the chance of accidental exposure 
and of what will happen following accidental exposure. These expectations are likely to 
be the source/predictors of HRQL changes in anaphylactic disorders 1 3. Additionally, the 
FAIM contains two questions which reflect disease severity. Each question was scored on 
a seven-point scale. Total FAIM score is the mean of all items and ranges from 1 (limited 
severity perception) to 7 (greatest severity perception). Instruments based on the method 
of expectation of outcome questions have proved to be useful independent measures for 
evaluating the construct validity of HRQL-instruments2•4•5•14•16 and are used in this study to 
evaluate the longitudinal validity of the FAQLQs. 
Statistical analysis 
Data were analyzed using SPSS software for Windows (Version 18.0). 
Change in HRQL and perceived disease severity following DBPCFC 
Changes in HRQL (follow-up minus baseline FAQLQ scores) were tested for significance 
(Wilcoxon signed rank test). P values �0.05 were considered to be statistically significant. 
The overall difference in HRQL changes was calculated as follows: HRQL change 
experimental group minus HRQL change control group. Following the outcome of the 
DBPCFC, participants in the experimental group (Exp_total) were split into three groups: 
1. positive outcome, i.e. food allergy in question confirmed (Exp_pos), 2. negative 
outcome, i.e. food allergy in question ruled out (Exp_neg), 3. questionable outcome, i.e. 
food allergy not confirmed/not ruled out (Exp_quest). Additionally, a subgroup analysis 
was performed on participants with a negative outcome and no remaining other food 
allergy (Exp_neg_NRFA). Changes in FAIM scores were analyzed in the same way. 
Relevance of changes in HRQL following DBPCFC 
Both a statistical and clinical method were used to evaluate whether a change in HRQL 
was considered to be relevant. 
Firstly, the smallest change in HRQL that is considered to be statistically important is 
called the standard error of measurement (SEM=ox.JJ -r,, ) 1 7•18• ox represents the standard 
deviation of the FAQLQ baseline measurement and rxx represents the reliability or intra 
class correlation coefficient of the FAQLQs6•1 4• 
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Secondly, the smallest change in H RQL that is considered to be clinically important 
by participants, is called the minimal important difference (MID) 19• The MID has been 
estimated to be approximately 0.5 in several HRQL questionnaires using a seven-point 
scale3•1 7•19•20 and can be used to calculate the therapeutic va lue of an intervention. The 
therapeutic value of an intervention is defined as the number of participants who 
need to undergo the intervention for one participant to have a cl inically important 
improvement over and above that which he/she would have experienced with the control 
intervention. The therapeutic value of a DBPCFC was calculated using the methodology 
of numbers needed to treat (NNT)21 • Percentages of participants who improve, remain 
stable and deteriorate were calculated as follows: change in  H RQL scores <-0.5 (important 
improvement in HRQL), between -0.5 and 0.5 (unchanged HRQL) and >0.5 (important 
deterioration in HRQL). The proportion of participants who fared better fol lowing a 
DBPCFC or who fared better in the control group were calculated from the proportion of 
participants with an important improvement in HRQL, unchanged HRQL or an important 
deterioration in H RQL (table 1 ). The overall proportion of participants who benefit from a 
DBPCFC is the difference of the two abovementioned proportions. The NNT of a DBPCFC 
is the reciprocal of the proportion of participants benefiting from DBPCFC. 
Table 1 .  Calculation of the proportion of patients showing improvement (HRQL change<-0.5), 
no change (HRQL change between -0.5&0.S) or deterioration (HRQL change>O.S) in their HRQL 
following a Double Blind Placebo Controlled Food Challenge (DBPCFC) 
Negative outcome DBPCFC Positive outcome DBPCFC 
(food allergy ruled out) (food allergy confirmed) 
Proportions improved unchang deterio Improved Unchang deterio 
DBPCFC (u) ed (vi rated (w) (xi ed (y) rated (z) 
Adults (0.63) (0.25) (0. 1 3) (0.46) (0.42) (0.13) 
Proportions Adolescents (0.69) (0.23) (0.08) (0.28) (0.48) (0.24) 
Control group Children (0.39) (0.48) (0.1 3) (0.42) (0.45) (0.13) 
improved {a) (au) (av) (aw) (ax) (ay) (az) 
Adults (0.25) 0.16 0.06 0.03 0.1 1 0.1 0 0.03 
Adolescents (0.44) 0.30 0.1 0  0.03 0. 1 2  0.21 0.1 1 
Children (0.20) 0.08 0. 1 0  0,03 0.08 0.09 0.03 
unchanged (b) (bu) (bv) (bw) (bx) (by) (bz) 
Adults (0.75) 0.47 0.1 9  0.09 0.34 0.3 1 0.09 
Adolescents (0.48) 0.33 0.1 1 0.04 0.1 3 0.23 0.12 
Children (0.55) 0.22 0.26 0.07 0.23 0.25 O.o? 
deteriorated (c) (cu) (cv) (cw) (ex) (cy) (cz) 
Adults (0.00) 0.00 0.00 0.00 0.00 0.00 0.00 
Adolescents (0.08) 0.06 0.02 O.Ql 0.02 0.04 0.02 
Children (0.25) 0.1 0  0.1 2 0.03 0.1 0  0.1 1 0.03 
The proportion of patients who fared better following a negative DBPCFC is the sum of bu, cu and cv. The 
proportion of patients who fared better in the control group is the sum of av, aw and bw. 
The proportion of patients whose outcome is the same irrespective of a positive diagnosis is the sum of au, bv 
and cw. Proportions following a positive DBPCFC were calculated in the same way. 
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Factors influencing HRQL changes 
Multiple linear regression analysis was performed to correct for factors possibly influencing 
change in HRQL. The change in FAQLQ scores was used as the dependent variable. The 
outcome of the DBPCFC (positive versus control/ negative versus control) and possible 
confounders (type of recruitment, center of recruitment, age, baseline HRQL scores and 
number of food allergies) were used as independent variables. 
Responsiveness of the FAQLQs 
Changes in HRQL scores were calculated and tested for significance (see change in HRQL 
following DBPCFC) to investigate the ability of the FAQLQs to measure relevant changes 
over time (responsiveness), 
Longitudinal validity of the FAQLQs 
Pearson's correlation coefficients were calculated between the change in FAQLQ scores 
and change in FAIM scores to assess the longitudinal validity of the FAQLQs. Moderate 
correlations were expected22• 
RESULTS 
Participants 
Questionnaire packages were sent to 392 participants and returned by 299 participants 
(response rate 76%) (Table 2). Follow-up questionnaire packages were returned by 235 
participants (response rate 79%). Fourteen participants were excluded (reasons listed in 
table 2). Therefore, 221 participants were eligible for analysis. Participant characteristics are 
shown in Table 3. There were no significant differences between participants in the control 
group and the experimental group, except for the mean age of adults (control group 49.3 
years, experimental group 32.4 years, p=0.002). Specifically, there were no differences 
between participants recruited from the two participating centers (experimental group) 
or between participants recruited by advertisement or from the clinic (control group) 
[data not shown]. 
Change in HRQL following DBPCFC 
There were no significant differences in baseline HRQL (FAQLQ) scores between the 
experimental and control group (adults p=0.956, adolescents p=0.622 and children 
p=0.908) or between patients recruited from the two participating centers (adolescents 
p=0.782, children p=0.384) or between participants recruited by advertisement or from 
the clinic (adolescents p=0.777) except for adults (5.68 vs 3.78, p=0.009). 
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Table 2. Flow chart participant recruitment 
All ages .-;18 years 1 3-17 years 8-1 2 years 
Recruited participants, n 392 1 37 1 1 7  1 38 
Returned 1st packages, n 299 92 96 1 1 1  
Returned 2nd packages, n 235 79 77 79 
Excluded participants, n 1 4  6 6 2 
<85% of questions completed 4 1 2 
Management intervention 6 2 4 
Did not complete DBPCFC 3 3 
Severe anaphylactic reaction 
prior to follow up measurement 
Included, n 221 73 7 1  77  
Experimental (Voorburg/Groningen), n 1 56 (20/1 36) 53 (0/53) 46 (6/40) 57 (1 4/43) 
Control, n (clinic/food allergy support 65 (42/23) 20 ( 1 4/6) 25 (9/16) 20 ( 1 9/ 1 )  
organizations) 
Table 3. Participant characteristics 
Age-group .-;18 years 1 3-1 7 years 8-12 years 
n' %2 (n, exp') n % (n, exp) n % (n, exp) 
Number 73 1 00% (53) 71 1 00% (46) 77 1 00% (57) 
Sex, female 58 79% (44) 35 49% (23) 29 38% (22) 
male 1 5  21% (9) 36 5 1 %  (23) 48 62% (35) 
Mean age, years (SD) 35.8 (1 4.9) 15.2 ( 1 .4) 10.4 (1 .6) 
DBPCFC 
Peanut 20 27% (204) 23 32% (23) 25 32% (25) 
Nut 1 2  1 6% ( 1 2) 9 1 3% (9) 18 23% ( 18) 
Milk 2 3% (2) 8 1 1 % (8) 7 9% (7) 
Egg 3 4% (3) 3 4% (3) s 6% (SJ 
Wheat 8 1 1 % (8) 1 1 %  ( 1 )  
Soy 4 5% (4) 3 4% (3) 1 %  ( 1 )  
Sesame 4 5% (4) 
Number of food allergies 
1 food 1 7  23% (1 3) 12 1 7% (9) 20 26% ( 1 3) 
2 foods 14 1 9% (1 2) 22 3 1 %  ( 1 3) 26 34% ( 1 7) 
3 foods 1 2  1 6% (9) 15  21% (9) 12 1 6% ( 10) 
> 3 foods 30 41% ( 1 9) 22 31% (1 5) 19 25% (1 7) 
Symptoms 
Cardiovascular 39 53% (29) 34 48% (21 )  1 9  25% ( 1 3) 
Respiratory 67 92% (49) 61 86% (42) 58 75% (41 )  
Gastro-intestlnal 44 60% (31 )  43 61% (28) 41 53% {26) 
Skin 53 73% (38) so 70% (30) 46 60% (32) 
Ever experienced anaphylaxls? 
Yes 62 85% (46) 55 77% (35) 56 73% (41 )  
No 1 1  1 5% (7) 16 23% (1 1 )  21 27% ( 16) 
n = number of participants (sum of experimental and control) 
% = percentage of participants {sum of experimental and control) 
(exp) = the number of participants in the experimental group 
DBPCFC not performed in participants of the control group 
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For adults, HRQL improved significantly fol lowing a DBPCFC when a l l  outcomes of the 
test were combined (baseline=4.35, fol low-up=3.8 1 ,  p=0.001 ,  n=53), whereas HRQL of 
participants in the control group did not change significantly (basel ine=4.35, fol low-
up=4.24, p=0.421 ,  n=20) (Table 4). 
Table 4. Mean Food Allergy Qual ity of Life (FAQLQ) scores and Food Allergy Independent Measure 






























Exp_neg: ,. Exp_negative_NRFA 
Exp_quest: 
FAQLQ scores 
2:18 1 3-1 7 
(53/20) (46/25) 
53 46 
4.35 ( 1 . 15) 3.89 (1 .03) 
3.81 (1 .35) 3.65 ( 1 .32) 
0.001 0.1 69 
24 29 
4.56 (0.93) 3.93 ( 1 . 12) 
4.21 (1 .2 1 )  3.92 ( 1 . 1 5) 
0.036 0.905 
24 1 3  
4.24 (1 .36) 3.68 (0.90) 
3.36 (1 .47) 2.71 (1 .29) 
0.009 0.013 
6 4 
4.20 (1 .85) 3.71 (0.75) 
1 .97 (1 .41 )  1 .58 (0.50) 
0.046 0.068 
5 4 
3.93 (1 .01 ) 4.32 (0.69) 
4.1 6  (0.77) 4.72 (1 .02) 
0.225 0.273 
20 25 
4.35 ( 1 .52) 4.03 ( 1 .28) 
4.24 (1 .53) 3.69 ( 1 . 19) 
0.421 0.01 8 




3.80 ( 1 .45) 
3.25 (1 .39) 
0.002 
31  
3.75 (1 .44) 
3.36 (1 .28) 
0.041 
23 
3.93 (1 .47) 
3.1 4 (1 .54) 
0.018 
4 
3.39 (1 .5 1 )  
2.55 (1 .5 1 )  
0.465 
3 
3.21 (1 .70) 
2.97 (1 .62) 
0.593 
20 
3.77 (1 .27) 














3.89 (1 .08) 
2.91 ( 1 .03) 
<0.001 
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3.3 1 (0.67) 
20 
3.79 ( 1 . 14) 
3.67 ( 1 . 18) 
0.1 95 
Experimental group, positive outcome of the DBPCFC 
Experimental group, negative outcome of the DBPCFC 
1 3-1 7 8-12 
(46/25) (57/20) 
46 57 
3.48 (0.86) 3.35 (0.97) 
3.33 (1 .05) 3.1 9 ( 1 .02) 
0.264 0.292 
29 31  
3.66 (0.89) 3.35 (0.97) 
3.76 (0.88) 3.33 (0.89) 
0.535 0.857 
1 3  23 
3.1 0  (0.83) 3.38 (0.96) 
2.35 (0.90) 3.02 ( 1 .2 1 )  
0.01 3 0.1 53 
4 4 
2.75 (0.67) 3.54 ( 1 .09) 
1 .33 (0.24) 2.88 ( 1 .7 1 )  
0.068 0.380 
4 3 
3.42(0.29) 3.1 1 (0.59) 
3.35 (0.36) 3.1 1 (0.59) 
0.593 
25 20 
3.75(1 .07) 3.31 (0.98) 
3.79 (0.85) 3.37 ( 1 .0 1 )  
0.884 0.75 1 
Experimental group, negative outcome of the DBPCFC and no remaining food allergy 
Experimental group, questionable outcome of the DBPCFC 
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A great improvement in HRQL was shown following a negative outcome (food allergy 
ruled out, n=24) and when there was no remaining other food allergy (baseline=4.20, 
follow-up=l .97, p=0.046, n=6). A smaller significant improvement in HRQL was shown 
following a positive outcome (baseline=4.56, follow-up=4.21, p=0.036, n=24). Following 
a questionable outcome, there was no significant change in HRQL (baseline=3.93, follow­
up=4.16, p=0.225, n=S). For children, similar results were shown. For adolescents, HRQL 
improved significantly following a negative DBPCFC (baseline=3.68, follow-up=2.71, 
p=0.013, n=l 3). However, HRQL did not improve significantly following a positive outcome 
(baseline=3.93, follow-up=3.92, p=0.905, n=29), whereas the HRQL of participants in the 
control group improved significantly (baseline=4.03, follow-up=3.69, p=0.018, n=25). 
Relevance of changes in HRQL following DBPCFC 
In order to assess the relevance of HRQL changes from a statistical and clinical point of 
view, the Standard error of measurement (SEM) was calculated (FAQLQ-AF=0.25, FAQLQ­
TF=0.16, and FAQLQ-CF=0.44) and the minimal important difference (MID) of 0.5 was used. 
The MID is the smallest difference in HRQL that is considered to be clinically important 
by patients. The overall improvement in HRQL following a negative DBPCFC exceeded 
the SEM and MID for adults, adolescents and children and was therefore considered to 
be statistically and clinically relevant (table 5). The overall differences in HRQL following 
a positive outcome of a DBPCFC only reached the SEM and were therefore considered 
to be statistically relevant. The overall improvement in HRQL nearly reached the MID for 
children. 
Table 5. Number needed to treat (NNT) of a double-blind placebo-controlled food challenge 
(DBPCFC) 
Outcome Overall Difference 
Proportion Proportion Proportion 
DBPCFC HRQL' 
better on better in benefiting NNT 
DBPCFC2 controP DBPCFC3 
Negative 
Adults -0.76 (p=0.023) 0.47 0. 1 9  0.28 3.56 
Adolescents -0.62 (p=0.040) 0.41 0.1 7 0.23 4.28 
Children -0.87 (p=0.023) 0.43 0.1 9 0.24 4. 1 8  
Positive 
Adults -0.24 (p=0.240) 0.34 0.23 0.1 1 8.75 
Adolescents 0.34 (p=0.078) 0.1 9  0.43 -0.24 -4. 15  
Children -0.47 (p=0.065) 0.45 0.1 9 0.26 3.83 
1 Overall difference Health-related Quality of Life (HRQL) = change experimental group (follow-up minus base­
line HRQL scores) minus change control group. A negative overall difference represents an improvement in 
HRQL. 
2 Proportion better on DBPCFC or proportion better in control group were calculated from the proportion of 
participants with an important improvement in HRQL, unchanged HRQL or an important deterioration in 
HRQL (table 1 ). 
3 Proportion benefiting DBPCFC is the difference of the two abovementioned proportions. 
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The proportion of participants with a clinically important improvement in HRQL (<-0.5) 
following a negative outcome of a DBPCFC was higher than in the control group (figure 1 ,  
Table 1 ). The proportions of participants whose HRQL was the same (-0.5 to 0.5) following 
a negative outcome was lower than in the control group. The proportion of participants 
with an important deterioration in HRQL (>0.5) were 13% (adults), 8% (adolescents) and 
13% (children) following a negative DBPCFC compared to 25% (adults), 8% (adolescents) 
and 0% (children) in the control group. The NNT of a negative DBPCFC was 4 (table 5). 
Thus, for every 4 participants who have a negative DBPCFC 1 participant has a clinically 
important improvement in HRQL. 
Following a positive DBPCFC, the NNT was higher (indicating lower effectiveness) 
compared to adults with a negative DBPCFC (table 5). Remarkably, adolescents in the 
control group fared better than adolescents following a positive DBPCFC (table 5, Figure 
1). 
Factors influencing HRQL changes 
A negative outcome of the DBPCFC resulted in improvement of HRQL compared to the 
control group after correction for confounding (Table 6). A positive outcome of the DBPCFC 
resulted in improvement of HRQL after correction for confounding in children. Having 
more than two food allergies was associated with deterioration in HRQL for children. 
Higher FAQLQ baseline scores (poorer HRQL) contributed significantly to improvement in 
HRQL for all ages. 
Table 6. Factors influencing change in HRQL scores (follow-up minus baseline) following positive 
and negative DBPCFC using multiple linear regression analysis 
Adults Adolescents Children 
B' p 95% Cl B p 95% Cl B p 95% Cl 
Outcome test 
Positive -0.16 0.68 -0.91 0.59 0.34 0.43 -0.52 1 .20 -0.94 0.02 -1 .74 -0. 1 8  
(control vs positive) 
Negative -0.74 0.03 -1 .42 -0.06 ·0.70 0.01 1 -1 .56 0.1 7  - 1 . 19  0.00 -1 .94 -0.45 
(control vs negative) 
Age (years) -0.01 0.42 ·0.03 0.01 -0.08 0.23 -0.22 0.05 0.06 0.42 -0.09 0.21 
Number of food 0.39 0.1 4 -0.1 3 0.92 0.31 0.1 6 ·0. 13  0.74 0.50 0.04 0.02 0.99 
allergies (s2 vs >2) 
FAQLQ baseline -0.26 0.02 -0.47 -0.05 -0.27 0.01 -0.45 -0.08 -0.37 0.00 -0.55 -0.20 
(1 =best HRQL to 
7= worst HRQL) 
Center recruitment n.a. n.a. n.a. n.a. -0.44 0.24 - 1 . 1 7  0.30 0.38 0.24 -0.26 1 .01 
(Voorburg vs Groningen) 
Type of recruitment -0.21 0.71 -0.89 1 .31 -0.52 0.1 1  - 1 . 1 6  0.1 2 n.a. n.a. n.a. n.a. 
(clinic vs advertisement) 
A negative B coefficient represents an improvement in HRQL. P values s0.05 were considered to be statisti· 
cally significant. 
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Figure 1 .  Percentages of participants whose HRQL deteriorate (change>0.S), show no change 
(change between -0.5&0.5) or improve (change<-0.5 following a double-blind placebo-controlled 
food challenge in A) Adults, B) Adolescents and C) Children. Additionally, Percentages of participants 
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Change in perceived disease severity (FAIM) following DBPCFC 
There were no significant differences in baseline FAIM scores between participants in the 
control and experimental group (adults: p=0.701, adolescents p=0.199, children p=0.986) 
or between participants recruited from the two participating centers (adolescents 
p=0.410, children p=0.875) or between participants recruited by advertisement or from 
the clinic (adults p=0.148, adolescents p=0.393). 
For adults, FAIM scores improved significantly following a DBPCFC when all outcomes 
of the test were combined (baseline=3.84, follow-up=3.3 l ,  p=0.001) (Table 4). A great 
improvement in perceived disease severity was shown following a negative outcome 
(baseline=3.89, follow-up=2.91, p<0.001 ). No improvement in perceived disease severity 
was shown following a positive outcome (baseline 3.91, follow-up=3.71, p=0.295). No 
change in perceived disease severity was shown in the control group (baseline=3.79, 
follow-up=3.67, p=0.195). Similar results were shown for adolescents and children. The 
percentages of participants with a clinically important change in FAIM score are shown in 
figure 1. 
Responsiveness 
All FAQLQs were able to measure changes exceeding the SEM and MID of the FAQLQs 
(Table 4). This supports the responsiveness of all FAQLQs. 
Longitudinal validation 
Significant correlations were shown between the change in FAQLQ scores and the change 
in FAIM scores for the FAQLQ-AF (Pearson 0.71, p<0.001), FAQLQ-TF (Pearson=0.35, 
p=0.018) and FAQLQ-CF (Pearson=0.51, p<0.001). This supports the longitudinal validity 
of the FAQLQs. 
DISCUSSION 
This study examined for the first time the longitudinal validity and responsiveness of the 
FAQLQ-AF, -TF and -CF and the self-reported impact of a DBPCFC on HRQL of food allergic 
patients. All FAQLQs were able to measure relevant changes in HRQL and correlated 
significantly to measures of perceived disease severity. These findings thus support the 
responsiveness and longitudinal validity of the FAQLQ-AF, -TF and -CF and the suitability 
of these instruments as outcome measures. Additionally, this study shows that adults, 
adolescents and children benefit from a negative DBPCFC and children even benefit if 
the outcome is positive. The NNT of a negative DBPCFC was four. Thus, for every four 
participants who have a negative DBPCFC, one participant has a clinically important 
improvement in HRQL. These findings thus support the large impact of food allergy on 
HRQL and illustrate which patients benefit from DBPCFC. 
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Overall, our findings are in agreement with previous literature, which showed that 
parent-proxy-reports on the child's HRQL improved significantly following a food 
challenge in children aged 0-12 years and that larger improvements in HRQL were shown 
following a negative outcome than following a positive outcome3• Additionally, other 
studies on parents' perceptions of their child's food challenge23•26 showed reduced parental 
concerns25•26 and parental anxiety24 following food challenges irrespective of the outcome 
of the challenge. It was hypothesized that these improvements in HRQUwellbeing were 
caused by the fact that a definitive diagnosis provides a sense of certainty. This hypothesis 
was based on findings that the main concerns of food allergic patients and their families 
were uncertainty and lack of information rather than fear of the challenge procedure3 and 
that a greater certainty of the diagnosis following a positive or negative outcome was 
perceived as positive in egg allergic children26• This hypothesis is further supported by our 
data showing no improvement in HRQL following challenges with an uncertain outcome. 
Thus, by providing a sense of certainty, a food challenge may have a positive impact on 
HRQL, irrespective of the outcome3•26 • 
There is much discussion on the interpretation of HRQL changes19•27-32• Different 
methods can be used to determine a minimal important change (the change in HRQL 
that is considered clinically relevant). Such methods may be distribution-based or anchor­
based. Distribution-based methods, such as the SEM, rely on scoring methods of an 
instrument and the distribution of the results29• Anchor-based methods use an external 
criterion (anchor) to interpret whether a particular magnitude of change is meaningful for 
patients/clinicians. As it is necessary to know whether the observed change is important 
from the patient's/clinician's perspective, anchor-based methods are still preferred in 
assessing the MID1 9• In our study, a distribution-based method (SEM) as well as an anchor­
based method (MID) were used. We found a statistically and clinically relevant change in 
HRQL following a negative DBPCFC, and for children following a positive DBPCFC. 
Although HRQL of adolescents improves significantly following a negative DBPCFC, 
some remarkable findings were shown for adolescents. Firstly, adolescents' HRQL did 
not improve following a positive outcome. Several factors may explain this finding. As 
different issues relating to food allergy may have different impacts at different stages of 
life2A,s, the experience of food allergy-related interventions, such as DBPCFC, may differ for 
each age-group as well. It may be that the impact of the feeling of certainty of diagnosis 
following a DBPCFC on HRQL, as is suggested by studies of parents of food allergic 
children23·26, is less relevant for adolescents themselves, because it is overshadowed by 
the impact of peer comparison and peer pressure3•33•34 on adolescent's perception of 
living with food allergy. A second remarkable finding was that HRQL of adolescents in the 
control group improved significantly, although less than the MID of 0.5 Despite this, the 
overall improvement in HRQL following a negative DBPCFC (improvement experimental 
group minus improvement control group) was statistically and clinically significant 0.62 
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(p=0.040). However, the nature of factors associated with HRQL changes in adolescents 
requires further investigation, because no predictive factors were identified in this study. 
Another unexpected finding was that HRQL of some participants deteriorated 
following a negative DBPCFC, even though this only occurred in seven participants. Further 
characterization of these participants showed that some participant characteristics tended 
to be more common in participants whose HRQL deteriorated following a negative DBPCFC 
compared to participants whose HRQL did not deteriorate. These factors are number of 
food allergies (4/2, p=0.062), percentage of peanut challenges (57%/21%, p=0.079) and 
percentage of participants who did not eat the tested food despite the negative DBPCFC 
(57%/33%, p=0.108). We hypothesize that these factors may influence deterioration in 
HRQL following a negative challenge. However, this needs further investigation with 
larger numbers of patients. 
This study also has some limitations. Although there was sufficient power to 
determine the longitudinal validity and responsiveness of the FAQLQ-AF, -TF and -CF and 
to determine the overall impact of a DBPCFC on HRQL, the power to study the impact of a 
DBPCFC in the different subgroups (age-specific & DBPCFC-outcome-specific) is moderate. 
Therefore, the sub-group analyses should be interpreted with caution. Secondly, the 
majority of participants was peanut or nut allergic, which may limit the generalisability 
of these findings to patients with other food allergies. Thirdly, due to logistic and ethical 
reasons we assigned participants to the control and experimental group based on the 
expected duration of time spent on the waiting list. Therefore, we corrected for possible 
confounders, such as method of recruitment, age and baseline HRQL scores. While a true 
randomized trial still is methodologically preferred it may be difficult to generalize results 
obtained from participants willing to be randomized to postponement of a DBPCFC to 
most other food allergic individuals. 
In summary, our results support the longitudinal validity and responsiveness of the 
FAQLQ-AF, -TF and -CF and the suitability of these instruments as outcome measures. 
Additionally, a DBPCFC is considered to be a time-consuming process and has previously 
been discussed in the literature as being potentially burdensome to patients. However, 
our study shows that children, adolescents and adults benefit from a negative DBPCFC 
and its subsequent changes in management, and children do so even if the outcome is 
positive. Thus, a DBPCFC is not only the gold standard for diagnosing food allergy, but also 
improves patient HRQL for specified groups. This provides clinicians with an additional 
reason to promote the use of DBPCFCs. Information from self-reported FAQLQs will help 
to optimize such interventions from a HRQL point of view. Further research is needed to 
study the predictors of HRQL changes following DBPCFC. 
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INTRODUCTION 
This thesis describes the reliability, longitudinal validity and responsiveness of the FAQLQ­
CF, -TF and -AF 1-3 (chapter 3, 4, 7) and the cross sectional validation of the FAQLQ-PF and 
FAQLQ-PFT for use in the Netherlands (chapter 5, 6). Additionally, generic and disease­
specific HRQL in food allergic patients were compared (chapter 2), parent-and self-reports 
on the patient's HRQL of food allergic children and adolescents were compared (chapter 
5, 6) and finally, the impact of a DBPCFC and its subsequent changes in management 
were analyzed (chapter 7). 
Considering the studies on the psychometric properties of the FAQLQs, this thesis 
provides for the first time evidence of the good reliability (chapter 3), the internal validity 
(chapter 2), longitudinally validity and responsiveness (chapter 7) of the FAQLQ-CF, -TF 
and -AF 1-3, Additionally, chapter 5 and 6 provide evidence of the cross-cultural validity of 
the FAQLQ-PF and PFT. Continuing the previously published findings on the development 
and the construct validity of the FAQLQs1 -5, this thesis thus presents emerging evidence 
on the suitability of the FAQLQs as tools capable of measuring self- and parent-reported 
HRQL of food allergic children, adolescents and adults. Moreover, the FAQLQ-CF, -TF 
and -AF are the only longitudinally validated and responsive instruments for measuring 
HRQL in food allergic patients from the patient's perspective. These instruments are thus 
promising tools for clinical research in which HRQL is the outcome of interest and may 
help to optimize (future) interventions from a HRQL point of view. 
Considering the outcome of the studies presented in this thesis, chapter 5 and 
6 demonstrate that both food allergic children and adolescents differed in their views 
with their parents on their HRQL. In children, parents systematically reported less impact 
of food allergy on their child's HRQL then children themselves (chapter 5). In contrast 
to children, differences between adolescent-parent pairs appeared at the individual 
adolescent-parent pair level rather than at the group level (chapter 6). Chapter 7 showed 
that children, adolescents and adults benefit from a negative DBPCFC (food allergy ruled 
out) and its subsequent changes in management and children benefit from a positive 
DBPCFC. These findings support the large impact of food allergy on HRQL and illustrate 
which patients benefit from a DBPCFC from a HRQL point of view. 
In this final chapter, the findings of this thesis will be summarized and integrated. 
The first part of this discussion will focus on methodological issues concerning the 
psychometric properties of the FAQLQs. The second part of this chapter discusses the 
outcome of the studies in addition to clinical implications and directions for future 
research. 
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METHODOLOGICAL ISSUES: PSCYHOMETIRC PROPERTIES OF THE 
FAQLQS 
Chapter 2, 3, 4 and 7 provide insight into the psychometric properties of the FAQLQs. 
Psychometric properties are important to ensure that the instruments measure what they 
are supposed to measure and to ensure that they are reproducible over time. 
Generic HRQL instruments and the FAQLQs 
Health-Related Quality of Life {HRQL) can be measured with generic and disease-specific 
instruments. Generic and disease-specific questionnaires had never been compared in the 
same group of food allergic patients. Therefore, chapter 2 described generic and disease­
specific HRQL of food allergic patients. The findings indicated that generic instruments are 
less sensitive than disease-specific instruments. Although generic HRQL questionnaires 
are indispensable for the comparison between different diseases, the FAQLQs were more 
sensitive and consequently were expected to be more suitable to measure clinically 
important impairments in HRQL (responsiveness). This hypothesis was supported by the 
findings in chapter 7. 
Reliability of the FAQLQs 
Reliability refers to whether an instrument is dependable and repeatable and can be 
examined assessing reproducibility (test-retest-reliability). The reproducibility of the 
FAQLQ-CF, -TF and -AF was assessed in chapter 3. Reproducibility was considered to be 
good with high ICCs and CCCs between 0.907 and 0.976 and mean differences in HRQL 
that were all close to zero. Therefore, the FAQLQ-CF, -TF and -AF are considered to be 
reliable tools for group comparisons in clinical trials. 
Considering the Bland-Altman plots, it was shown that most of the individual 
differences in HRQL between the test and re-test lie between the 1 .96 SD limits of 
agreement, supporting the reliability of the FAQLQ-CF, -TF and -AF. However, because the 
FAQLQ-CF, -TF and -AF have to be able to differentiate between minimal but potentially 
important changes in clinical status, the limits of agreement must not only be statistically 
narrow, but also be narrow enough to be clinically meaningful. The smallest difference or 
change in score associated with a change in health status which patients find important 
is called the minimal important difference (MID). This minimal important difference 
is usually around 0.5 in HRQL questionnaires using a seven-point scale6, but has to be 
defined yet in following studies assessing responsiveness of the FAQLQ-CF, -TF and -AF. 
An initial estimate can be made, using the MID as limits of agreement (mean difference 
+/- 0.5 MID), showed that 77% of the differences for the FAQLQ-CF, 91 % for FAQLQ-TF 
and 78% for FAQLQ-AF lie within these limits. Since a relatively small percentage of test­
retest variability is in the range that patients find clinically important, we think the FAQLQ-
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CF, -TF and -AF have sufficient interpretability to yield meaningful information in group 
comparisons in clinical trials. 
In order to assess whether a newly developed instrument is also a reliable tool for 
monitoring individual patients specific criteria are needed. To our knowledge, only one 
study was available on the criteria for monitoring individual patients at the start of the 
study described in this thesis7• For monitoring individual patients reliability should be 
higher (ICC/CCC > 0.90-0.95) than for group comparisons in clinical trials (ICC/CCC > 0.7)7· 
Additional criteria for the application of instruments for individual patients are a small 
standard error of measurement and the usual qualities such as construct validity and 
sensitivity to clinical change. Since reliability statistics were above 0.90 (chapter 3), the 
standard error of measurement was relatively small (FAQLQ-AF=0.25, FAQLQ-TF=0.16, and 
FAQLQ-CF=0.44) (chapter 7), minimal floor and ceiling effects were shown (chapter 2) 
and construct validity1 ·3 (chapter 4) and sensitivity to clinical change (chapter 7) has been 
shown, the FAQLQs are promising tools for monitoring individual patients. 
Another theory has recently been proposed for assessing whether an instrument is 
suitable for monitoring individual patients using qualitative methods rather than statistical 
methods assessing psychometric properties of questionnaires8• In this methodology 
the focus of interest to be measured (i.e. HRQL) should be fully assessed by an in-depth 
interview9• Additionally, this 'reality' as measured by the in depth interview may be used as 
the gold standard and should be correlated with the patient's score on the questionnaire. 
When there is good agreement this supports the suitability of the instruments for 
monitoring individual patients. The use of qualitative methods to assess the individual 
accuracy of a questionnaire in routine practice may provide additional insight into the 
suitability of an instrument for monitoring individual patients in addition to statistical 
methods. 
Thus, considering the reliability and other psychometric properties of the FAQLQ-CF, 
-TF and -AF, these instruments are suitable tools for group comparisons in clinical trials 
and promising tools for monitoring HRQL in individual patients. However, it would be 
informative to further evaluate their feasibility in daily clinical practice before these tools 
are used for monitoring individual patients. 
Validity of the FAQLQs 
The validity of an instrument refers to the instruments ability to measure what it 
is supposed to measure. Chapter 4 and 7 are related to the validation of the FAQLQs 
and continue the studies on the cross-sectional validation of the FAQLQ-CF, -TF and 
-AF published by Flokstra-de Blok et al.1 •3_ Chapter 4 described the instrument used for 
validating the FAQLQs and chapter 7 described the longitudinal validity of the FAQLQs. 
During the validity process of the FAQLQs some issues were encountered, which are 
common in HRQL research. These issues will be discussed below. 
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The first issue we encountered was that a new instrument is usually compared to the 
true value, a gold-standard, to make it plausible that the new instrument is valid (criterion 
validity). However, in HRQL research no such a gold standard exists to which a new HRQL 
questionnaire could be compared. Thus, other methods (and other instruments) are 
needed to validate a new HRQL questionnaire. In HRQL research, the best way to assess 
validity is called construct validity. Construct validity is assessed by correlating the HRQL 
questionnaire with an independent measure which reflects the severity of the disease 
in question in order to validate the disease-specificity of the HRQL questionnaire. Thus, 
in order to validate the FAQLQs, an appropriate food allergy independent measure was 
needed. 
The second issue we encountered was the fact that no appropriate independent 
measure existed in food allergy that could be used in order to assess construct validity of 
the FAQLQs in terms of disease-specificity. Therefore chapter4 described the development 
of a new instrument, the Food Allergy I ndependent Measure (FAIM), consisting of items 
reflecting several aspects of the severity of disease such as risks of outcome of a food 
allergic reactions following exposure, more objective aspects of severity of disease, such 
as the number of products that should be avoided, and more social aspects of severity 
of disease. The development of the FAIM was built upon the method of expectation of 
outcome 1°. This approach has been successfully implemented to validate disease-specific 
HRQL instruments1 1•12• Face validity and relevance of the developed FAIM items were 
determined by expert opinion. FAIM items were considered valid if they addressed aspects 
of food allergy outcomes that patients were likely to perceive as determining the severity 
of their condition. FAIM items showing no correlation to any potential FAQLQ item were 
not considered relevant and therefore eliminated. Overall, the face validity, relevance 
and the reliability of the FAIMs were shown to be good. Therefore the final FAIMs were 
considered to be suitable instruments for validating the FAQLQs. 
The third difficulty in measuring construct validity was the fact that there is no real 
guideline in literature on what correlations should be expected between an independent 
measure and a newly developed HRQL instruments, because such correlations depend 
on several factors such as the disease studied and the type of independent measure that 
is used. Additionally, there are multiple other factors influencing HRQL. It has previously 
been suggested that such correlations should be moderate 13. Therefore, we hypothesized 
that moderate correlations were to be expected between the FAQLQ and the FAIM. This 
hypothesis was supported by previous findings of studies using HRQL instruments that 
were validated using comparable independent measures built upon the methods of 
expectation of outcome questions. These studies showed correlations between HRQL and 
expectation of outcome at baseline measurement of 0.41 and 0.59 for the Food Allergy 
Quality of Life Parental Burden questionnaire (FAQL-PB, 2004) 1 1  and the Vespid Allergy 
Quality of Life Questionnaire (VAQLQ, 2002) 12, respectively. 
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In chapter S and 6, the cross cultural validity of the FAQLQ-PF and -PFA was assessed 
by correlating the FAQLQ with the FAIM. Correlations of 0.58 and 0.64, respectively, were 
shown, supporting the cross-cultural validity of these instruments. Longitudinal validity 
was assessed in chapter 7 by measuring correlations between the change [baseline 
minus follow-up] in FAQLQ scores and the change in FAIM scores. Higher correlations were 
shown for adults (0.71 ), than for children (0.50) and adolescents (0.35). The longitudinal 
validity of the adult-form (FAQLQ-AF) was comparable to the longitudinal validity of 
other HRQL instruments completed by adults: for the VAQLQ, a correlation of 0.72 was 
shown 1 2  and for the FAQLQ-PF, correlations were ranging from 0.65-0.7414• The finding 
that higher correlations were shown for adults than for children and adolescents may 
suggest that the longitudinal validity of the FAQLQ-AF is better than the longitudinal 
validity of the FAQLQ-CF and -TF. However, this may also reflect age-related differences in 
factors determining changes in health-related quality of life in food allergic patients. The 
influence of such factors determining HRQL changes needs further investigation. Since 
moderate to good correlations were shown between the change in FAQLQs and FAIMs 
and because all FAQLQs were able to measure statistically and clinically relevant changes, 
we feel the FAQLQs have sufficient longitudinal validity to yield meaningful information in 
group comparisons in clinical trials. 
Thus, measuring construct validity is a lengthy and ongoing process of learning 
more about the construct, making new predictions and then testing them. Each study 
that supports the theoretical construct strengthens the theory. Our results support 
the reliability, relevance and validity of the independent measure, the FAIM (chapter 
4). Additionally, our results support the reliability (chapter 3) and the cross-sectional 
validity of the FAQLQ-CF, -TF and -AF1 3 and the cross cultural validity of the FAQLQ-PF and 
-PFA(chapter S and 6). Chapter 7 supported the longitudinal validity and the ability of 
the FAQLQ-CF, -TF and -AF to measure change over time. These studies thus support the 
suitability of the FAQLQs for measuring HRQL in food allergic patients. This would not 
have been the case if establishing construct validity of the FAQLQs with an expectation of 
outcome measure was somehow invalid or tautological. 
Responsiveness of the FAQLQs and relevant differences in HRQL 
The responsiveness of a newly developed instrument refers to the ability of the instrument 
to measure relevant changes. The responsiveness of the FAQLQ-CF, -TF and -AF is described 
in chapter 7. Currently, there is much discussion in literature on the definition of a relevant 
change. Although HRQL measurements are increasingly being used as outcome measure, 
results are not always analyzed and interpreted identically15-19, because there are different 
methods to assess the relevance of HRQL differences. Distribution-based or anchor-based 
methods can be used to determine the change in HRQL that is considered relevant (the 
minimal important difference, MID). Distribution-based methods, such as Cohen's effect 
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size or SEM, rely on scoring methods of an instrument and the distribution of the results 17• 
The SEM, which is not sample dependent, has been proposed as a method of relevance 
to MID estimation, because a SEM change often corresponds well to an anchor-based 
MID change of 0.5 on a seven-point response scale20 22• However, distribution-based 
methods provide no information regarding the importance of the change; i.e. although 
the magnitude of the change may certainly be significant, it is not necessarily meaningful 
to patients. 
Anchor-based methods use an external criterion (anchor) to interpret whether a 
particular magnitude of change is meaningful for patients/clinicians. The global rating 
of change questionnaire19 is often used as an anchor and contains broadly evaluative 
questions to examine overall HRQL-changes and to classify patients according to whether 
their HRQL has improved or deteriorated. A disadvantage of global rating of change may be 
that patients are unable to accurately recall their initial health status which causes global 
measures of change to be highly correlated with the current state and uncorrelated with 
the initial state20• As it is necessary to know whether the observed change is important from 
the patient's/clinician's perspective, anchor-based methods are still preferred in assessing 
the MID19• Distribution-based methods can be used when anchor-based estimates are 
unavailable1 8  or to support estimates from anchor-based methods. 
Another method to improve the evaluation of the relevance of a HRQL change, is to 
compare the HRQL change in the intervention group with the HRQL change of a control 
group. This overall differences (change in HRQL following DBPCFC minus change in HRQL 
in the control group) should exceed the MID/SEM. Additionally, the use of a control group 
allows calculation of the number needed to treat (NNT ) 1 5• 23, representing the number of 
patients that need to be treated for one patient to have a clinically important improvement 
in HRQL. It is our considered opinion that this approach is the best way to evaluate 
whether the change in HRQL score of an intervention is clinically significant. Therefore, 
we recommend a combination of these methods to assess the clinical relevance of HRQL 
changes. 
In chapter 7, this combined approach was used to investigate whether the HRQL 
change following DBPCFC was relevant for children,  adolescents and adults. It was shown 
that the FAQLQ-CF, -TF and -AF were all able to measure relevant changes in HRQL. 
Consequently, our results support the responsiveness of the FAQLQ-CF, -TF and -AF. 
OUTCOME OF THIS THESIS 
HRQL following DBPCFC 
Chapter 7 showed that adults, adolescents and children benefit from a negative DBPCFC 
and its subsequent changes in management. Children also benefit if the outcome is 
positive. These findings are in line with previous studies14• 24-28• The improvement in HRQL 
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following a negative DBPCFC was significantly greater than the change in HRQL of the 
control group and this overall improvement exceeded the MID as well as the SEM after 
correction for confounding. The NNT of a negative DBPCFC was 4 for all age-groups. 
Thus, for every 4 participants who have a negative DBPCFC 1 participant has a clinically 
important improvement in HRQL. These findings thus support the large impact of food 
allergy on HRQL and the clinical effectiveness of a DBPCFC and its subsequent changes 
in management. Following a positive DBPCFC the NNT was 4 for children and 8 for adults. 
Other studies describing the impact of interventions on HRQL in allergic disorders 
showed NNTs between 1 .4 and 1 4: The NNT of Levocetirizine as ad-on therapy to 
Fluctiasone was shown to be 1 4  in patients suffering from seasonal allergic rhinitis29• The 
NNT of Montelukast compared to placebo was shown to be 9 in children (2-5 years old) 
with intermittent asthma30• The NNT of Omalizmab as add-on therapy to high-dose inhaled 
corticosteroids and long acting b2-agonists was shown to be 7.6 in patients with severe 
persistent asthma31 . The NNT of venom immunotherapy compared to epinephrine auto­
injector was shown to be 1 .4-1 .7 in patients suffering from jellow jacket venom allergy32• 
We found an NNT of 4 following a DBPCFC compared to a control group (following a 
negative outcome: all ages, following a positive outcome: children only). Comparing 
our results to the results described above, a DBPCFC was considered to be a relevant 
intervention for these specified groups. An NNT of a positive DBPCFC of 8 for adults can 
be considered to be intermediate compared to other published results. Our findings thus 
provide clinicians with an additional reason to perform a DBPCFC in food allergic patients 
from a HRQL point of view. 
Differing views of food allergic patients and their parents on the patient's HRQL 
Chapter 5 and 6 describe differing views of food allergic children/adolescents and 
their parents on the patient's HRQL. Chapter 5 demonstrated that children (8- 12  years) 
systematically reported a significantly greater impact of food allergy on their HRQL 
than their parents, whereas child- and parent-reported perception of disease severity, 
expectation of outcome of an allergic reaction and the psychometric properties of the 
FAQLQ-CF and -PF were nearly identical. Chapter 6 illustrated that relevant differences 
between adolescents and their parents appeared at the individual adolescent-parent 
pair level (for 63% of all adolescent-parent pairs) rather than at the group level. Although 
a trend was shown in the direction of a systematic underestimation of parents on the 
adolescent's HRQL (parents 3.56 versus adolescents 3.78, p=0.1 03), this difference was not 
statistically or clinically significant. 
When interpreting the outcome of chapter 5 and 6, it is important to notice that the 
relevance of the difference between child- and parent-reported HRQL depends on whether 
the questionnaires are intended to be used to provide substitute or complementary 
data on the patient's HRQL33• The term 'substitute perspective' is used when the parent-
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report is used as a proxy-report to provide a substitute for the child's response (FAQLQ­
PF for children aged 0-8 years). The term 'complementary perspective' is used when both 
a parental and a child report are used and to provide additional insight into the child's 
HRQL (FAQLQ-PF for children aged 8-1 2  years and FAQLQ-PFA for adolescents aged 1 3-1 7 
years). As HRQL is concerned with an individual's perception, self-reports are the primary 
method of assessment and instruments developed to provide a substitute perspective 
do need to reflect the child's experience accurately. Therefore, the extent of agreement 
between child- and parent-reports indicates the validity of the parental response as a 
proxy measure. Chapter S showed that child-parent correlation was moderate (ICC=0.57) 
and that children systematically reported a significantly greater impact of food allergy on 
their HRQL than their parents. This suggests a moderate validity of the parental response 
as a proxy-measure and it is important to know that in situations in which a child is unable 
to complete a self-report, the parent is likely to underestimate the deterioration of the 
child's H RQL as measured with the FAQLQ-PF. 
A second important subject to notice when interpreting the outcome of chapter 5 
and 6, is the phenomenon that apparent agreement does not necessarily represent true 
concordance33• This can be noticed in chapter 6, where moderately good correlations 
(ICC=0.61 )  and no significant differences were shown between the parent and adolescent­
report, which may indicate relatively good agreement. However, Bland-Altman plots 
illustrated that relevant differences between adolescent-parent pairs appeared for 63% of 
all individual adolescent-parent pairs. This illustrates that agreement may be poorer than 
it initially seems to be. 
The findings of moderate child-parent agreement and moderate adolescent-parent 
agreement on the patient's HRQL are perhaps not surprising. From a clinical point of view, 
it is most interesting what the direction of the difference is and why there is a difference. 
We identified some factors that were associated with such disagreement on HRQL as will 
be described in the next section. 
Emerging insight in factors associated with HRQL in food allergic patients 
As mentioned in Chapter 1 ,  HRQL is a multidimensional concept, a dynamic concept 
and a concept that is influenced by several factors. Although it was not the main aim of 
this thesis to identify which factors predict HRQL, some interesting results regarding this 
topic were identified. Therefore, factors associated with HRQL will be summarized and 
discussed below. 
Factors associated with HRQL in food allergic children, adolescents and adults 
Chapter 2 describes some factors associated with food allergy related quality of life. The 
FAIM was shown to have the strongest association with HRQL in children, adolescents 
and adults. Thus, risk perception and expectations on the outcome following accidental 
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exposure are substantial predictors of HRQL. Less prominent predictors were severity of 
symptoms and number of food allergies. The type of food allergy showed no association 
with HRQL at all. These findings underline our previously mentioned hypotheses that 
objective parameters in food allergy are not as closely linked to HRQL of food allergic 
patients as risk perceptions and expectations regarding the outcome of an allergic 
reaction following accidental exposure. It is rather the risk of food reactions and measures 
to avoid them that are associated with lower HRQL than the clinical reactivity induced by 
food intake34• Thus, HRQL is determined not only by the patient's health status problems 
but also by their response and interpretation of their health status problems. 
Factors associated with patient-parent disagreement on HRQL of food allergic children 
and adolescents 
Chapter 5 and 6 describe factors associated with patient-parent disagreement on the 
patient's HRQL. Disagreement between child- and parent-proxy-reports may reflect real 
differences in perspectives of children and parents and may relate to several factors. Firstly, 
patient-parent disagreement on the patient's HRQL was related to the age of children 
and adolescents. It was shown that child-parent agreement was highest for food allergic 
children aged 1 1 - 1 5  years (chapter 5 and 6). Secondly, higher perceived disease severity 
(FAIM-TF) contributed significantly to a larger difference between adolescent- and parent­
reported HRQL (in line with chapter 2). Another factor associated with larger adolescent­
parent disagreement was poorer adolescent-reported perceived illness comprehension. 
Overall, adolescent-reported illness perceptions and expectations showed stronger 
associations with the mean difference on HRQL than parent-reported illness perceptions 
and expectations, which suggests that most determinants of the adolescent's HRQL are 
poorly perceived by their parents. 
A recently published study on adolescent-parent disagreement on the adolescent's 
HRQL in chronically ill adolescents35 confirmed our findings. It was shown that adolescent­
parent disagreement on the adolescent's HRQL was associated with factors such as 
experienced disease burden, a higher adolescent age ( 1 5.3 years old versus 1 4.8 years old) 
and a lower educational level of the adolescent. It would be interesting to study whether 
an education program for adolescents may improve the adolescent's understanding of 
food allergy, the adolescent's HRQL and consequently, adolescent-parent disagreement 
on the adolescent's HRQL. 
Factors associated with the impact of a DBPCFC on HRQL in food allergic patients 
Chapter 7 describes the impact of a DBPCFC and its subsequent changes in management 
on HRQL. Although it was not the main aim of this study, some findings were presented 
on factors associated with the impact of a DBPCFC on HRQL. Firstly, the outcome of the 
DBPCFC was associated with change in HRQL (i.e. larger improvements in HRQL were 
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shown following a negative outcome than following a positive outcome). Additionally, 
having more than two food allergies was associated with deterioration in HRQL following 
a DBPCFC for children. Finally, higher FAQLQ baseline scores (poorer HRQL) contributed 
significantly to improvement in HRQL for all ages. Another small subgroup analysis was 
performed on participant characteristics that tended to be more common in participants 
whose HRQL deteriorated following a negative DBPCFC compared to participants whose 
HRQL did not deteriorate. These factors are number of food allergies, percentage of 
peanut challenges, percentage of participants who did not eat the tested food despite the 
negative DBPCFC. These factors may influence deterioration in HRQL following a negative 
challenge. However, this needs further investigation with larger numbers of patients. 
There are a few other studies describing factors influencing the impact of a food 
challenge on HRQL24 28• Some distressing factors influencing the impact of a food challenge 
were seeing their child fall ill (following a positive outcome), inconclusive outcome and 
continuing uncertainty, difficulties in getting their child to consume peanut during the 
challenge, inadequate follow-up and distress during intravenous cannula insertion25• 
Dunn Galvin et al. showed some additional distressing factors such as a positive outcome 
of the food challenge, a high HRQL baseline score (worse HRQL), high level of FAIM (high 
risk perception), recent experience of anaphylaxis, more severe symptoms and having 
more food allergies 14• Remarkably, severity of the reaction during the challenge was not 
a significant predictor14. Additionally, another study illustrated that during the challenge, 
the experience of a previous allergic reaction was related to parental state anxiety and two 
weeks after the challenge, the outcome of the DBPCFC was related to state anxiety28• The 
most distressing factor that appeared following reintroduction of a food after a negative 
DBPCFC in food allergic children (as perceived by their mothers), was fear of living with 
the unknown including feelings of fear of losing control and causing harm26• Some 
factors positively influencing HRQL following a food challenge were also identified. These 
factors were clarification of the severity of the child's peanut allergy, support provided 
by staff and determining the child was tolerant of peanut or assessed to be at low risk of 
anaphylaxis from accidental exposure25. It would be interesting to further analyze which 
factors predict HRQL changes following a DBPCFC using the FAQLQs in order to identify 
targets aimed at improving HRQL of food allergic patients following a DBPCFC. 
IMPLICATIONS FOR CLINICAL PRACTICE 
The studies in this thesis have several implications for clinical practice. Firstly, the studies 
in this thesis present for the first time evidence of the reliability (chapter 3), longitudinally 
validity, responsiveness (chapter 7) and cross cultural validity (chapter S and 6) of 
instruments capable of measuring self- and parent-reported HRQL of food allergic 
children, adolescents and adults. As there are no other clinical instruments for measuring 
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the ongoing impact of food allergy, the FAQLQs are suitable tools for measuring the 
impact of future interventions such as immunotherapy on HRQL of food allergic patients. 
Information from the FAQLQs may help to optimize interventions from a HRQL point of 
view. 
Secondly, we evaluated the impact of a DBPCFC from a HRQL point of view (chapter 
7) and it was shown that children, adolescents and adults benefit from a negative DBPCFC 
and children (and to a lesser extent adult) benefit from a positive DBPCFC. As a DBPCFC 
is considered to be a time-consuming process and has previously been discussed in the 
literature as being potentially burdensome to patients, it is important for clinicians to know 
that a DBPCFC is not only the gold standard for diagnosing food allergy, but also improves 
HRQL for specified groups. This message is of interest to all health-care professionals who 
deal with food allergic patients as it provides them with an additional reason to invest the 
time and effort to offer these patients DBPCFCs where appropriate. 
Thirdly, it is important for clinicians to know that self- and parent-reports on the child's 
HRQL differ, in which direction the difference is and which factors are associated with such 
disagreement (chapter 5 and 6). As parental attitudes may influence the utilization of 
health-care services for their child and may indirectly influence clinical decision making, 
it is important to keep in mind that parents tend to underestimate the deterioration of 
their child's HRQL (8-12 years) and that adolescent-parent pairs differed in their views on 
the adolescent's HRQL on the individual adolescent-parent pair level (13-17 years). It is 
thus recommended to include both opinions of parents and patients in clinical decision 
making in order to make a complete assessment of the impact of food allergy and related 
interventions on HRQL. 
Regarding the determinants of such disagreement, it was shown that illness 
comprehension of the adolescent was associated with adolescent-parent disagreement 
on the adolescent's HRQL. As already mentioned, this may be an important target for 
intervention aimed at improving the adolescent's understanding of food allergy and 
consequently the adolescent's HRQL. 
Fourthly, in addition to differing views between adolescents and parents on the 
adolescent's HRQL (chapter 6), it was also shown that the adolescent's perspective on 
HRQL (and determinants of HRQL) differed from the child's and the adult's perspective 
in several ways. At first, it was shown that the content of the FAIM of adolescents differed 
from the FAIM of children and adults: the item "how big do you think the chance is that 
you will die if you accidentally eat something to which you are allergic?" was considered 
to be inappropriate for adolescents in contrast to children, adults (chapter 4) and parents 
of food allergic children4, because this item did not correlate with any of the FAQLQ-TF 
items. This might indicate that adolescents are not afraid of dying of anaphylaxis and 
underestimate exposure in contrast to adults and children. Secondly, adolescent's did not 
improve in HRQL following a positive DBPCFC, in contrast to children and adults. Thirdly, 
adolescents in the control group showed a statistical (but not a clinical) improvement in 
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their HRQL in contrast to children and adults (chapter 7). In line with previous findings36, 
above results indicate that (determinants of ) HRQL may well be age-related. Consequently, 
it is important for clinicians to realize that it is highly likely that targets aimed at improving 
HRQL of food allergic adolescents may differ from children and adults as well. 
Finally, this thesis illustrated the importance of patient-reported outcomes to get 
insight into aspects of food allergy considered important by patients. It was shown 
that some aspects of food allergy that are generally considered important by clinicians 
(severity of symptoms, number of food allergies and type of food allergy) had weaker 
associations with the patient's HRQL than patient's risk perceptions and expectations 
regarding the outcome of an allergic reaction (FAIM) (chapter 2). These findings confirmed 
previously published studies that HRQL of food allergic patients is determined not only 
by the patient's health status problems but also by their response and interpretation of 
their health status problems37• Information from patient-reported outcomes may improve 
the ability of health-care professionals to help food allergic patients with managing their 
specific problems in order to improve the patient's HRQL. 
FUTURE PERSPECTIVES 
Although this thesis outlines the current knowledge regarding food allergy and HRQL, 
there are still many unanswered and interesting research questions that need further 
investigation. Some of them are mentioned below. 
Regarding the psychometric properties of the FAQLQs, the first important issue to ana­
lyze is the assessment of the minimal important difference (MID). Assessment of the MID 
is useful, because it will enhance our understanding of the interpretation of the relevance 
of changes as measured by the FAQLQs. Currently, the MID of the FAQLQs is unknown. 
Therefore, this needs further investigation using methods described earlier in this thesis. 
A second issue involves the validation of the FAQLQs i n  other countries and languages. 
Before the FAQLQ-CF, -TF and -AF can be used in other languages and cultures the ques­
tionnaires should be cross-culturally validated in the new language or culture, because 
some items generated and selected in one culture may not always be considered impor­
tant in other cultures. Cross cultural validation involves several phases such as forward 
and backward translations and cross sectional validation, after which the FAQLQs can be 
incorporated into a longitudinal study in the new language. It would be interesting to 
compare self- and parent-reported HRQL of food allergic patients in several countries. 
A third issue regarding the psychometric properties of the FAQLQs is related to the 
suitability of the FAQLQs as tool for monitoring individual patients. The FAQLQs have 
shown to be suitable tools for group comparison studies. Although the FAQLQs fulfilled 
the available psychometric criteria for monitoring individual patients, it is recommended 
to further analyze the suitability of the FAQLQs for this purpose. 
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In addition to research questions regarding the psychometric properties of the 
FAQLQs, some other research questions can be mentioned. This thesis identified some 
factors that were associated with HRQL. However, which factors influence HRQL remains 
largely unknown and it would be interesting to find out which factors predict HRQL in 
order to identify targets aimed at improving HRQL of food allergic patients. In line with 
this research question, it would be interesting to identify which factors predict change 
in HRQL following a DBPCFC in order to answer questions such as why some patients 
deteriorate following a negative food challenge and why adolescents perceive a positive 
outcome differently than adults and children. Some determinants may be targets for 
intervention aimed at improving the patient's HRQL following a DBPCFC. 
Additionally, it would be interesting to further analyze the association between 
the adolescent's illness comprehension and adolescent-parent disagreement on the 
adolescent's HRQL and the hypothetical association with self-management. An education 
program may be a useful target for intervention aimed at improving the knowledge of 
adolescents on their food allergy, the adolescent's HRQL, adolescent-parent disagreement 
on HRQL and possibly self-management. Although, there is growing interest in food 
allergic adolescents and HRQL38•39, these questions are still unanswered. 
Finally, it would be interesting to compare HRQL outcome with economic 
measurements developed in the Europrevall project. The economic instruments were 
developed to measure the economic impact of food allergy. It would be interesting to 
investigate whether socio-emotional impact of food allergy is related to the economic 
impact of food allergy. 
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WAT IS VOEDSELALLERGIE? 
Voedselallergie is een veelvoorkomende ziekte in de westerse wereld en komt voor bij 
ongeveer 6-8% van de kinderen en 3-4% van de volwassenen. Bij een voedselallergie is 
er sprake van een abnormale reactie van het afweersysteem op het eten van bepaalde 
voedingsmiddelen. leder voedingsmiddel kan voedselallergie veroorzaken, maar de 
meest voorkomende voedingsmiddelen die voedselallergie veroorzaken zijn pinda, 
noten, ei, melk, tarwe, vis, sesam, groente en fruit. Een allergie voor melk of ei verdwijnt 
vaak naarmate iemand ouder wordt, maar een allergie voor pinda of noten heeft een 
patient meestal levenslang. Voedselallergie kan huid-, maag-, darm- of luchtwegklachten 
veroorzaken. In het ergste geval kan een patient in een shock raken en overlijden. De 
ernst van een allergische reactie kan erg varieren en een patient met alleen een milde 
allergische reactie in het verleden kan soms een levensbedreigende allergische reactie 
krijgen wanneer hij of zij opnieuw wordt blootgesteld aan hetzelfde voedingsmiddel. 
Sams kan slechts een hele kleine hoeveelheid van het voedingsmiddel al leiden tot een 
ernstige allergische reactie. 
De enige behandeling voor voedselallergie is strikte vermijding van de 
voedingsmiddelen waar hij of zij allergisch voor is. Toch bestaat er altijd nog een kans dat 
iemand het voedingsmiddel waar hij of zij allergisch voor is binnenkrijgt met als mogelijk 
gevolg een ernstige allergische reactie. Deze onzekerheid en onvoorspelbaarheid van 
voedselallergie kan angstklachten veroorzaken. Goede diagnostiek en voorlichting is 
daarom erg belangrijk, zodat een patient goed weet welke voedingsmiddelen wel en niet 
gebruikt mogen worden en hoe en in welke gevallen noodmedicatie (een adrenaline-pen) 
gebruikt moet worden. In het dagelijkse leven lopen patienten vaak tegen verschillende 
problemen aan. Het is bijvoorbeeld belangrijk dat patienten met een voedselallergie 
continu alert zijn op wat ze eten. Patienten zijn dus genoodzaakt om etiketten van 
voedselproducten goed te lezen. Dit kan soms veel frustratie opleveren, bijvoorbeeld 
door slechte of onvolledige etikettering van voedselproducten of wanneer ingredienten 
van deze producten wijzigen. Daarnaast kan het hebben van een voedselallergie onrust 
veroorzaken wanneer de patient het gevoel heeft dat andere mensen onvoldoende 
rekening houden met de voedselallergie, zoals in een restaurant of als andere mensen 
voor ze koken of met traktaties in de klas en schoolfeestjes. Zo zijn er nag veel meer 
voorbeelden te noemen. Logischerwijs kunnen bovengenoemde factoren invloed 
hebben op de kwaliteit van leven van patienten met voedselallergie. 
WAT IS KWALITEIT VAN LEVEN? 
Kwaliteit van leven is een heel breed begrip en er zijn daarom ook heel veel verschillende 
definities van dit begrip. Meestal wordt kwaliteit van leven omschreven als het fysieke, 
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psychische en sociale functioneren van iemand en de subjectieve evaluatie daarvan. 
Het staat dus centraal wat iemand zelf van zijn of haar fysieke, psychische en sociale 
functioneren vindt. lemands kwaliteitvan leven wordt bepaald doorverschillende factoren 
zoals iemands financiele situatie, het gevoel van veiligheid en vrijheid, de kwaliteit van de 
leefomgeving en van iemands opleiding of gezondheid. Daarnaast kan iemands kwaliteit 
van leven be'invloed worden door de cultuur waarin iemand leeft, de religie die iemand 
aan hangt en zijn of haar verwachtingen, normen en waarden. Het gedeelte van kwaliteit 
van leven dat bepaald wordt door iemands gezondheid, wordt gezondheidsgerelateerde 
kwaliteit van leven genoemd. In het Engels wordt gezondheidsgerelateerde kwaliteit 
van leven "Health-Related Quality of Life" (HRQL) genoemd. Dit proefschrift gaat over de 
gezondheidsgerelateerde kwaliteit van !even bij patienten met een voedselallergie. 
WAAROM IS HET BELANGRIJK OM KWALITEITVAN LEVEN TE METEN? 
Het is om verschillende redenen belangrijk om de gezondheidsgerelateerde kwaliteit van 
!even bij patienten met een voedselallergie te meten. Ten eerste kan het meten van de 
gezondheidsgerelateerde kwaliteit van !even bij patienten met een voedselallergie inzicht 
geven in deverschillende problemen waar patienten meteen voedselallergie meete ma ken 
hebben in het dagelijkse !even. Hierdoor kunnen artsen, dietisten en verpleegkundigen de 
patienten betere adviezen geven voor het omgaan met hun voedselallergie. Ten tweede 
kunnen kwaliteit van leven metingen gebruikt worden om het effect van interventies te 
meten vanuit het perspectief van de patient. Er kan bijvoorbeeld onderzocht worden wat 
de invloed is van diagnostische testen op iemands kwaliteit van !even of wat het effect 
is van nieuwe behandelmethoden op iemands kwaliteit van !even. Uiteindelijk kan dit 
helpen om de kwaliteit van de diagnostiek of de behandeling te verbeteren en daardoor 
ook de kwaliteit van leven van de patienten. Ten derde zijn kwaliteit van leven metingen 
bij voedselallergie belangrijk, omdat er voor voedselallergie eigenlijk geen objectieve 
maat bestaat die de voortdurende ernst van voedselallergie weergeeft, zoals bijvoorbeeld 
de luchtweggevoeligheid bij iemand met astma of de bloedsuikerspiegel bij iemand met 
suikerziekte. Het is natuurlijk wel mogelijk om de ernst van een allergische reactie weer 
te geven, maar dan wordt eigenlijk alleen de ernst ten tijde van een allergische reactie 
gemeten en niet de voortdurende ernst van de voedselallergie. De patient heeft namelijk 
n iet alleen last heeft van zijn voedselallergie tijdens een allergische reactie, maar ook in 
de tussenliggende perioden bijvoorbeeld door de noodzaak om continu alert te zijn op 
wat h ij of zij eet en door de angst voor een ernstige allergische reactie. De voortdurende 
ernst van voedselallergie (vanuit het perspectief van de patient) kan onderzocht warden 
met kwaliteit van !even metingen. 
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HOE WORDT KWALITEIT VAN LEVEN GEMETEN? 
Gezondheidsgerelateerde kwaliteit van leven kan gemeten warden met vragenlijsten. 
Er bestaan verschillende typen vragenlijsten: generieke en ziektespecifieke kwaliteit 
van leven vragenlijsten. Generieke kwaliteit van leven vragenlijsten bevatten vragen 
over iemands algemene gezondheid, maar geen vragen gericht op een bepaalde 
ziekte. Deze generieke vragenlijsten zijn bijvoorbeeld heel geschikt om de invloed van 
verschillende ziekten op gezondheidsgerelateerde kwaliteit van leven met elkaar te 
vergelijken of om een beeld te krijgen van de gezondheidsgerelateerde kwaliteit van 
leven van de algemene bevolking. Ziektespecifieke vragenlijsten zijn speciaal ontwikkeld 
voor een bepaalde ziekte en gaan in op de specifieke problemen van deze ziekte. Deze 
vragenlijsten zijn daarom juist beter in staat om belangrijke veranderingen in kwaliteit 
van leven te meten bij patienten met deze specifieke ziekte. Ziektespecifieke vragenlijsten 
warden daarom veel gebruikt om inzicht te krijgen in een bepaald ziektebeeld en om 
het effect van bepaalde behandelingen of diagnostische testen op iemands kwaliteit 
van leven te onderzoeken. Het hangt dus heel erg af van het doel van het onderzoek 
welk type vragenlijst het meest geschikt is. Deze vragenlijsten kunnen ingevuld warden 
door de patient zelf. Dit noemt men zelf-rapportages. De vragenlijsten kunnen ook door 
anderen warden ingevuld (bijvoorbeeld ouders van patienten met voedselallergie of door 
medische professionals). In het laatste geval gaat het erom hoe de ander de kwaliteit van 
leven van de patient in schat. Dit noemt men proxy-rapportages. Het behulp van beide 
rapportages kan men een compleet beeld krijgen van iemands kwaliteit van leven vanuit 
verschillende perspectieven. 
DE VOEDSELALLERGIE EN KWALITEIT VAN LEVEN VRAGENLIJSTEN 
Tot voor kort bestonden er nog geen goede ziektespecifieke kwaliteit van leven 
vragenlijsten voor patienten met een voedselallergie. Daarom zijn er een aantal jaren 
geleden, in het kader van een grootschalig Europees onderzoek naar voedselallergie (het 
EuroPrevall project), drie ziektespecifieke kwaliteit van leven vragenlijsten ontwikkeld 
in Groningen om kwaliteit van leven te meten bij kinderen (8-12 jaar), tieners (13-17 
jaar) en volwassenen (2: 18 jaar) met voedselallergie. ledere leeftijdsgroep heeft een 
aparte vragenlijst, omdat iedere leeftijdsgroep zijn eigen specifieke problemen kent. De 
vragenlijsten warden door de patient zelf ingevuld (zelf-rapportages). Daarnaast zijn er 
binnen dit project nog twee ziektespecifieke kwaliteit van leven vragenlijsten ontwikkeld 
in lerland en Engeland voor ouders van voedselallergische kinderen (0-12 jaar) en tieners 
(13-17 jaar). Deze vragenlijsten warden dus door de ouders van de patient ingevuld (proxy­
rapportages). In het Engels heten deze vijf vragenlijsten the Food Allergy Quality of Life 
Questionnaires (FAQLQs). De ontwikkeling van de voedselallergie en kwaliteit van leven 
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vragenlijsten heeft plaatsgevonden met behulp van een speciale methode. De eerste 
stap van deze methode is het verzamelen van alle mogelijke vragen voor de vragenlijst. 
Hiervoor werden verschillende bronnen gebruikt zoals patientinterviews, literatuurstudies 
en klinische experts op het gebied van voedselallergie. Vervolgens werden alleen de 
vragen die het meest belangrijk waren voor patienten geselecteerd voor de vragenlijsten. 
Daarna is gekeken of de vragenlijsten valide waren. Onder validiteit wordt verstaan of 
een vragenlijst meet wat het behoord te meten. Dus meten de vragen dat stukje kwaliteit 
van leven wat met voedselallergie te maken heeft. Uit al deze onderzoeken is gebleken 
dat de kwaliteit van leven vragenlijsten voor voedselallergie valide waren, dus dat ze dat 
meten wat ze behoren te meten. Naast de validiteit van vragenlijsten is het belangrijk 
dat vragenlijsten betrouwbaar zijn (oftewel reproduceerbaar en consistent) en dat ze in 
staat zijn om verschillen in kwaliteit van leven te meten over de tijd (responsiviteit). Deze 
eigenschappen van de voedselallergie en kwaliteit van leven vragenlijsten waren voor de 
start van dit proefschrift nog niet bekend. 
OVERZICHT VAN DIT PROEFSCHRIFT 
Dit proefschrift had verschillende doelstellingen. De eerste hoofdstukken (hoofdstuk 
2, 3 en 4) gaan vooral over de technische eigenschappen van de voedselallergie en 
kwaliteit van leven vragenlijsten. De laatste hoofdstukken (hoofdstuk 5, 6 en 7) gaan 
meer over de toepassing van de vragenlijsten in de praktijk. Allereerst was het nodig om 
te onderzoeken of de voedselallergie en kwaliteit van leven vragenlijsten die een paar 
jaar geleden zijn ontwikkeld betrouwbaar (hoofdstuk 3), valide (hoofdstuk 4 en 7) en 
responsief zijn (hoofdstuk 7) en dat ze van toegevoegde waarde zijn ten opzicht van de 
reeds bestaande generieke vragenlijsten (hoofdstuk 2). Vervolgens was het nodig om 
te onderzoeken of de voedselallergie en kwaliteit van leven vragenlijsten die ontwikkeld 
zijn in Engeland en lerland ook geschikt zijn voor gebruik in Nederland (hoofdstuk 5 
en 6). Daarna is onderzocht in hoeverre de meningen van ouders en kinderen (dan wel 
tieners) wat betreft de kwaliteit van leven van het voedselallergische kind (/tiener) met 
elkaar overeenkomen en in hoeverre de ouder de kwaliteit van leven van het kind (/tiener) 
betrouwbaar weer kan geven (hoofdstuk 5 en 6). Laatstgenoemde is vooral belangrijk 
om te weten wanneer het kind (/tiener) zelf niet in staat is om zijn of haar kwaliteit van 
leven weer te geven, bijvoorbeeld wanneer het kind te jong is of verstandelijk beperkt. In 
hoofdstuk 7 wordt beschreven wat de invloed is van de belangrijkste diagnostische test 
voor voedselallergie (de dubbelblinde placebo-gecontroleerde voedselprovocatie) en de 
daaropvolgende behandeling op iemands kwaliteit van leven. 
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SAMENVATTING VAN DE HOOFDSTUKKEN 
Hoofdstuk 1 is een algemene introductie op dit proefschrift. Hierin wordt 
achtergrondinformatie van voedselallergie en kwaliteit van leven weergegeven en hierin 
warden de doelstellingen van het proefschrift uitgelegd. 
Hoofdstuk 2 beschrijft de overeenkomsten en verschillen tussen de generieke en de 
ziektespecifieke voedselallergie en kwaliteit van leven vragenlijsten. Aan dit onderzoek 
deden 79 kinderen, 74 tieners en 72 volwassenen mee. Uit het onderzoek bleek dat de 
ziektespe,ifieke voedselallergie en kwaliteit van leven vragenlijsten beter geschikt lijken 
te zijn om verschillen in kwaliteit van leven te meten bij voedselallergische patienten 
dan de generieke kwaliteit van leven vragenlijsten. De ziektespecifieke vragenlijsten zijn 
dus van aanvullende waarde ten opzichte van de generieke vragenlijsten. Oak hebben 
we onderzocht welke factoren van invloed zijn op kwaliteit van leven bij patienten met 
voedselallergie. Hieruit konden we concluderen dat er een sterk verband was tussen de 
risico-inschatting van een patient met betrekking tot de ernst van een allergische reactie 
en zijn of haar kwaliteit van leven. Dus als een patient het risico op een ernstige allergische 
reactie na een mogelijke inname van het voedingsmiddel heel hoog in schat zal zijn of 
haar kwaliteit van !even sterk dalen. Deze daling in kwaliteit van !even was dus duidelijk 
sterker dan wanneer iemand meerdere voedselallergieen heeft of wanneer iemand erg ere 
symptomen heeft tijdens een allergische reactie. Dit bevestigt onze vooronderstellingen 
dat de subjectieve verwachtingen van patienten over de mogelijke ernst van een 
allergische reactie een grotere invloed hebben op iemands kwaliteit van !even dan de 
meer objectievere maten zoals de ernst van de symptomen tijdens een allergische reactie 
of het aantal voedselallergieen dat iemand heeft. Dit is belangrijk voor dokters, dietisten 
en verpleegkundigen om te weten, omdat zij patienten eerder neigen te behandelen op 
basis van de objectieve maten dan op basis van ziektebeleving en kwaliteit van leven. 
Hoofdstuk 3 beschrijft de betrouwbaarheid van de voedselallergie en kwaliteit van 
!even vragenlijsten voor kinderen, tieners en volwassenen. Het is belangrijk om de 
betrouwbaarheid van een vragenlijst te onderzoeken om te beoordelen of een vragenlijst 
reproduceerbaar en consistent is. Met and ere woorden, wanneer een vragenlijst meerdere 
malen afgenomen wordt bij dezelfde persoon hoeveel verschil is er dan tussen de 
ingevulde antwoorden. Voor dit onderzoek hebben ruim 100 patienten de vragenlijsten 
twee keer ingevuld met een tussenliggende periode van ongeveer 14 dagen. We konden 
op deze manier aantonen (met behulp van correlatie coefficienten en grafieken) dat de 
antwoorden die patienten hebben gegeven op de twee verschillende tijdstippen goed 
met elkaar overeenkwamen. Dit betekent dat de voedselallergie en kwaliteit van !even 
vragenlijsten betrouwbaar zijn. 
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Hoofdstuk 4 is gerelateerd aan de validiteit van de voedselallergie en kwaliteit van 
!even vragenlijsten en is een vrij technisch hoofdstuk. Met valideren bedoelt men of de 
voedselallergie en kwaliteit van !even vragenlijsten meten wat ze behoren te meten, 
namelijk dat stukje kwaliteit van !even dat bepaald wordt door iemands voedselallergie. 
Normaal gesproken wordt een nieuwe vragenlijst gevalideerd door de nieuwe vragenlijst 
te vergelijken met een soortgelijke vragenlijst die tot dat moment het best beschikbare 
instrument is om te meten wat je wilt meten (de gouden standaard). Helaas bestaat er 
voor kwaliteit van !even vragenlijsten niet een dergelijke gouden standaard. Daarom 
moest er een nieuw instrument ontwikkeld warden om de voedselal lergie en kwaliteit 
van !even vragenlijsten mee te vergelijken om ze te valideren. Hoofdstuk 4 beschrijft 
de ontwikkeling en betrouwbaarheid van het instrument dat ontwikkeld is om de 
voedselallergie en kwaliteit van !even lijsten te valideren, namelijk de Onafhankelijke Maat 
voor Voedselallergie, oftewel the Food Allergy Independent Measure (FAIM). De FAIM 
bestaat uit 6 vragen die de risico-inschatting van de patient weergeeft wat betreft de ernst 
van een eventuele toekomstige allergische reactie. De FAIM is dus eigenlijk een vragenlijst 
die de subjectieve ernst van voedselallergie weergeeft vanuit de beleving van de patient. 
Uit voorgaande onderzoeken is gebleken dat zulke risico-inschattingen en verwachtingen 
belangrijke voorspellers zijn voor iemands kwaliteit van !even en dus geschikt zijn om 
kwaliteit van leven vragenlijsten te valideren. Uit de resultaten van hoofdstuk 4 blijkt 
dat de FAIM een geschikt instrument is om de voedselallergie en kwaliteit van leven 
vragenlijsten te valideren. 
Hoofdstuk 5 beschrijft het verschil in mening tussen ouder en kind wat betreft de impact 
van voedselallergie op de kwaliteit van leven van het voedselallergische kind (8-1 2 jaar). 
Allereerst werd in dit hoofdstuk onderzocht of de Engelse voedselallergie en kwaliteit van 
leven vragenlijst voor ouders van voedselallergische kinderen (0-1 2 jaar) geschikt was 
voor gebruik in Nederland en dat bleek zo te zijn. Vervolgens hebben we de kwaliteit van 
leven vragenlijsten die door de ouders en hun voedselallergische kind werden ingevuld 
met elkaar vergeleken. We vonden dat ouders op groepsniveau een betere kwaliteit van 
leven voor hun kind rapporteerden dan het kind zelf. Deze bevinding suggereert dat de 
meeste ouders de impact van voedselallergie op hun kind neigen te onderschatten. Tussen 
voedselallergische tieners en hun ouders (hoofdstuk 6) werden ook verschillen in mening 
gevonden, maar die lagen meer op individueel niveau dan op groepsniveau. Het was 
bijvoorbeeld zo dat bij het ene ouder-tiener paar de ouder de impact van voedselallergie 
op de kwaliteit van leven van de tiener als grater in schatte dan de tiener zelf en bij het 
andere ouder-tiener paar was het juist precies andersom. Op groepsniveau vind je dan 
geen verschil, omdat deze waarden tegen elkaar uit middelen als je ze bij elkaar optelt. 
Dus zowel kinderen als tieners verschillen in mening ten opzichte van hun ouders met 
betrekking tot de impact van voedselallergie op hun kwaliteit van leven, a Ileen de richting 
van het verschil (verbetering/verslechtering) in kwaliteit van !even is anders. 
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Omdat de mening van de ouder over de kwaliteit van leven van hun voedselallergische 
kind/tiener van invloed is op het besluit van de ouder om wel of niet met hun kind naar 
een arts te gaan, is het voor medische professionals belangrijk om te realiseren dat 
ouders de impact van voedselallergie op de kwaliteit van leven van hun kind neigen te 
onderschatten en dat er tussen ouders en tieners oak wel degelijk verschillen in mening 
bestaan, maar dan meer op individueel niveau. Om een zo compleet mogelijk beeld te 
krijgen van de kwaliteit van leven van het kind of de tiener is het dus van belang voor 
medische professionals om zowel de mening van het kind of de tiener als de mening van 
de ouder te betrekken bij de medische besluitvoering over de voedselallergische patient. 
In hoofdstuk 7 wordt allereerst het onderzoek beschreven dat de longitudinale validiteit 
en responsiviteit van de voedselallergie en kwaliteit van leven vragenlijsten evalueert. Met 
responsiviteit wordt bedoeld of de vragenlijsten in staat zijn om verschillen in kwaliteit van 
leven te meten over de tijd. Met longitudinale validiteit wordt bedoeld of de vragenlijsten 
valide zijn over de tijd, dus dat ze meten wat ze moeten meten over de tijd, namelijk dat 
stukje kwaliteit van leven dat bepaald wordt door voedselallergie. Om dit te onderzoeken 
vu Iden 235 patienten de vragenlijsten in 1 maand voor en 6 maanden na een dubbelblinde 
placebo gecontroleerde voedselprovocatie. Een dergelijke voedselprovocatie is de meest 
betrouwbare diagnostische test om voedselallergie aan te tonen of uit te sluiten. We 
hebben voor deze studieopzet gekozen, omdat onze vooronderstelling was dat kwaliteit 
van leven zou veranderen na het vaststellen of uitsluiten van de diagnose voedselallergie 
en deze veranderingen in kwaliteit van leven zouden de voedselallergie en kwaliteit van 
leven vragenlijsten moeten kunnen meten. Uit ans onderzoek bleek dat de vragenlijsten 
in staat waren om deze verschillen in kwaliteit van leven te meten over de tijd en het bleek 
oak dat ze valide waren over de tijd. Dit betekent dus dat de voedselallergie en kwaliteit 
van leven vragenlijsten geschikte instrumenten zijn om kwaliteit van leven bij patienten 
met voedselallergie te meten. Omdat er geen andere instrumenten beschikbaar zijn om 
de voortdurende ernst van voedselallergie te meten, zijn dit belangrijke instrumenten om 
de impact van bepaalde diagnostische testen en behandelingen op kwaliteit van leven te 
evalueren. lnformatie uit deze studies kan dan gebruikt warden om zulke interventies te 
verbeteren en daardoor ook de kwaliteit van leven van de patient te verbeteren. 
Het tweede doel van deze studie was om te onderzoeken wat nou eigenlijk de impact is 
van een dubbelblinde placebo-gecontroleerde voedselprovocatie op kwaliteit van leven. 
Uit deze studie bleek dat de kwaliteit van leven van kinderen, tieners en volwassenen 
met een voedselallergie verbeterde na een negatieve testuitslag van de dubbelblinde 
voedselprovocatie en de daaropvolgende behandeling (dus na het uitsluiten van de 
diagnose voedselallergie). Bij kinderen en in mindere mate ook bij volwassenen bleek 
dat de kwaliteit van leven ook verbeterde na een positieve testuitslag en de daarop 
volgende behandeling (dus na het aantonen van de diagnose voedselallergie). We 
denken dat deze verbetering in kwaliteit van leven komt doordat de onzekerheid van 
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patienten af neemt en ze beter weten waar ze aan toe zijn. Vervolgens weten ze oak beter 
welke voedingsmiddelen ze wel en niet moeten vermijden. De grootste verbeteringen in 
kwaliteit van leven werden gevonden als de diagnose voedselallergie werd uitgesloten. 
Deze bevindingen bevestigen de grate impact die voedselallergie heeft op het dagelijks 
leven van patienten en laten zien welke patienten baat hebben bij een dubbelblinde 
placebo gecontroleerde voedselprovocatie. 
Het is voor medische professionals oak belangrijk om te weten dat een dubbelblinde 
placebo-gecontroleerde voedselprovocatie en de daarop volgende behandeling in veel 
gevallen de kwaliteit van leven van patienten verbetert, omdat er in het verleden veel 
discussie geweest is in de literatuur over het tijdrovende proces van deze diagnostische 
test en de mogelijke lasten van deze test voor de patient. Nu gebleken is dat kwaliteit 
van leven van patienten juist verbetert na deze diagnostische test, geeft het medische 
professionals eigenlijk een extra reden om deze diagnostische test juist wel uit te 
voeren, naast het feit dat deze test de meest betrouwbare test {gouden standaard) is om 
voedselallergie aan te tonen. 
Hoofdstuk 8 geeft een algemene samenvatting en discussie van het hele proefschrift 
weer. 
CONCLUSIE 
Dit proefschrift laat zien dat er betrouwbare, valide en responsieve vragenlijsten 
beschikbaar zijn gekomen om kwaliteit van leven te meten bij kinderen, tieners en 
volwassenen met een voedselallergie in Nederland. Omdat er geen andere instrumenten 
beschikbaar zijn om de voortdurende ernst van voedselallergie te meten vanuit het 
perspectief van de patient, zijn dit belangrijke instrumenten om de impact van bepaalde 
diagnostische testen en behandelingen op kwaliteit van leven te evalueren. lnformatie 
uit deze studies kan dan gebruikt warden om zulke interventies te verbeteren en 
daardoor oak de kwaliteit van leven van de patient te verbeteren. Daarnaast warden deze 
vragenlijsten momenteel vertaald en gevalideerd in andere landen, zodat kwaliteit van 
leven bij patienten met voedselallergle in verschillende culturen met elkaar vergeleken 
kan warden. Andere belangrijke bevindingen van dit proefschrift zijn dat ouders de 
impact van voedselallergie op de kwaliteit van leven van hun klnderen {8-1 2 jaar) neigen te 
onderschatten en dat oak tieners {13-17 jaar) over dit onderwerp van mening verschillen 
ten opzicht van hun ouders. Daarnaast werd gevonden dat een dubbelblinde placebo­
gecontroleerde voedselprovocatie {de beste test om voedselallergle aan te tonen of uit 
te sluiten) en de daaropvolgende behandeling de kwalitelt van leven van de meeste 
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DANKWOORD 
"Dokter, wilt u even helpen met de patient van kamer 5?'; hoorde ik plots een stem achter 
mij zeggen. Even links achter me kijken en gauw ook even rechts achter me kijken. Nee, 
daar stand echt niemand anders. Vervolgens met iets luidere stem: "Dokter van der Ve Ide, 
wilt u nu even helpen met de patient van kamer 5?" Langzaam realiseerde ik me dat de 
verpleegkundige het daadwerkelijk tegen mij had. lk zei dus wat aarzelend: "Oke, ik kom 
wel mee . . . :' Dat was in januari 2008. Ben je net goed en wel gewend aan deze nieuwe 
identiteit van dokter zijn, ben je ineens doctor. Gelukkig scheelt het maar een paar letters. 
Oat went vast makkelijker . . . .  
Alie gekheid op een stokje, "ineens doctor" dat is natuurlijk maar een halve waarheid. Toen 
het besluit uiteindelijk genomen was om te gaan promoveren, zijn er ontzettend veel 
mensen bij betrokken geweest om het hele onderzoeksproject tot een succesvol en mooi 
einde te brengen. Deze mensen kwamen uit verschillende richtingen, zowel deskundigen 
op het gebied van voedselallergie, als collega's, patienten, vrienden en familie. Zander al 
die mensen was dit proefschrift er nooit gekomen. Daarom ben ik zo blij met dit hoofdstuk 
uit het proefschrift. lk maak dus dankbaar gebruik van de gelegenheid om mijn dank uit 
te brengen. 
Belangrijke mensen die aan de basis stonden van dit proefschrift zijn vooral: Prof. dr. 
A.E.J. Dubois, mijn eerste promotor, beste Ewoud, bedankt voor je snelle en grondige 
commentaren, voor je inspirerende en originele ideeen, voor je geduld en voor je 
onuitputtende bran van kennis over voedselallergie. lk heb veel van je geleerd zowel 
in wetenschappelijk als in maatschappelijk opzicht. Bedankt ook voor de educatieve 
momenten en de gezelligheid op congressen samen met je vrouw Joyce. Prof. dr. E.J. 
Duiverman, beste Eric, als tweede promotor was je wat meer op de achtergrond aanwezig, 
maar wel altijd en overal beschikbaar indien nodig. Bedankt voor alle uren die je voor mij 
hebt vrij gemaakt, voor je inbreng en je praktische en verfrissende kijk op verschillende 
zaken. Dr. B.M.J. Flokstra-de Blok, mijn copromotor, beste Bertine, oak jij ontzettend 
bedankt. Het bleek al meteen uit ons eerste contact dat je erg betrokken was bij je 
onderzoek en daarnaast heel gestructureerd en punctueel. lk had daarom meteen het 
gevoel dat mijn afstudeeronderzoek van destijds, mede door jou karaktereigenschappen 
en begeleiding, wel een goede kans van slagen zou hebben. Gelukkig bleek dit ook te 
kloppen en bleef het niet alleen bij een afstudeerscriptie. Je had de weg alvast geplaveid 
voor mij. lk kon altijd bij je terecht en daarnaast bleek je oak nog eens erg prettig 
gezelschap. lk denk nag regelmatig terug aan de Spaanse churros op de Plaza Mayor in 
Madrid . . . .  
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Daarnaast zou ik graag de leden van de leescommissie, Prof. dr. R. Gerth van Wijk en 
Prof. dr. T. van der Molen, willen bedanken voor het beoordelen en goedkeuren van mijn 
proefschrift. Prof. dr. J. O'B Hourihane, I would like to thank you for attending the scientific 
assessment committee to judge (and to approve) the scientific quality of my thesis. Beste 
leden van de corona, bedankt dat jullie aanwezig willen zijn op deze dag. 
Alie mede-auteurs, bedankt voor jullie afzonderlijke bijdrages aan de verschillende 
artikelen. Beste Hanneke Oude Elberink, Berber Vlieg-Boerstra en Hans de Groot, bedankt 
voor jul lie praktische bijdragen aan de uitgevoerde studie(s) en voor jullie commentaren 
op de artikel(en). Dear Jonathan O'B Hourihane, Audrey DunnGalvin, Rebecca Knibb and 
Ann Hamp, I would like to thank you for the collaborations and your critical comments 
on my papers. Beste Jan Schouten en Marjan Kerkhof, bedankt voor jullie onmisbare 
statische ondersteuning. 
Beste medewerkers van de functieafdelingen van de Allergologie en Kinderallergologie, 
bedankt voor jullie hulp bij het zoeken naar patienten voor het onderzoek. 
Beste Joke, bedankt voor je enthousiasme tijdens je wetenschappelijke stage, voor je 
bijdrage aan het verzamelen van de tienerdata en voor de gezelligheid op het congres 
in Venetie (Jij vraagt tenminste gewoon in al je onschuld aan een willekeurige man bij 
de boothalte welke boot terug gaat naar ons hotel! "Was dat Hugh Sampson!?'; hahaha!). 
Beste Jacquelien, ook jij bedankt voor je bijdrage aan de tienerdata en je (toekomstige) 
bijdrage aan de MID studie tijdens je Md PhD traject. 
Beste Laura, bedankt voor je hulp bij het vertalen van de FAQLQ-PF en -PFA. Beste Edwin 
de Raaij, bedankt voor je hulp met de handleiding van de Nederlandse IPQ. 
Beste Janyte, bedankt voor het ontwerpen van mijn kaft en het brainstormen daarover 
op jullie fantastische vlonder met egel Frits. Je bent tijdens het ontwerpen lekker je 
eigen gang gegaan terwijl je heel goed hebt begrepen wat ik graag zou willen en wat 
bij me past. Enne, . . . .  Deze kaft is toch echt wel de mooiste u it je hele collectie! lk ben me 
overigens bewust van het feit dat deze laatste opmerking een bias bevat. 
Beste Jannie Tjassing, Aad van Mourik, Janette Tienkamp, bedankt voor jullie praktische 
en organisatorische steun bij allerhande zaken rondom de verschillende studies. 
Dan kom ik vervolgens bij mijn kamergenootjes uit "de kelder''. Promoveren zou werkelijk 
maar half zo leuk zijn zonder de steun en gezelligheid van je medepromovendi/ 
kamergenootjes. Vooral een hoop gezelligheid, maar soms gewoon ook even lekker zeuren 
en zaniken over allerlei onderzoeksperikelen. Beste Deirdre, wat was het leuk om met jou 
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op de kamer te zitten en vervolgens daarna samen de huisartsopleiding in te stappen. 
Super! Bedankt voor je gezell igheid, warmte, lekkere theetjes en al les daar rondom. Beste 
Karin, ookjij bedankt voor de leuke tijd! Wij hebben samen de komkommertijd overleefd: 
Tsjonge, wat was het uitgestorven in de zomermaanden in "de kelder" en wij maar 
ploeteren. En natuurlijk supertoevall ig dat wij een week na elkaar promoveren. Dan kan ik 
nag een keer bij jou spieken hoe promoveren eigenlijk moet, voordat ik zelf aan de  beurt 
ben! Heel veel succes met je promotie en daarna met je welverdiende opleidingsplaats 
kindergeneeskunde! Met jou doorzettingsvermogen en strijdlust gaat dat zeker lukken. 
Beste Nicole, jij volgt later in het dankwoord. Beste Djoeke, Jacquelien en Jose, oak jull ie 
bedankt voor de korte, maar gezel l ige tijd op de kamer. Beste andere promovendi uit "de 
kelder'; ik heb met heel veel plezier met ju l l ie a l ien in "de kelder" gezeten! 
Beste Siebo Postma, bedankt voor je enthousiasme, flexibiliteit en de mogelijkheden die 
je bood om mijn onderzoek tijdens mijn eerste huisartsenstage in Vlagtwedde voort te 
zetten. Deze stage heeft mijn beroepskeuze voor huisarts evident bevestigd. 
Beste paranimfen, beste N icole en Marianne, superleuk dat jul l ie naast mij wil len 
staan op deze bijzondere dag! N icole, kamergenootje, onderzoeksmaatje, in hetzelfde 
schuitje, gezel l igheid, overleggen, zeuren en lachen, maar oak turbulentie, jetlag en 
kermisattracties . . . . Het laatste bedoel ik meer in de figuurlijke zin van het woord: We leken 
op het congres in New Orleans soms wel een kermisattractie, wanneer ze ans gekscherend 
nariepen: "The Dutch Twin Towers" of"Grandia Hollanda"! Beste Nicole, eeneiige helft van 
the Dutch Twin Towers (ik heb dit oak niet zelf bedacht), ik vond het heel leuk om met jou 
binnen hetzelfde onderzoeksproject te werken. Super dat je mijn paranimf wilt zijn .  Beste 
Marianne (K), vrijetijdsmaatje, lekker eten, gezell igheid, slappe lach, door dik en dun, lief 
en leed, Jut en Jul, lekker eten, koken, boer zoekt vrouw, Australie, vakantie, bellen, bel len, 
bellen, struisvogels, bla bla bla, lekker eten . . . . J ij hebt vooral je steentje bijgedragen 
aan het hoofdstuk "afleiding tijdens de promotie" en dat is zeker niet minder belangrijk. 
Wat zal ik verder zeggen. lk ken je al veel langer wel dan niet en dat bevalt heel goed. 
Bedankt voor wie je bent en dat je er a ltijd en nu oak bent. Op naar de volgende 1 7  jaar 
vriendschap! 
Oat is een mooie brug naar het gedeelte van mijn dankwoord dat ik graag wil besteden 
aan de mensen die in deze periode het dichtst bij mij stonden. Er is overigens geen 
evenredig verband tussen het aantal woorden dat ik aan mensen besteed en de 
hoeveelheid dank. Lieve, leuke en gekke vrienden van dansen, het GsP, geneeskunde, de 
middelbare school, de basisschool en andere plekken waar ik vrienden heb opgeduikeld, 
bedankt voor jullie gezelligheid en afleiding, leuke uitjes en alle belangstel l ing die jul l ie 
hebben getoond ondanks al le drukke agenda's en de afstanden die we hiervoor moesten 
overbruggen. Beste Roald en famil ie, bedankt voor jul l ie intensieve steun in deze periode. 
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Lieve familie van zowel moeders kant als vaders kant, bedankt voor jullie belangstelling 
en steun op vele fronten. Beste opa's en oma's, jam mer dat jullie er niet meer bij kunnen 
zijn. Beste pap en mam, bedankt voor jullie opvoeding, veilige haven en jullie rotsvaste 
vertrouwen in mij. Jullie zijn er altijd als het nodig is (en gelukkig ook als het niet per 
se nodig is). Eigenlijk verdienen jullie ook wel een eretitel vind ik. En nee, ik zal mijn 
allereerste diploma (veterstrikdiploma) ook nooit vergeten hoar, beloofd! Daar zijn we 
ook nog steeds heel trots op en blij mee. 
Als laatste heel veel dank aan de mensen die belangeloos hebben deelgenomen aan 
de studies, de mensen over wie dit proefschrift uiteindelijk allemaal gaat, de voedsel­
allergische patienten. Ook al dachten jullie waarschijnlijk regelmatig: "Alweer een 
vragenlijst?!'; toch bleef het responspercentage hoog. Zonder patienten is er geen 
onderzoek mogelijk naar patientgerapporteerde uitkomsten over kwaliteit van leven, zo 
simpel liggen de zaken wel. Daar hoef je geen wetenschappelijke studies en analyses op 
los te laten. 
Kortom, iedereen die een steen of kei heeft bijgedragen aan dit proefschrift: Bedankt! 
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CURRICULUM VITAE 
Tina van der Velde werd geboren op 18 augustus 1983 te Hardenberg in Nederland. Zij 
volgde het lager onderwijs op basisschool de Wiekslag in het Overijsselse Bruchterveld. 
In 2001 behaalde zij haar Gymnasium diploma aan het Vechtdal College in Hardenberg. 
Vervolgens ging zij Geneeskunde studeren aan de Rijksuniversiteit van Groningen. In het 
begin van haar studententijd had zij een bijbaan als assistent-activiteitenbegeleidster bij 
een sociale werkplaats van een instelling voor mensen met een verstandelijke beperking 
(de Baalderborg in Hardenberg). Vervolgens had zij een bijbaan als student-assistent bij 
de PREVt:ND studie (PREVention of renal ENdstage Diseases). Haar co-schappen volgde 
zij grotendeels in hetTwenteborg Ziekenhuis in Almelo. Zij ging voor een aanvullend co­
schap naar het Misikhu Mission Hospital in Kenia en haar keuzeco-schap volgde zij op de 
spoedeisende hulp in Assen. In 2007 studeerde zij af op "de test-hertest betrouwbaarheid 
van de voedselallergie en kwaliteit van !even vragenlijsten" en behaalde zij eveneens 
haar arts-examen. Na haar studie kon zij het onderzoek rond het thema "kwaliteit van 
leven van patienten met voedselallergie" als promovenda vervolgen, met dit proefschrift 
als resultaat. Ook werkte zij daarnaast als basisarts op de spoedeisende hulp in Assen 
en later als basisarts in een instelling voor mensen met een verstandelijke beperking in 
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